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ABSTRACT 
The Immunological and Neurochemical Toxicity of Benzene 
and Its Interaction with Toluene in Mice 
by 
X 
Gin-Chang Hsieh , Doctor of Philosophy 
Utah State University, !988 
Major Professor : Dr . R. D. R. Parker 
Department: Biology/ Toxicology Program 
Benzene and toluene are known groundwater contaminants . Male CD-I 
mice were continuously exposed to 0, 31 , !66 , and 790 mg/ L benzene and 
0, 17 , 80, and 405 mg/ L toluene, respectively, in drinking water for 
four weeks. Benzene caused a reduction of leukocytes, lymphocytes and 
erythrocytes, and resulted in a macrocytic anemia. Lymphocyte response 
to both B- and T-cell mitogens, mixed lymphocyte response to 
alloantigens, and the ability of cytotoxic lymphocytes to lyse tumor 
cells were enhanced at the lowest dose of benzene and depres sed in the 
higher dosage animals. Benzene at doses of 166 and 790 mg/L decreased 
the number of sheep red blood cell (SRBC) -s pecific plaque-forming cells, 
the level of serum anti-SRBC antibody, and the activity of interleukin-2 
( IL -2). 
Benzene treatment increased endogenous concentrations of the brain 
biogenic amines norepinephrine (NE), dopamine (DA) and serotonin (5-HT), 
and concomitantly, elevated the levels of their respective major 
metabolites vanillymandel ic acid (VMA), 3,4-dihydroxyphenyl acetic acid 
(DOPAC) and homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (S-
HIM), in several brain regions . In most cases, the changes were dose-
xi 
related; in several instances, maximum effects occurred at the 166 mg/ L 
benzene dose . 
Toluene did not adversely affect the hematological parameters. 
Depres sion of immune function was evident at the highest dose (405 
mg/L), except for mitogeneses. Increased neurochemical concentrations 
caused by toluene displayed a dose-dependent bi phasic manner which 
began at a dose of 17 mg/L, peaked at 80 mg/L, and decreased at 405 
mg/ L. Toluene treatment had more selective effects on NE , 5-HT , VMA and 
5-HIAA, than DA, DOPAC and HVA. 
Both compounds, by increasing concentrations of the hypothalamic NE 
and its major metabolite VMA, stimulated the hypothalamic -pituitary-
adrenocortical axis activity, resulting in an elevated plasma 
adrenocorticotropic hormone and serum corticosterone which had an 
additive adverse effect on IL-2 synthesis. 
Toluene, 325 mg/ L, completely inhibited benzene - induced cytopenia 
and immunosuppression when it was coadministered with benzene (166 
mg/ L) . The low dose of toluene (80 mg/L ) did not antagonize benzene 
immunotoxicity. Mice given the combined exposures exhibited raised 
levels of regional neurochemicals when compared to the untreated 
controls. Increased levels of monoamine metabolites in several brain 
regions were greater in the combined treatments of benzene and toluene 
than when either chemical was used alone. The results of the interaction 
studies support the known metabolic interaction mechanisms of benzene 
and toluene. 
(226 pages) 
CHAPTER I 
INTRODUCTION 
Benzene, the simplest aromatic hydrocarbon, is ubiquitous in 
occurrence . Its solubility and volatile nature indicate possible 
environmental mobility . This chemical has a long history of extensive 
use in industry. At present it is produced primarily by petrochemical 
industries and is used as a starting material for the manufacture of 
many chemica 1 s . Benzene is a 1 so emp 1 oyed as a essent i a 1 canst ituent in 
motor fuel (Fishbein, 1984; Brief et al., 1980). It has been identified 
in ambient water (U.S . Environmental Protection Agency, 1980a ; Cotruvo, 
1985) at concentrations up to 10 mg/ L (U.S . National Toxicology 
Program, 1981). 
Due to the high 1 ipophil ic nature of benzene which causes it to 
accumulate in lipid rich tissue, particularly the bone marrow and brain 
(Snyder et al., 1981a; Rickert et al., 1979), and because of the 
production of biologically reactive intermediates through metabolic 
biotransformations (Snyder et al., 1987; Irons, 1985 ; Sawahata et al., 
1985; Bolcsak and Nerland, 1983), benzene is considered to be a 
potential health hazard . Like most organic solvents, benzene is a 
central nervous system depressant at high concentrations (Brief et al ., 
1980). Accumulation of this chemical in the nervous system may lead to 
impairment of the neuronal function. It has been shown that the major 
toxic effect of benzene for human beings or laboratory animals is 
primarily disturbance of the hematopoietic system, an effect unique to 
benzene and which can affect every subsequent cell 1 ine resulting in a 
variety of blood dyscrasias (Fishbein, 1984). The mechanism of benzene-
induced hematopoietoxic effects has not been well elucidated , however, 
most researchers believe oxidative benzene metabolites rather than 
benzene itself, are required to mediate these hematopoietic effects 
(Sawahata et al., 1985; Irons, 1985; Bolcsak and Nerland, 1983 ; Greenlee 
et al., 1981b). A number of recent studies on benzene carcinogenesis 
and mutagenesis have been reviewed by Dean (1985) who also suggests that 
benzene could be regarded as a classical initiator or a promotor to 
explain its leukaemogenesis. 
Toluene is also considered a major aromatic chemical 
environmental and occupational significance (Fishbein, 1985). 
with 
It is 
produced in enormous quantities mainly from petroleum or petrochemical 
processes, and is employed as a solvent (for which it is increasingly 
used as a "safe" replacement for benzene) and as a starting compound 
for other chemicals and a component in gasoline (U . S. Environmental 
Protection Agency, 1980b) . The neurotoxic property of this chemical 
represents its main health hazard (Benignus, 1981a,b). It has been 
detected in concentrations up to 6.4 mg/L in finished water (Tardiff 
and Youngren, 1986). Furthermore, it should be noted that commercial 
toluene contains varying amounts of benzene and it is frequently 
employed in industry with benzene (U.S . National Academy of Sciences, 
1982). Toluene, in sufficient amounts, appears to have the potential to 
significantly alter the metabolism and resulting bioactivity of certain 
other chemica 1 s, thereby possessing a potentia 1 for alteration of the 
toxicity of numerous chemical agents (Hayden et al., 1977). For 
example, it has been documented that toluene is a competitive inhibitor 
of the biotransformation, and antagonizes myelotoxic and genotoxic 
effects of benzene (Ikeda et al., 1972; Andrews et al., 1977; Sato and 
3 
Nakajima, 1979; Tunek et al., 1981; Gad-El-Karim et al., 1984; 1986) . 
Although there is a large amount of information available detailing 
the effects of benzene on the hematopoietic system, studies concerning 
the immunotoxic evaluations of this chemical are scant . Also, little 
information is available regarding the effects of toluene exposure on 
immune systems. Meanwhile , despite several published studies about the 
positive effects of benzene and toluene on behavior changes, research 
conducted on the neurotox ic potential e.g., alterations in brain 
neurochemicals}, is still limited. Therefore the objective of this 
study was to investigate basic immunotoxic and neurotoxic mechanisms by 
utilizing various immunological and neuro-endocrinobiochemical 
parameters to better understand the mode of toxic actions of these two 
chemicals and their interactions in experimental animals . Because 
benzene and toluene are known contaminants of groundwater, which is a 
primary source of drinking water for approximately half the population 
of the United States (U.S. Office of Technology Assessment, 1984}, 
oral administration via drinking water in animals wa s employed. 
Consequently, the information gathered may contribute to support of the 
development of groundwater quality standards and protection efforts. 
CHAPTER II 
LITERATURE REVIEW 
IMMUNE SYSTEM AS A TARGET ORGAN FOR TOXICITY 
4 
The immune system is comprised of complex but well-defined 
network of specialized cells that interact to mount a response following 
recognition of foreign materials termed antigens. The potential 
responses of the system range from the production of antibody or cell-
mediated reactions to the induction and modulation of allergic and 
inflammatory responses (Sick et al., 19S5). The response to antigens 
and the mechanisms of many cellular interactions is under genetic 
control. The use of the immune system as a target organ for detecting 
toxicity of drugs, chemicals or environmental toxicants recently has 
received considerable attention (Sick , 19S2; Dean et al. , 19S5a). It ha s 
many sensitive parameters whose alterations, as a result of experimental 
procedures, are easily determined (Dean et al., 1982; 1986 ; Thomas et 
al. , 1985) . 
Introduction of a chemical into a host may elicit a variety of 
reactions. Many chemicals, or their metabolites, may be recognized as 
antigens. This response may be directed at the native molecule or 
metabolite or may result from the chemical group binding to host protein 
creating new antigenic determinants . Foreign chemicals may enhance or 
suppress immune competence. Enhancement of immune potential may lead to 
increased host resistance, or to autoimmunity. Decreased immune 
function may lead to the lack of an appropriate response. It is 
possible for these interactions to occur at the same time in various 
combinations. Lastly, a chemical may have no effect on the immune 
5 
system at doses that produce toxicity in other organ systems. 
In order to be able detect slight modifications in immune 
responsiveness, sensitive assay systems (Dean et al., 1986; Thomas et 
al., !985a; Sharma and Zeeman, 1980) must be employed and require 
better standardization so little variation in data occurs . Table Il - l 
summarizes a compre hensive panel of in vivo and in vitro assays used to 
measure host resistance and immunity, and the end points measured. A 
number of industrial and environmental chemicals have been shown to 
affect the immune response in human beings and animals (Dean et al . , 
1985a; Sharma, 1981; Faith et al ., 1980). Risk assessment scientists 
have begun to recognize that immunological information gained from 
cel lular and molecular approaches for the safety assessment of a drug or 
chemical should facilitate improved human risk assessment . 
NEUROBIOCHEMICAL APPROACHES TO TOXICOLOGY 
As technology has become more refined in recent years, useful 
biochemical methods are available to understand the mechanisms involved 
in normal and altered nervous system function (Narahashi, 1984; Bondy, 
1986) . It is through the determination of such mechanisms that 
neurochemistry can best contribute to the overall assessment of 
neurotoxicity . Neurotoxic agents can affect the nervous system in a 
number of diverse ways (Bondy, 1985; Norton, 1986; Cooper et al ., 1986; 
Mitchell, 1982). Some agents act directly on the nervous system, 
whereas others disturb non-neuronal processes which affect the nervous 
sys tem indirectly. In most instances, biochemical systems are affected 
through genera 1 or specific mechanisms. A neurotoxin can disturb the 
blood-brain barrier; interfere with energy metabolism or the 
6 
TABLE II -1 
IMMUNE FUNCTION ASSAYS FOLLOWING CHEMICAL OR DRUG EXPOSURE* 
parameter 
Immunopathology 
Hematology 
Weights 
Histology 
Cellularity 
Mitogenesis 
LPS 
PHA, Con A 
PWM 
Mixed lymphocyte 
response 
lymphokines 
Cytotoxic cells 
en 
K 
NK 
Endpoint measured 
Complete blood count, WBC 
differentia 1 s 
Body, spleen, thymus, kidney, 
ad rena 1 
Spleen, thymus, bone marrow, 
lymphonode, adrenal 
Spleen, bone marrow, B-cell 
progenitor, pluripotent stem 
cell, granulocyte/macrophage 
progenitor, cell surface marker 
profile (% T, B, macrophage; 
T -cell subsets) 
Incorporation of radiolabled 
nucleic acid precursors into 
DNA of dividing lymphocytes 
Incorporation of radiolabled 
nucleic acid precursors into 
DNA of dividing responder cells 
Quantitated by incorporation 
of radiolabled nucleic acid 
precursors into DNA of dividing 
lymphokine-dependent cells 
% cytotoxicity of 5lcr-labeled 
tu~[, target cells (determined 
by Cr-release assay) 
Inunune correlate 
Overall immune 
system 
B-cells 
T-cells 
B- and T-cells 
CMI 
CMI 
CMI 
Natural or innate 
111111unity 
" 
TABLE 11-1 (CONT.) 
IMMUNE FUNCTION ASSAYS FOLLOWING CHEMICAL OR DRUG EXPOSURE 
Parameter 
Antibody response 
T-dependent 
antigen ( SRBC) 
T-independent 
antigen (LPS) 
Delayed hypersen-
sitivity response 
Host resistance 
BIGFJO 
melanoma 
Endpoint measured 
Specific serum antibody level 
or quant it at ion of anti body 
plaque forming cells (PFC)/106 
spleen cells 4 days after 
antigen immunization 
Radiometric assay with T cell-
dependent antigen 
Measurement of lung tumor cell 
growth 21 days post-challenge 
b.y25quant it at ion of uptake of [ I] i ododeoxyuri dine 
Immune correlate 
AMI, macrophage 
CMI 
CM I , macrophage 
NK 
PYB6 sacroma lethal tumor frequency 100 CHI, macrophage 
Listeria 
monocytogenes 
Streptococcus 
zooepidemicus 
Influenza 
A2/Taiwanj64 
Host resistance 
Herpes 
simplex virus/ 
type I and 2 
exposure days post-challenge NK 
Cumulative% mortality 14 days CMI, macrophage 
post-challenge, mean survival 
time 
Cumulative% mortality 14 days 
post-challenge, mean survival 
time 
Cumulative %mortality 14 days 
post-challenge, mean survival 
time 
Cumulative %mortality 21 days 
post-change, mean survival time 
AMI, macrophage 
polymorphonuclear 
1 eukocyte, non-
specific immunity 
CMI, AMI, 
interferon, 
macrophage, non-
specific immunity 
CMI, AMI, 
macrophage, 
interferon, NK 
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TABLE II -1 (CONT.) 
IMMUNE FUNCTION ASSAYS FOLLOWING CHEMICAL OR DRUG EXPOSURE 
Parameter Endpoint measured Immune correlate 
Macrophage** 
function 
CMI, AMI, 
non -specific 
immunity 
Peritonea 1 
macrophage 
Phagocytosis 
ability 
Cytolysis of 
tumor cell 
Cytostasis 
Bactericidal 
activity 
Ectoenzyme 
levels 
Cellularity quantitation 
%phagocytosis of Slcr-labeled 
chicken or sheep erythrocytes 
Slcr-release assay 
Inhibition of MBL-2 murine 
leukemia cell growth (measured 
by uptake of radiolebeled ONA 
precursors) 
~tio of the viable bacterial ( S-labeled Klebsiella 
pneumoniae) counts 
Quant it at ion 
Granulocyte 
function test 
Nitroblue terazolium (NBT) dye Non-specific 
immunity 
* Abbreviations used in this table: AMI, antibody-mediated immunity; CMI, 
cell-mediated immunity; Con A, concanavalin A; CTL, cytotoxic T-
lymphocyte; K, killer cell; LPS, lipopolysaccharide; NK, natural killer 
cell; PHA, phytohemagglutinin; PWM, pokeweed mitogen ; SRBC, sheep red 
blood cell; WBC , white blood cell 
**soth resident and activated peritoneal macrophages 
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biosynthetic pathways of neuronal macromolecules; alter axoplasmic flow 
or cellular permeability; affect neurotransmitter synthesis, storage, 
release, and uptake; or interfere with neurosecretory processes (Bondy, 
19B5; Mail man and Dehaven, 19B4) . Such changes can occur in l oca 1 i zed 
brain regions, in specific cell types, or in subcellular organelles. 
Most of the studies have focused mainly on the levels of monoaminergi c 
neurotransmitters, namely, catecholamines (dopamine and norepinephrine) 
and indoleamine (5-hydroxytryptamine) . Functional significance of 
monoamine alterations has now been well documented (Rogawski and Baker, 
19B5). A number of neurological and psychiatric syndromes are caused by 
an excess or deficiency of these specific neurotransmitters (Willis and 
Smith, 1985; Poirier and Bedard, 19B4). However, assays of steady state 
levels of neurotransmitters are difficult to interpret particularly when 
they are measured in whole brain homogenates or in large brain regions. 
Therefore monoamine metabolite levels would be a reflection of 
monoaminergic neuronal activity and yield more useful information 
(Commissiong, 1985; Bondy, 1986) . A number of environmental chemicals, 
either of natural origin or products of industrial processes, have been 
shown to cause a variety of effects on neurochemical transmitters 
(D ' Donoghue, 19B5; Sharma et al ., 19B6; Coulombe and Sharma, 1985; 
19B6). 
The hypothalamus is an area where around 40,000 nerve fibers 
mediate between central nervous system and the rest of the body, by way 
of release factors, trophic hormones, and endocrine hormones. In view of 
the incompleteness of the blood-brain barrier, it is more exposed to 
systemically circulating materials such as neurotoxins (Bondy, 1985). 
Thus, the function a 1 changes in this rather small area can have major 
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reverberations. Classically, stress responses (as determined by 
increased circulating corticosteroid hormone levels) were thought to be 
mediated and regulated entirely by the hypothalamic-pituitary-
adrenocortical (HPA) axis through the following cascade (Axelrod and 
Rei sine, 1984; Besedovsky et al., 1985). The central or peripheral 
nervous system recognizes "stressors" (e.g. infections, chemical 
intoxications, trauma, pain, psychologic stress) and leads to increase 
of hypothalamic noradrenergic neural activity, which in turn increases 
the secretion of corticotropin - releasing factor (CRF) into the 
hypophyseal portal circulation. As a consequence of the actions of CRF 
at the corticotrope in the anterior pituitary, adrenocorticotropic 
hormone (ACTH) is released into the systemic circulation. ACTH acts on 
the adrenal cortex to stimulate the synthesis and secretion of 
corticosteroids. Corticosteroids, the end products of HPA axis, are 
well known to impair various aspects of immunocompetence (Besedovsky et 
al. , 1985; Cupps et al., 1985) and · have been shown to inhibit 
interleukin-2 (IL-2) as well as interleukin-1 (IL-l) production (Gill is 
et al., 1979a,b; Snyder and Unanue, 1982; Goodwin et al., 1986). 
ENV IRONMENTAL ASPECTS OF BENZENE 
Chemical and Physical Properties 
Benzene (C6H6), an aromatic hydrocarbon with a molecular weight of 
78.1, is a volatile, colorless, clear, highly flammable liquid 
hydrocarbon. Pure benzene has a boiling point of 80 .!°C and a melting 
point of 5.5°C. Benzene has a density less than that of water (0.879 at 
20°C) and is soluble in water at concentrations which have been shown to 
be toxic to aquatic organisms. Benzene is also readily soluble in 
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natural fats and fat-soluble substances. It may accumulate in 1 iving 
organisms and appears to accumulate in ani rna 1 tissues that exhibit a 
high lipid content or that represent major metabolic sites such as liver 
and brain. The fairly volatile nature (high vapor pressure of 74 .6 mm 
Hg at 20°C) and a relatively high solubility (1,780 mg/L at 25°C) 
indicate that benzene could be washed out of the atmosphere with 
rainfall and then be evaporated back into the atmosphere, causing a 
continuous recycling between the two media. It is miscible with 
acetone, alcohol, carbon disulfide, carbon tetrachloride, chloroform, 
ether, gl ac i a 1 acetic acid and oi 1 s. Benzene undergoes the typi ca 1 
reactions of aromatic hydrocarbons including: chlorination, nitration, 
oxidation, and sulfonation (U .S. Environmental Protection Agency, 1980a; 
Maltoni, 1983; Fishbein, 1984). Benzene is also expected to be 
photooxidized in air and otherwise biodegraded in the environment (Korte 
and Klein, 1982) . 
Occurrence and Usage 
Benzene has been produced industrially from coal tar distillation 
since 1849, and from petroleum by catalytic reforming of light naphthas 
from which it is isolated by distillation or solvent extraction since 
1941. At present the major source of benzene is petroleum. It is one 
of the 1 argest produced compounds and has been detected at various 
concentrations in the atmosphere and ambient water. Benzene is reported 
to occur in fruits, fish , vegetables, nuts, dairy products, beverages, 
eggs, cooked chicken and heat-treated or canned beef. Benzene has also 
been identified in cigarette smoke at levels of 150-204 mg/m3. Its 
major use in the past was in blends with gasoline. Although this use has 
been reduced in the United States, benzene is still largely employed in 
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many countries for the production of commercial gasoline . The benzene 
content i n gaso 1 i ne varies from country to country and its range is 
es timated to be from I to 15% . Presently , benzene is largely employed 
as a chemical intermediate for the production of many important 
industrial compounds, such as ethyl benzene, styrene, phenol, 
cyclohexane, maleic anhydride, aniline, dichlorobenzenes, etc . In the 
past, benzene was used as a solvent for paints and rubber . It has also 
been used in medicine, in the treatment of hemoblastosis (leukemia s, 
po 1 ycythemi a and ma 1 ignant lymphomas) , and in the veterinary fie 1 d for 
disinfestat i ng wounds (Brief et al ., 19BO; U.S. Environmental Protection 
Agency, 1980a; Fishbein , 1984) . 
Populations at Risk and Allowed Levels 
The following population groups may be exposed to benzene: workers 
engaged in i ts production; workers in chemical industries using benzene 
as an intermediate ; workers in industries producing material containing 
benzene ; workers utilizing or handling compounds containing benzene ; 
people liv i ng in industrialized town s near factories producing or 
employing benzene, or compounds containing it; the general overall 
population since benzene is contained in gasoline and can also be found 
as a contaminant in drinking water. The 1 eve 1 s of benzene a 11 owed in 
workplaces vary from country to country . Until I 978, in the United 
States the Occupational Safety and Health Administration (OSHA) standard 
for benzene prescribed an 8-hour time-weighted average (TWA) of 10 ppm 
with an acceptable ceiling concentration of 25 ppm in air. In addition, 
this standard allowed excursions above the ceiling to a maximum peak 
concentration not exceeding 50 ppm, provided that such exposure occurred 
for no more than 10 minutes in any 8-hour work period . In 1978, OSHA 
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stated that : "1 ppm TWA, with 5 ppm ceiling limit for 15 minutes during 
the 8-hour day , is the level which most adequately assures, to the 
extent feasible, the protection of workers exposed to benzene." However , 
that rule was annulled by the U.S. Supreme Court (Maltoni, 1983; Brief 
et al., 1980; Holmberg and Lundberg, 1985; Fishbein, 1984). 
For the maximum protection of human health from the potential 
carcinogenic effects of exposure to benzene through ingestion of 
contaminated water and contaminated aquatic organisms, the ambient water 
concentrations should be zero, based on the non-threshold assumption for 
this chemical. However, zero level may not be attainable at the present 
time . Therefore , if the incrementa 1 increase of cancer risk over a 
lifetime is estimated at 10 -5, 10 -6, and 10 -7 (one additional case of 
cancer in populations of 100,000, 1,000,000, and 10,000,000}, the 
corresponding recommended criteria are 6. 6 ).Jg/ L, 0. 66 ).Jg/ L, and 0. 066 
).Jg/ L, respectively . If these estimates are made for consumption of 
aquatic organi sms only , excluding consumption of water , the levels are 
400 .ug/ L, 40 . 0 .ug/ L, and 4.0 .ug/ L, respectively (U . S. Environmental 
Protection Agency, 1986a). 
Route s of Exposure 
The respiratory route is believed to be the major source of human 
exposure to benzene. Benzene diffuses rapidly through the lungs and is 
quickly absorbed into the blood , with the rate of absorption being 
greatest at the beginning of exposure. Inhalation of benzene vapors may 
be supp 1 emented by percutaneous absorption, although benzene is poorly 
absorbed through i ntack skin. In the genera 1 population , much of the 
benzene exposure is from gasoline vapors and automotive emissions 
(Fishbein, 1984) . The dermal route is only a minor source of human 
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exposure since skin contact is infrequent (Franz, 1983) . Exposure to 
benzene through oral ingestion is also cons ide red to be a problem for 
the general population (Lee et al., 1983 ; U.S. Environmental Protection 
Agency, 1980a) . It has been reported that chromosomal damage is higher 
with ora 11 y administered benzene than ot her exposure routes in mice 
(Gad-El-Karim et al., 1986). 
BENZENE METABOLISM 
Metabolism and Toxicity of Benzene 
Benzene metabolism is required for its toxicity (Snyder et al., 
1983). Exposure to benzene has long been associated with toxicity to 
blood and bone marrow, including lymphocytopenia, pancytopenia, 
thrombocytopenia, and aplastic anemia (Brief et al., 1980; Goldstein, 
1983). Benzene is also a carcinogen and mutagen (Aksoy, 1985; Oean, 
1985 ; Ereson et al., 19B5) . It is associated with an increased 
incidence of acute myelogenous leukemia and some of its variants in 
humans (Infante and White, 1985; Rinsky et al., 1987), an increased 
incidence of several solid tumors (Maltoni et al . , 1985; Oean, 1985), 
and possibly leukemia/lymphoma in rodents (Snyder et al . , 1980; 
Cronkite et al . , 1984). Several studies are also in agreement that 
benzene possesses embryotoxic/teratogenic pote ntial in experimental 
animals (Green et al., 1978; Kuna and Kapp, 1981; Ungvary and Tatrai, 
1985). 
The metabolic fate of benzene has interested biochemists and 
toxicologist throug hout this century. A variety of studies have 
established that benzene itself is not the toxic species but requires 
metabolism to reactive intermediates (Snyder, 1g84; Irons, 1985), 
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through complex bioactivation mechanisms (Pellack-Walker et al. , 1985) . 
In vivo metabolic studies following benzene exposure have identified 
phenol as the primary metabolite of benzene with hydroquinone, catechol , 
trans,trans -muconic acid and 1,2,4-trihydroxybenzene as significant 
secondary metabolites (Snyder et al, 1981; Gad-El-Karim et al., 1985b). 
The semiquinone radicals and/or p-benzoquinone derived from hydroquinone 
and/ or catechol are generally considered to be the toxic metabolites 
(Tunek et al., 1980). Recently, it has been shown that trans,trans-
mucondialdehyde, an open-ring product of catechol, is a possible toxic 
reactive intermediate (Witz et al., 1985; Latriano et al., 1986). 
Ethanol potentiates benzene toxicity in vivo by accelerating the 
hydroxylation of benzene and the conversion of phenol into toxic 
metabolites, thus, increasing benzene hematotoxicity (Nakajima et al., 
1985). The major sites of benzene met abo 1 ism are 1 i ver and bone 
marrow. Benzene is converted by the 1 iver to (a) metabol ite(s) whi ch 
travel(s) to the bone marrow and exert s its toxic effects. 
Metabolism of Benzene in Liver 
In the 1 i ver , the major s ite of benzene met abo 1 ism, benzene is 
converted via a cytochrome P-450-mediated pathway (Gonasun et al ., 1973) 
to benzene oxide . The majority of benzene oxide formed spontaneously 
rearranges to yield phenol (Tunek et al., 1978), with a small portion of 
the oxide undergoing hydrolysis (catalyzed by epoxide hydrolase) to 
benzene-1,2-trans-dihydrodiol. The dihydrodiol can be further converted 
to catecho 1 by cytoso 1 i c dehydrogenase (Jeri na et a 1 . , 196B) . This is 
believed to be the major metabolic pathway from benzene to catechol 
(Tomaszewski et al., 1975) . Phenol can be further hydroxylated by the 
cytochrome P-450-dependent monoxygenase system to hydroquinone and 
catechol, the former being the major product 
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(Tunek et al., 1980 ; 
Sawahata and Neal, 1983) . Different isozymes of cytochrome P-450 may be 
involved in the formations of hydroqui none and catechol ( Sawahata and 
Neal , 1983) . 
Metabolism of Benzene in Bone Marrow 
The bone marrow is the target organ of benzene. However, since the 
concentration of cytochrome P-450 measured in bone marrow is low 
compared with that measured in liver or lung (Andrews et a l., 1979; 
Sawahata et al., 1985), it possesses a limited capacity to metabolize 
benzene (Andrews et al., 1977 ; 1979; Rickert et al ., 1979) . This 
suggests that the metabolism of benzene by bone marrow cannot account 
for the concentration of metabolites reported in this ti ss ue in vivo . 
Andrews et a l . ( 1979) also found the metabolism of benzene by bone 
marrow microsomes required NADPH and was inhibited by carbon monoxide . 
Phenol, hydroquinone, and catechol are more toxic to bone marrow 
cultures than benzene . After benzene exposure, phenol concentrations 
within the bone marrow rise and decrease relatively quickly, whereas 
hydroquinone and catechol concentrations, although moderately low 
initially, rise with time and persist in relatively high concentrations 
(Rickert et al ., 1979; Greenlee et al ., 1981a,b). The retention of 
phenol, hydroquinone and catechol in bone marrow could result from the 
formation of these compounds in the liver and their subsequent uptake by 
bone marrow cells. The importance of hepatic metabolism of benzene in 
production of benzene metabolites found in the bone marrow is supported 
by the experiments performed by Sammett et al . (1979). They found that 
partial hepatectomy resulted not only in a reduction in amounts of 
benzene metabolites excreted in urine, but also in a decrease in 
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concentrations of benzene metabolites detected in bone marrow. 
Microsomal Metabolism Q_f Benzene 
Benzene induces the enzymes required for its metaboli sm. Benzene 
is converted to phenol by rat liver microsome (Gilmour et al . , 1986; 
Sawahata and Neal, 1983). Small amounts of hydroquinone and catechol are 
produced from both benzene and phenol in a reaction mediated by 
cytochrome P-450 and stimulated by benzene pretreatment. Two di sti net 
forms of mixed-function oxidase activity in rat liver microsomes appear 
to metabolize benzene (Post and Snyder , 1983) . Benzene pretreatment 
i ncreases enzyme activity without affecting total cytochrome P-450 
content (Post and Snyder , 1983 ; Pathiratne et al . , 1986a) . The 
addition of methyl groups to the aromatic ring influences the inductive 
pattern of benzene hydroxylase (Pathiratine et al . , 1986b). Gilmour et 
al. (1986) also found that metabolism of benzene and phenol was 
competitively inhibited by toluene , and benzene and phenol reciprocally 
i nhibited the metaboli sm of each other . The rate of convers ion of 
phenol to hydroquinone by mouse liver microsomes is signifi cantly higher 
than the rate of metabolism of benzene (Lunte and Kissinger , 1983) . 
The mechanism of the microsomal cytochrome P- 450-dependent 
oxidation of benzene has been studied with rabbit liver microsomes and 
reconstituted membrane vesicles containing cytochrome P-450 LM2 by 
Johansson and lnge lman-Sunberg ( 1983) , who concluded that the reaction 
is media ted by free hydroxyl radi ca 1 s generated from hydrogen peroxide 
and superoxide anion in a modified Haber -Weiss reaction . However, the 
hydroxyl radicals do not contribute significantly to the metabolism of 
benzene to phenol when the concentration of benzene is close to the Km 
value for P-450 LM2. At a benzene concentration below the Km values, 
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the free radical-mediated pathway of phenol formation becomes 
increasingly predominant {Gorsky and Coon, 1985). Involvement of free 
radicals in benzene metabolism is also suggested by Khan et al. {1984) 
and Latriano et al. {1985). The microsomal cytochrome P-450 conversion 
of benzene to phenol via an arene oxide intermediate is demonstrably 
followed by an NIH shift {Hinson et al., 1984; 1985). Hinson et al. 
{1985) studied the role of the NIH shift in the formation of phenol 
from the deuterated benzene derivative, 1,3,5-[2H3] benzene, and found 
the expected products, 2, 3, 5- [2H3] phenol and 2, 4- [2Hz] phenol, which 
indicated that the shift had occurred. 
Peroxidase-Dependent Metabolism 
of Benzene Metabolites 
The isolation of phenol, hydroquinone, and catechol in the bone 
marrow following benzene exposure suggests the possibility that the 
critical metabolic events may involve an interaction of these phenolic 
compounds during localized metabolism within the bone marrow {Sawahata 
et al., 1985 ; Eastmond et al., 1987b). Since bone marrow contains 
relatively low concentrations of cytochrome P-450-dependent-
monooxygenases, the metabolism of hydroxylated benzene metabolites, i.e. 
phenol, hydroquinone and catechol, in bone marrow by enzyme systems 
other than the cytochrome P-450-mediated system has been reported. Bone 
marrow contains appreciable levels of myeloperoxidase for which phenol 
is a known substrate and hydroquinone and catechol are probable 
substrates {Eastmond et al., 1986) . Myeloperoxidases are capable of 
converting phenol to reactive protein-binding species {Eastmond et al ., 
1986; 1987a,b) . A secondary peroxidase-dependent metabolism of phenol, 
hydroquinone, and catechol may be occurring within the bone marrow . This 
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mechanism may be responsible for benzene - induced myelotoxi city . It ha s 
been suggested that phenol metabolized to hydroquinone and catechol , and 
hydroquinone oxidized to p-benzoquinone is mediated by the 
myeloperoxidase -dependent pathway (Pellack-Walker et al . , 1985) . 
Covalent Binding of Reactive 
Benzene Metabolites 
Several studies have indicated that benzene and certain benzene 
met abo 1 i tes are converted in nuc 1 ei and mitochondria to bi o 1 ogi ca lly 
reactive intermediates that covalently bind to macromolecules and cause 
DNA damage in the form of strand breaks and covalently bound adducts in 
liver and bone barrow in vivo or in vitro (Lutz and Schlatter, 1977 ; 
Irons et al., 1980 ; Gill and Ahmed, 1981 ; Rushmore et al., 1984; 
Artellinoi et al., 1985; Kalf et al., 1985 ; Wallin et al. , 1985 ; Snyder 
et al . , 1987) . The level of DNA binding is highest in bone marrow . 
Either benzene-induced aplastic anemia or leukemia might be related to 
an interact i on of the bi o 1 ogi ca lly reactive intermediates derived from 
benzene with nuclei acids. It has been shown that covalent binding wa s 
greatly enhanced by H2o2 and horseradi sh peroxidase or myeloperoxidase, 
and prevented by ascorbate (Smart and Zannoni , 1984; 1985) . Peroxidase 
appears to be res pons i b 1 e for the oxidation of pheno 1, as ascorbate 
blocks the oxidation of phenol, and H2o2 is required for the activation 
of phenol to covalently binding species. The myelotoxicity of benzene 
may result from the high ratio of peroxidase activity to quinone 
reductases, the enzymes which reduce quinone to hydroquinone or catechol 
via a two-electron transfer, activity in bone marrow (Smart and 
Zannoni , 1984) . Lack of benzene toxicity in the liver , as compared to 
the bone marrow, may thus result from the high quinone reductase 
activity in the liver (Wermuth et a l. , 1986) . 
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DNA synthesis i s 
inhibited in mouse lymphoma cells after exposure to the benzen e 
metabolites, bd not to benzene (Pellack-Walker et al., 1985; Pellack-
Walker and Blumer, 1986). Benzoquinone is the most potent inhibitor, 
followed by hydroquinone , 1,2,4-benzenetriol, catechol, and phenol . 
These findings suggest that inhibition of DNA synthesis correlates with 
the ease of oxidation to reactive metabol i te(s}. Decreased synthes i s of 
DNA or RNA in vitro by benzene metabolites is also observed in rat 
liver and rabbit bone marrow mitochondria (Schwartz et al., 1985; Kalf 
et al . , 1982}, mouse lymphocytes and macrophages (Po st et al ., 1985; 
1986}, and rabbit bone marrow nuclei (Po st et al. , 1984) . Rat bone 
marrow mitoplasts, prepared by stripping the outer membrane of 
mitochondria to avoid microsomal contamination , in vitro incubated with 
benzene metabolites show concentration-dependent inhibition of 
mitochondrial RNA synthesi s (Kalf et al. , 1985). 
HEMATOTOXICITY AND BENZENE 
Benzene- Induced Hematotoxicity 
Benzene is a proven hematoxi n and is well known to exert its 
greatest toxicity on hematopoietic cells both in the peripheral blood 
and in the hematopoietic organs (Fishbein, 1984; Bolcsak and Nerland, 
1983). Repeated benzene exposure in humans and laboratory animals 
results in the induction of pancytopenia, a condition characterized by 
markedly decreased numbers of ci rcul at i ng erythrocytes , 1 eukocytes and 
thrombocytes . The resultant aplastic anemia, i.e., pancytopenia 
associated with fatty replacement of functional bone marrow, is a 
potentially fatal disorder which in its severe form has greater than a 
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fifty percent mortality rate (Green et al., 198la,b; U.S . Environmental 
Protection Agency, 1980a; Brief et al., 1980). In certain individuals, 
continued exposure to berzene leads to both pancytopenia and bone marrow 
hyperplasia, a condition that may indicate a preleukemic state (Snyder 
et al., 1977) . It was suggested that chronic benzene poisoning is most 
easily detected by using erythrocyte reduction and increased mean 
corpuscular volumes (MCV) but other hematologic parameters increase the 
diagnostic accuracy (Haley, 1977). In mice Baarson et al. (1984) 
reported that low-level repeated exposure to benzene (10 ppm) via 
inhalation could markedly depress the number of erythrocytes. 
A number of observations have demonstrated that lymphocytes are 
particularly sensitive to benzene toxicity in animals (Aoyama, 1986; 
Rozen and Snyder, 1985 ; Dempster et al . , 1984; Baarson et al., 1984; 
Snyder et al., 1982; Green et al., 1981a), or in humans who are 
inadvertently exposed to this chemical in the workplace (Moszczynsky and 
Lisiewicz, 1984; Brief et al ., 1980). Mice exposed to benzene via 
inhalation showed significant depressions in the numbers of a-
lymphocytes (s-IgM+ cells) in blood, bone marrow and spleen, and in the 
numbers of T-lymphocytes (Thy1,2+ cells) in blood, thymus and spleen 
(Aoyama , 1986; Rozen and Snyder, 1985). In addition, benzene has been 
shown to increase the permeability of lymphocyte lysosomal membranes and 
to release lysosomal enzyme into the cytoplasm, resulting in decrease of 
lymphocytes (Moszczynski and Lisiewicz, 1984). 
The mechanism for benzene-induced hematopoietoxic effects has been 
studied for many years. Studies have shown that oxidative benzene 
metabolites, rather than benzene itself, are required to mediate these 
hematopoietic effects of benzene (Sawahata et al ., 1985; Irons, 1985; 
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Bolcsak and Nerland, 1983; Snyder et al., 1981c; Greenlee et al., 
1981 a, b). The increases in 1 eukocyte a 1 ka 1 i ne phosphatase activity were 
reported both in humans occupation~lly exposed to benzene (Moszczynski, 
1980; Yin et al., 1982) and in experimental animals (Li et al., 1986; 
Yin et al ., 1982). The validity of the increase in activity of alkaline 
phosphatase in leukocytes as an early indicator of benzene-induced 
leukopenia has been demonstrated (Li et al., 1986). Hematopoietic 
toxicity of benzene would arise from the toxic damage to one or more of 
the components of the hematopoietic system: stem cells, trans it ce 11 s 
(progenitor cells in various degrees of differentiation), and the bone 
marrow stromal microenvironment (Kalf et al., 1987). 
Effect of Benzene on Stem Cell 
Several studies have shown that benzene causes reductions in the 
numbers of pluripotent stem cells (CFU-S) in mice following exposure to 
benzene (Uyeki et al., 1977; Green et al., 1981b; Snyder et al . , 198lb; 
Tunek et al., 1981; 1982) , whereas other workers have reported no change 
(Frash et al., 1976). This discrepancy has been explained, in part, by 
a toxic effect of benzene on the transit cells, which signals stem-cell 
proliferation and different iation, and thus depletes the stem-cell pool 
(Snyder et al ., 1977; Gill et al., 1980; Cronkite et al., 1982) . 
Effect of Benzene on Progenitor Cell 
Benzene affects committed progenitor cells by a decrease in the 
numbers of differentiating erythroid and myeloid progenitors i n benzene-
exposed rats, without an effect on the number of progenitor cells or 
mature cells in the bone marrow (Irons et al. , 1979) . Studies on the 
effects of benzene on the kinetics of 59 Fe uptake into maturing mouse 
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erythrocytes indicated that the pronormoblast was the progenitor most 
sensitive to benzene, whereas stem cells and nondi vi ding ret i cu l ocytes 
were not affected (Lee et al., 1974). The m~tabolites phenol, catechol, 
and hydroquinone have also been reported to reduce 59Fe incorporation 
into developing erythrocytes . The erythropoietic toxicity of benzene and 
phenol is completely alleviated by the mixed-function oxidase inhibitor, 
but not of hydroquinone or catechol (Bolcsak and Nerland, 1983). 
Trans,trans-mucondialdehyde, a six-carbon alpha, beta-diene aldehyde and 
an open-ring metabolite of benzene, is a potent bone marrow toxin in CD-
I mice in a manner similar to benzene (Witz et al., 1985; Latriano et 
al., 1986). Other studies have shown that the number of erythroid (CFU-
E) and granulocyte/macrophage (CFU-GM) progenitor cells was depressed in 
benzene-exposed mice (Tunek et al., 1981; Baarson et al., 1984; Keller 
and Snyder, 1986). A reduction of lymphocyte progenitor cells was also 
observed in the spleen and bone marrow of hydroquinone or catechol-
treated animals (Wierda and Irons, 1982; King et al . , 1986) . 
Effect of Benzene on Marrow Stromal Cells 
Bone marrow stromal cells act as an essential component for 
hemopoiesis by forming a supporting matrix for developing precursor 
cells and releasing soluble factors involved in the regulation of 
hemopoiesis (Lichtman, 1981; Tavassoli and Friedenstein, 1983; Allen and 
Dexter, 1984). Stromal cells produce colony-stimulating factors (CSF), 
growth factors, which induce myelopoietic cell proliferation, and 
maturation. Ext race ll ul ar matrix components produced by bone marrow 
stromal cells may also regulate myelopoiesis. Several studies have 
indicated that administration of benzene, phenol, or hydroquinone to 
animals altered cellular characteristics of the bone marrow stromal 
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cells and inhibited the ab ility of stromal cells to support hemopoiesis 
in culture (Harigaya et al., 1981; Garnett et al. , 1983; Gaido and 
Wierda , 1985; 1987). Gaido and Wierda (1984) showed that phenol, 
hydroquinone, and p-benzoquinone were most effective in decreasing the 
ability of stromal cells to s upport the colony formation 
granulocyte/ macrophage progenitor cells (CFU -GM) in a coculture sys tem , 
whereas catechol only inhibited stromal cells at high concentrations . 
Benzene administration in vivo induced elevated prostaglandin E2 
(PGE2) in bone marrow samples (Gaido and Wierda, 1987). These authors 
suggested that increases in PGE2 may be involved in myelosuppression by 
benzene. Prostaglandin E2 can act as a negative regulator of 
hemopoiesis. In vivo administration of PGE2 can block the ability of 
myelopoietic cells to respond to colony-stimulating factor (CSF) 
(Gentile and Pel us, 1987; Tavassol i and Friedenstein, 1983) and can 
inhibit CSF production by peritoneal macrophages and bone marrow stromal 
cells (Kriegler et al., 1984). Thus, bone marrow stromal cells, by 
producing both an inducer, CSF, and an inhibit or, PGE 2, can act to 
regulate myelopoiesis via a feedback control system (Kurland and Moore, 
1977; Oayer et al ., 1985). 
Phenol and hydroquinone also alter prostaglandin production 
(Pol sky-Cynkin et al., 1976; Hemler and Lands, 1980; Gollmer et al., 
1984; Gaido and Wierda , 1987) . One possible mechanism may be via 
cooxidation with prostaglandin synthetase (Hirafuji and Ogura, 1985). 
Through cooxidation, phenol and hydroquinone can be activated to more 
reactive intermediates, such as semiquinone, which bind to 
macromolecules and inhibit cellular enzymes (Tunek et al ., 1982). The 
tendency of these agents to cooxidize with prostaglandin synthetase and 
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alter PGE2 synthesis may contribute to benzene hematoxicity (Gollmer et 
al., 1984) . However, benzene toxicity to stromal cells is not due 
solely to increased prostaglandin synthetase activity (Gaido anc Wierda, 
1987). 
Benzene and Leukemia 
There is no longer any real doubt that benzene is considered to be 
a leukemogenic agent in man (Aksoy, 1985) . The evidence is derived from 
a number of different approaches including different types of 
epidemiological studies and a series of case reports beginning more than 
50 years ago (Aksoy, 1985; Infante and White, 1985; Rinsky et al . , 
1987) . These observations were corroborated recently by carcinogenesis 
bioassays in mice and rats (Snyder et al., 1980; Maltoni et al., 1983; 
1985; Cronkite et al., 1984; 1985) . 
The type of leukemia most commonly associated with chronic benzene 
exposure is acute myelogenous leukemia and its variants, including acute 
myelomonocytic leukemia, acute erythroleukemia and acute myelocytic 
leukemia (Goldstein, 1983; Aksoy, 1985) . Acute myelogenous leukemia is 
the adult form of acute leukemia, and is a rapidly fatal disease . The 
other major acute form of leukemia, acute lymphocytic leukemia, has been 
reported to be associated with benzene exposure. There are several 
reports (Goldstein, 1983) describing the frequency of occurrence of 
chronic myelogenous leukemia or even chronic lymphoid leukemia following 
benzene exposure. Other hematological disorders possibly associated with 
benzene exposure include Hodgkin's disease, lymphoma, myeloid metaplasia 
or myeloma. leukemia associated with benzene exposure frequently 
develops following a peri od of bone marrow depression, i . e., benzene-
induced pancytopenia has been followed through a preleukemic phase into 
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the development of acute myelogenous leukemia {Vigliani, 1976) . 
IMMUNOTOXICITY OF BENZENE AND ITS METABOLITES 
Immunotoxicity of Benzene 
The sensitivity of lymphocytes to benzene indicates an immunotoxic 
potential for this compound since lymphocytes play a principal role in 
alterations of the immune function. Evidence has been presented in 
several reports that the short-term administration of benzene by 
inhalation or intraperitoneal injection to experimental animals results 
in abnormalities of immune-associated parameters including a 
suppression in mitogenic response of B-and T-lymphocyte proliferations 
{Rozen and Snyder, 1985; Rozen et a l. , 1984; Wi erda et a 1 . , 1981), an 
impairment in humor a 1 anti body response as measured by p 1 aque- fermi ng 
cells to sheep erythrocytes {Aoyama, 1986; Wierda et al., 1981), and an 
increased susceptibility to pathogenic microorganisms, such as Listeria 
monocytogenes {Rosenthal and Snyder, 1985) and Klebsie11a pneumoniae 
{Aranyi et al., 1986). Pandya et al. {1986) also showed that serum 
hemaglutinating SRBC antibody titers and interferon levels were reduced 
in rats exposed to benzene via intraperitoneal administration . 
Recently, it has been demonstrated that exposure to 100 ppm 
benzene {5 days/week x 4 weeks) via inhalation in mice depressed the 
mixed lymphocyte culture {MLC) responses and also reduced the cytolytic 
abilities of cytotoxic T lymphocytes, and ruled out the possibilities 
that depressions in immune function are due to an induction of 
suppressor cell activity {Rosenthal and Snyder, 1987). As MLC 
responsiveness is generally thought to represent the in it i a 1 phases in 
the induction of cytotoxic T ce 11 s {CTL), the benzene-induced 1 oss of 
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CTL lytic ability to tumor cells might be explained by an impaired 
ability of T cells to recognize foreign tissue or tumor-associated 
antigens during T-helper-cell -mediated induction of CTL cells. More 
importantly, short-term exposure of mice to benzene concentrations at 
the industrial standard -exposure level (10 ppm) significantly depresses 
mitogen - induced lymphoproliferation of both B- and T-lymphocytes (Rozen 
et al., 19B4). 
Immunotoxicity of Benzene Metabolites 
In vitro. Benzene metabolites have been shown to produce a variety 
of alterations in immune function in vitro. The ability of phenol, 
hydroquinone, and catechol to suppress lymphocyte growth and function in 
vitro correlates with their capacity to undergo oxidation and with 
their concentration in the bone marrow or lymphoid organs (Irons et al., 
19B1; Pfeifer and Irons, 1981; 1982; 1983). Hydroquinone and its 
oxidation product, p -benzoquinone , inhibit proliferation and 
differentiation in lectin -st imulated lymphocytes in culture at 
concentrations that are not cytotoxic, while phenol or catechol suppress 
lymphocyte growth or function only at concentrations that result in cell 
death. Suppression of lymphocyte blastogenesis by hydroquinone is 
postulated to be mediated by the interaction of p-benzoquinone with 
sulfhydryl ( SH) groups on tubuli n (Irons et a l . , 1981; 1984 ; Pfeifer and 
Irons, 1983). Tubulin has previously been shown to possess highly 
nucleophilic SH groups that are required for guanosine triphosphate 
(GTP) binding during the process of microtubule assembly (Mann et al ., 
1974). This binding interferes with microtubular integrity, which is 
required not only for cell division via spindle formation but also for 
regulation of surface receptor movement and normal signal transduction 
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at the cell membrane. 
In vivo. Benzene metabolites are also immunotoxic in vivo . Post 
et al. (1985) demonstrated that exposure to p-benzoquinone in mice 
completely inhibits the proliferation and production of the T-cell 
lymphokine, interleukin-2, by concanavalin A (Con A) -stimulated T-
lymphocytes. Proliferation and maturation of lymphocyte cells are 
regulated by this polypeptide lymphokine (Dinarello and Mier, 1986) . 
Hydroquinone and catechol have been shown to reduce the frequency of 
spleen and bone marrow progenitor B-lymphocyte and inhibit polyclonal 
plaque-forming cells (Wierda and Irons, 1982) . 
NEUROTOXICITY OF BENZENE 
Effect of Benzene on Neurobehavior 
Organic solvents have long been associated with neurophysiological 
and psycho 1 og i ca 1 disorders (Grasso et a 1 . , 1984; Savo 1 a i nen, 1977) . 
The critical acute effects associated with inhalation of high 
concentrations of benzene, namely, depression of central nervous system 
function and narcosis, most likely ensues directly from benzene itself 
rather than from its metabolites (Dempster et al., 1984; Brief et al. , 
1980; Haley, 1977). Exposure of human beings to lower concentrations 
(250-500 ppm) of benzene has been reported to cause the following 
clinical symptoms: vertigo, drowsiness, giddiness, euphoria, headache, 
and nausea (Brief et al., 1980; Haley, 1977). Chronic industrial 
exposure to benzene also cause neurological abnormalities (Baslo and 
Aksoy, 1982) . The behavioral endpoints including locomotor activity, 
appetitive indices and hind-limb grip strength were also demonstrated to 
be altered by benzene in experimental animals (Dempster et al., 1984). 
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In another study, i nha 1 at ion of 300 or 900 ppm benzene increased t he 
occurrence of eating and grooming, and reduced the number of mice that 
were sleeping or resting (Evans et al. , 1981) . 
Effect of Benzene on Neurochemicals 
Despite numerous positive investigations on neurobehavior effects, 
few published data are available on the neurochemical effects of 
benzene . Recently, Paradowsk i et al . (1985) showed that a four week 
prolonged subcutaneous administration of benzene to rats increases the 
contents of norepinephrine (NE) and dopamine (DA) in brain or other 
i nterna 1 organs such as sp 1 een , 1 i ver and kidney . Under the same 
conditions, increases of the indoleamine serotonin (5-HT) and its 
metabolite, 5-hydroxyindole acetic acid (5 -HIAA) were also observed in 
brain tissues, particularly in the striatum (Paradowski et al . , 1984). 
The mechani sm for the benzene - induced changes in levels of monoamines 
and their metabolites is not yet known . It appears that the effects of 
benzene on the major enzyme systems in the monoaminergi c biosynthetic 
pathway have never been clearly shown. Intraperitoneal admini stration 
of benzene to mice increased striatal levels of tryptamine, 5-HT, and 5-
HIAA , and produced an induction aromatic-L-amina acid decarboxylase 
(AADC) but ruled out the possibility of inhibition of monoamine oxidase 
(MAO) (Juorio and Yu, 1985a) . Benzene also produced marked increases in 
mouse and rat striatal concentrations of beta-phenylethylamine, p-
tyramine and, to a lesser extent , m-tyramine (Juorio and Yu , 1985b). 
ENVIRONMENTAL AND TOXICOLOGICAL ASPECTS OF TOLUENE 
Chemica 1 and Phys i ca 1 Properties 
Toluene (C6HsCH3), also referred to as toluol, methyl benzene, and 
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phenylmethane, is a colorless liquid with both volatile and flammable 
properties. It has a molecular weight of 92 . 13, boiling point of 
110.63°C , freezing point of 94 .9°C, specific gravity of 0.867 at 20°C, 
and a vapor pressure of 30 mm Hg at 26°C. This chemical is only slightly 
so 1 ubl e in water, 535 mg/L in fresh water and 379 mg/L in sea water 
(U.S. Environmental Protection Agency, 1980b). It is miscible with 
alcohol, chloroform, ether, acetone, glacial acetic acid, carbon 
disulfide, and other organic solvents . Toluene is soluble in natural 
fats and fat-soluble substances, and accumulates readily in animal 
tissues that exhibit a high lipid content or represent major metabolic 
sites such as liver and brain . The nucleus of toluene, like that of 
benzene, undergoes substitution reactions. Substitution occurs a 1 most 
exc 1 us i ve 1 y in the orthro and para pas it ions and occurs faster with 
toluene than benzene. The presence of a methyl group offers additional 
possibilities for reaction; the most important is dealkylation to 
benzene (U.S. National Academy of Sciences, 1982). 
Occurrence and Usage 
Toluene is produced primarily from catalytic reformating processes 
in refineries and from petroleum-derived pyrolysis gasoline as a by-
product of olefin manufacture during the cracking of hydrocarbons (96%). 
Small amounts (4%) of toluene are also produced in coal-derived coke 
oven light oil and as a by-product in the manufacture of styrene (Merian 
and Zander, 1g82). Toluene is extensively employed in a wide spectrum of 
applications. Approximately 70% of toluene is converted to benzene, 
another 15% is used as a starting agent for other chemica 1 s (e .g. , 
benzoic acid, nitrotoluene, toluene dii socyanates, as well as dyes , 
pharmaceuticals, food additives, plastics, etc.), and the remainder 
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(15%) is used as a solvent (which is increasingly being used as a 
"safe" replacement for benzene) for consumer products and as an 
esse~tial gasoline component . Additionally, toluene has been widely 
abused by "glue sniffers". Hence, there is a broad potential for 
exposure both for industrial workers and the general public ( Fishbein, 
1985). It has been detected at various concentrations in the atmosphere 
and ambient water . There is a paucity of data ava i 1 ab 1 e on 1 eve 1 s of 
toluene in food (Fishbein, 1985). 
Population at Risk and Allowed Levels 
It is known that workers and segments of the general public are 
exposed to to 1 uene from chemica 1 manufacturing processes, coke ovens, 
petroleum refineries, solvent operations , the storage and distribution 
of gasoline , urban automobile emission, urban gasoline service stations, 
the use of se lf -service gasoline, and from consumer product s containing 
toluene as well as from drinking water contaminated with this compound 
(Fishbein, 1985) . 
The occupational exposure limits for toluene vary from country to 
country. In the United States, the National Institute for Occupational 
Safety and Health ( 1973) has recommended a workplace 1 imit of 100 ppm 
(8 -hr TWA) with a ceiling of 200 ppm (750 mg/m3) for a 10 -minute 
sampling period. Occupational exposure levels are generally lower than 
this standard, although short exposures to higher vapor concentrations 
occur (Fishbein, 1g85). 
Toluene is also a major organic chemical contaminant in drinking 
water . For the protection of human health from the toxic propert ies of 
toluene following ingestion of contaminated water and aquatic organisms, 
the ambient water criterion is set at 14.3 mg/L (U.S. Environmental 
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Protection Agency, 1986a). This permissible concentration is basically 
extrapolated from a general toxicity evaluation of an oral do se study in 
rats (Wolf et al . , 1956), which at the time was thought to be well below 
any toxicity -based criterion. A level up to 6.4 mg/ L has been detected 
in drinking water {Tardiff and Youngren , 1986) . 
Routes of Exposure 
Toluene may enter the human body by inhalation of vapor , 
percutaneous absorption of liquid, ingestion, and eye contact . Most 
actua 1 exposures have occurred in re 1 at ion to its use as a so 1 vent , 
vapor inhalation being the mode of entry of major concern. Skin contact 
with toluene is of far less significance (U .S. National Academy of 
Sciences, 1982). Exposure to toluene through oral ingestion is 
considered to be a problem for the general population (U.S . 
Environmental Protection Agency, 1980b). After toluene is absorbed , it 
i s rapidly di stributed to the higher vascular tissues includ i ng the 
brain and eventually accumulates in adipose tissue (Savolainen , 1978). 
Metabolism of Toluene 
In vivo studies have shown that toluene exposure is as sociated with 
the induction of microsomal cytochrome P-450 dependent enzymes and 
conjugation enzymes (Pyykko, 1980; Toftgard et al., 1982; Pathiratne et 
al., 1986b). The time-course of effects of toluene on several microsomal 
monooxygenases in the liver or some non-hepatic tissues of rat s exposed 
to toluene have been reported (Pyykko, 1983). 
An important pathway of toluene metabolism proceeds initially 
through the oxidation of its methyl group by microsomal monooxygenase to 
benzyl a 1 coho 1 in the endop 1 asmi c ret i cul urn of the 1 i ver. In turn, the 
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benzyl alcohol is oxidized to benzaldehyde and, subsequently, to benzoic 
acid by alcohol dehydrogenase . The benzoic acid is then conjugated with 
glycine to form so-called hippuric acid which is excreted via urine in 
man and animals, (Ikeda et al., 1972; U.S. National Academy of Sciences, 
1982; Toftgard et al ., 1982). Conjugation of benzoic acid with 
glucuronic acid to produce benzoyl glucuronide apparently occurs when 
the glycine conj ugation reaction is saturated after heavy toluene 
absorption (Fishbein, 1985). 
Toluene is also metabolized via (a) chemically reactive 
intermediate(s) . The formation of o-cresol and p-cresol from aromatic 
oxidation of the absorbed toluene is mediated by cytochrome P-450 
enzymes in the liver. These metabolites are synthesized through an arene 
oxide intermediate which is a reactive metabolite and is responsible for 
the binding of toluene to biomacromolecules (Bakke and Scheline, 1970; 
Pathiratne et al., 1986b). In the formation of p-cresol , a part of the 
hydrogen in the para position migrates to the meta position . Superoxide 
anions are a 1 so formed during the formation of secondary met abo 1 ites, 
such as semiquinones and quinones, from the oxidation of cresol 
(Pathiratne et al . , 1986b) ; covalent binding of toluene to biological 
macromolecules involves more than one reactive metabolite. 
Toxicity of Toluene 
Exposure to toluene is reported to produce a variety of pathologic 
states in humans or experimental animals, including cardiac 
sensitization, kidney and liver damage, and various neurological 
disorders (Benignus, 1981a,b; Hayden et al . , 1977). The neurotoxic 
properties of toluene represent the main health hazards (Fishbein, 
1985). Although there is general agreement that toluene does not have 
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the hematotoxic properties of benzene, alterations of lymphocyt e 
f unctions , host resistance to infectious microorganisms, and 
clastogenic activity by toluene were reported (Mohtashamipur et al ., 
1985; 1987 ; Suleiman, 1987; Schmid et al ., 1985 ; Dean, 1985 ; Aranyi et 
al ., 1985; Fishbein, 1985). Toluene was also found to be embryotoxic in 
rats, mice, and rabbits (Courtney et al., 1986; Ungvary and Tatrai, 
1985; Nawrot and Stap 1 es, 1979) . 
Toluene appears to have a pronounced effect on behavior; schedule -
controlled behaviors have been reported to produce inverted U- shaped 
concentration effect curves on response rates , i.e . initially i ncreasing 
r ate s and at higher levels decreasing rates of response (Dyer et al., 
1984; Benignus, 1981b) . Several studies have indicated that 
concentrations of various brain biogenic monoamines are affected by 
acute or subchroni c administration injection to rats . Increases in 
steady -s tate levels of NE , DA, and 5-HT have been reported in whole -
brain homogenates or discrete brain areas of rats who continuously 
inhaled 100 , 300 , or 1,000 ppm toluene for 8 hr (Rea et al ., 1984). 
Subchronic repeated exposure of rats to toluene vapor al so increased 
concentrations of catecholamines and their turnover rates in 
hypothalamus or median eminence (Anders son et al . , 1980 ; 1983) . After a 
single ip administration of 200 mg toluene/kg body weight to rats, Arito 
et al . (1984) reported an increase in the regional concentrations of NE, 
5-HT and their respective metabolites, 3- methoxy-4-hydroxyphenyl 
ethyleneglycol (MHPG) and 5-HIAA; alterations in DA and its metabolites 
3-4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were 
not detected . In their follow up study, however, 14 consecutive days of 
i p injection of to 1 uene in rats increased NE and MHPG on 1 y (Ari to et 
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al ., 1985). Pronounced increases in the concentrations of serum 
corticosterone, growth hormone , follicle stimulating hormone , and 
prolactin were increased in rats under the ~nfluence of toluene exposure 
via inhalation (Andersson et al., 1980; 1983) . 
Evaluations of the myelotoxicity of toluene in laboratory animal s 
have generally indicated that the chemical is nontoxic. Wolf e t al. 
(1956) conducted a long-term toxicity study in which toluene was given 
orally to rats and indicated there we re no adverse effects on the cell 
counts of circulating blood and bone marrow. Andrews et al. (1977) noted 
that benzene inhibited the incorporation of 59 Fe into erythrocytes of 
mice but that toluene did not. A marked decrease in leukocyte counts 
were reported in dogs exposed to 200 - 700 ppm toluene, but these changes 
were found to be temporary (Hobara et al ., 1984). After exposure to 
toluene vapor at concentrations ranging from 2.5 to 500 ppm, mice 
exhibited increased susceptibility to respiratory infection with 
Streptococcus zooepidemicus and decreased pulmonary bactericidal 
activity to K1ebise71a pneumoniae (Aranyi et al., 1985). Several reports 
have appeared in the literature which link exposure of toluene to 
altered immunocompetence in animals and humans (U.S. National Toxicology 
Program, 1987; U.S. Environmental Protection Agency, 1980b). 
BENZENE -TOLUENE INTERACTION 
One possible mode by which xenobiotics modify the toxicity of their 
own and also that of other compounds is alteration of their metabolism 
by induction of drug-metabolizing enzymes (Sipes and Gandolfi, 1986). 
Toluene is frequently employed in industry with other chemicals (U.S . 
National Academy of Sciences, 1982) . In sufficient amounts, it is known 
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to possess the potential for significantly altering metabolism and 
resulting bioactivity of certain chemical agents (Hayden et al ., 1977 ; 
Fishbein, 1985) . Toluene exposure can stimulate the activity of many 
microsomal monoxygenases and increase the concentration of cytochrome P-
450 (Pyykko , 1980 ; Toftgard et al., 1982; Pathiratne et al., 1986a), 
thereby enhancing metabolism of the second chemical. The time of 
exposure to to 1 uene re 1 at i ve to the time of exposure to a second 
chemical could be quite important (Sipes and Gandolfi, 1986) . Time -
course of effects of toluene on several microsomal enzymes in the liver 
and some non-hepatic tissues of rats exposed to toluene has been 
demonstrated (Pyykko, 1983). Should concurrent exposure occur, toluene , 
which is readily hydroxyl a ted by the microsomal monooxygenease system, 
would be expected to inhibit the metabolism of other compounds which are 
acted upon by this same enzyme system. This phenomenon would be expected 
to result in a prolonged half-life of both toluene and the other 
compound. Inhibition of metabolism of a second compound may be 
beneficial or detrimental , depending upon the toxicity of the parent 
compound versus its metabolite ( s). To 1 uene a 1 so undergoes a 1 coho 1 i c 
oxidation and conjugation reactions subsequent to the initial 
hydroxylation reaction. Therefore, a substantial dose of toluene could 
conceivably interfere with the metabolism of compounds that undergo 
oxidation and glycine conjugation (U.S. National Academy of Sciences, 
1982; Ungvary et al., 1983 ; Takahashi et al ., 1987) . 
Several in vitro or in vivo studies indicate that toluene is a 
competitive inhibitor of the biotransformation of benzene and can 
significantly influence the myelotoxic and genotoxic effects of benzene. 
The conversion of benzene to phenols in rats, mice or in vitro has been 
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reported to be suppressed when benzene was given in combination with 
toluene (Ikeda et al. , 1972; Andrews et al. , 1977; Sato and Nakajima, 
1979; Gilmour et al., 1986) . Andrews et al . (1977) coadministered 
benzene and toluene to mice or rabbits and observed a marked reduction 
in levels of benzene metabolites in bone marrow, coupled with a 
compensatory increase in pulmonary excretion of unmetabol ized benzene . 
It was also demonstrated using liver microsomes in vitro that toluene is 
a competitive inhibitor of benzene metabolism. When benzene and toluene 
were administered in combination to rats intraperitoneally, their 
disappearance rates from blood and the rates of uri nary excretion of 
their metabolites were delayed compared with those observed when they 
were given separately. Their metabolic interaction was found to be 
dose-dependent (Sato and Nakajima, 1979). 
Toluene protects against benzene -i nduced depression of red cell 
59 Fe uptake in bone marrow of mice (Andrews et al., 1977). Toluene not 
only alleviates the benzene - induced leukopenia but also the benzene-
induced increase in leukocyte alkaline phosphatase activity (Li et al., 
1986) . Toluene significantly decreases the adverse effects of benzene 
on granulopoietic stem cells (CFU per tibia) and on tibial bone marrow 
cellularity in mice (Tunek et al., 1981; 1982). When benzene-exposed 
mice were simultaneously given an ip injection of toluene, the sister 
chromatid exchange ( SCE) incidence was reduced by up to 90% compared 
with animals exposed to benzene alone (Ti ce et a l., 1982). Gad -El-Kari m 
et al. (1984; 1985a; 1986) also found that toluene antagonized 
benzene's myeloclastogenicity and metabolism when mixtures of both 
chemicals were administered orally to CD- 1 mice . 
CHAPTER III 
ALTERATION OF HUMORAL AND CELLULAR IMMUNITY 
BY BENZENE IN CD-1 MICE 
INTRODUCTION 
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Concern for the safety of po 11 utants present in ground water i s 
attracting attention, since ground water is a major source of dr inking 
water supplies . The major concern is the possible subclinical effects 
after long-term exposure. The immune system is being studied as a 
target organ for detecting toxicity since its sensitive parameters are 
eas ily evaluated (Bick et al ., 1985 ; Dean et al . , 1982) . A number of 
industrial and environmental chemicals induce immunosuppression (Faith 
et al . , 1980) . Benzene, a ubiquitous environmental pollulant , exert s it s 
greatest toxicity on hematopoietic cells, including erythroid, myeloid 
and lymphoid lineages both in the peripheral blood and in t he 
hematopoi etic organs (F i shbe i n, 1984; Bolcsak and Nerland, 1983) . 
Repeated benzene exposure in human and laboratory animals induces 
various forms of cytopenia, aplastic anemia , 1 eukaemi a and the 
development of chromosomal abnormalities (Dean , 1985; Green et al ., 
1981a; U.S. Environmental Protection Agency, 1980a; Brief et al . , 1980). 
The mechanism for benzene-induced hematopoietoxic effects has not been 
well elucidated , however, most researchers believe oxidative benzene 
metabolites, rather than benzene itself , are required to mediate these 
hematopoietic effects of benzene (Sawahata et al., 1985; Irons, 1985; 
Bolcsak and Nerland , 1983 ; Greenlee et al . , 1981b). 
Lymphocytes in animals are sensitive to benzene toxicity (Rozen and 
Snyder, 1985; Dempster et al., 1984; Snyder et al . , 1982; Green et al., 
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1981a; Aoyama, 1986), as are those from humans who are inadvertently 
exposed to this chemical (Moszczynsky and Lisiewicz, 1984; Brief et al ., 
1980) . Benzene-induced depressions in 1 ymphocyte counts may impair 
immunocompetence, since lymphocytes play a principal role in immune 
function. The short-term admi ni strati on of benzene by i nha 1 at ion or 
intraperitoneal injection to experimental animals has caused 
abnormalities of immune-associated parameters, including a 
suppression in mitogenic response of B-and T-lymphocyte proliferations 
(Rozen and Snyder, 1985; Rozen et al., 1984; Wierda et al., 1981 ; Aoyama 
1986), impaired humoral antibody response as measured by plaque-forming 
cells to sheep erythrocytes (Wierda et al., 1981; Aoyama , 1986), and an 
increased susceptibil ity to pathogenic microorganisms (Rosenthal and 
Snyder, 1985; Aoyama, 1986) . Similarly, treatment with benzene 
metabolites has also impaired immune responses (Pfeifer and Iron s, 1982; 
Wierda and Irons , 1982) . 
The inbred C-57BL mice used in experiments described above may 
harbor an endogeneous lymphoma virus (Kaplan , I967) ; activation of this 
latent virus after benzene treatment may influence the toxicity of 
benzene (Snyder et al., 1980; Longacre et al. , 1981) . The outbred CD-1 
mice were used in this study. There are relatively few reports on 
effects of benzene after oral ingestion. Because some water supplies 
may be contaminated with benzene (U.S. Environmental Protection Agency, 
1980a), oral administration was employed via drinking water for a four -
week period . 
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MATERIALS AND METHODS 
Animals 
Male, adult CD-I mice (Charles River Breeding Laboratory Inc., 
Wilmington, MA) were procured at 5 to 6 weeks of age (approximately IB 
g) and were acclimatized to the AAALAC-accredited animal care facility 
for 1 week before use. Mice were randomly assigned to control and 
treatment groups and housed five per group in plastic cages with 
hardwood-chip bedding. They were maintained on 1 aboratory rodent chow 
and tap water ad libitum. Room conditions were maintained at an ambient 
temperature of 21 ± I°C and a relative humidity of 50 ± 10%. The 
light/dark cycle was maintained at 12 -hr intervals. 
Exposure 
Analytical reagent grade of benzene (99 .99% purity, J.T . Baker 
chemical Co. Phillipsburg , NJ), was dissolved in normal tap water to 
make nominal concentrations of 40 , 200, and 1000 mg/ L. Benzene has a 
sol ubility of 1,7BO mg/L in water at 25°C (U .S. Environmental Protection 
Agency, 19BOa). The benzene-treated water was administered to mice 
continuously for 2B days via drinking water; the control group received 
untreated tap water. To minimize decomposition and to maintain the 
concentration of benzene, drinking water was provided in glass water 
bottles, was shaken frequently during treatment and was changed every 
three days. Feed and water consumption was monitored continuously, and 
animals were weighed once a week. Benzene concentrations in drinking 
water were confirmed on different days by a gas chromatography (U .S. 
Environmental Protection Agency, 19B6a). 
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Gross Observations and Hematology 
Twenty -eight days after the exposure to benzene, mice were killed 
by decapitation, and gross patho 1 ogi ca 1 ex ami nations were performed on 
all mice. Major organs, i.e., 1 iver, spleen, thymus and kidney were 
removed, trimmed and weighed. Blood samples were collected in 
siliconized test tubes coated with potassium ethylene-
diaminetetraacetate . Leukocytes and erythrocytes were counted with an 
automated electronic cell counter (Model ZBI, Coulter Electronics, Inc . , 
Hialeah , FL) . Hematocrits were performed with microhaematocrit 
equipment. Differential leukocyte counts were evaluated by Wright ' s-
Giemsa stained thin smears . 
Isolation and Culture of Splenic Lymphocytes 
After sacrifice, the spleen was aseptically removed from each 
animal, rinsed in ice-cold sterile isotonic saline and single cell 
suspens ions were prepared and cultured according to Sharma and Gehring 
(1979) . Cells were suspended in RPM! 1640 media (Gibco Laboratories , 
Grand Island , NY) supplemented with 5% heat-inactivated fetal calf serum 
(Hyclone Sterile Systems, Inc., Logan, UT) and 100 units penic i llin and 
100 ~L streptomycin per mL. Cell counts were made by using the Coulter 
counter . 
Lymphocyte Proliferation to Mitoqens 
Splenic lymphocytes were plated in triplicate cultures (5 x 105 
cells/culture well) in 96-well flat -bottom microtiter plates (Microtest 
II, Falcon Plastics, Oxnard , CA) to assay their responses to £. coli 
lipopolysaccharide (LPS; Sigma Chemical Co., St. Louis, MO), pokeweed 
mitogen (PWM; Gibco Laboratories, Grand Island, NJ), Concanavalin A (Con 
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A; Sigma Chemical Co . , St. Louis, MO), or phytohemagglutinin (PHA; 
Well come Reagents Ltd., Beckenham, England). Culture media with or 
without mitogen was added; total well volum2 was adjusted to 0.15 mL. 
The optimized concentrations of mitogens were 20 ~g/mL, 30 ~g/mL, 2.5 
~g/mL, and 6.0 ~g/mL for LPS, PWM, Con A and PHA, respectively . Cultures 
were incubated at 37°C in a humidified atmosphere with 3.5-4% co2 for 
4B hours and harvested after an additional 6-hr pulse with 0.5 ~Ci of 
[methyl-3H]-thymidine (3H -TdR; New England Nuclear, Boston, MA) per 
we 11 . The ce 11 s were co 11 ected on a glass fiber filter using an 
automated multiple sample cell harvester (Model M12, Biomedical Research 
and Development Laboratory, Rockville , MD) . The amount of radioactivity 
(dpm) incorporated was measured with a scintillation counter (Model 
2660, Packard Instrument Co., Drowners Grove , IL). 
Mixed Lymphocyte Culture iMb£1 Response 
The proliferation of splenic lymphocytes (responders) from benzene-
treated or control animals in response to challenge with allergenic YAC-
1 tumor cells (stimulators) was evaluated . The exponential growth phase 
YAC-1 murine lymphoma cells (H-2a) of A/ Sn origin previously maintained 
in culture medium (> 90% viability by trypan blue exclusion) at a 
concentration of 2 x 107 cells/mL were treated with 50 ~g/mL mitomycin 
C (Sigma) for I hr at 37°C, then washed three times immediately before 
putting into culture. Cultures were set up in triplicate in 96-well 
microtiter plates. Responder cells from the spleen of CO-l mice were 
cocultured alone or with stimulator cells at a responder-stimulator 
ratio of 2:1. The complete RPM! culture medium was supplemented with 
5 x 10-5 M 2-mercaptoethanol (2-ME) . The proliferative response was 
assessed by [methyl-3H]-thymidine incorporation during the last 24 hr of 
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a 3-day culture. The cultures were harvested and counted as described 
for the mitogenesis assays above. 
Cell-Mediated Cytolysis~ Response 
Cytotoxic activities of splenic cytotoxic T-lymphocyte {CTL) were 
generated in vitro against YAC-1 tumor cells as described by Grabstein 
(1980) with modifications. The splenic lymphocytes (responder cells) 
were incubated with mitomycin C-treated YAC-1 cells (stimulator cells) 
in RPM! complete medium supplemented with 5 x Io- 5 M 2-ME for 5 days at 
37°C in a 3.5-4% co2 atmosphere. The exponential growth phase YAC-1 
cells were labeled with 0. 25 mCi of sodium chromate-51 (New England 
Nuclear) by incubation at 37°C for 1 hr under gentle agitation and then 
washed , counted, and resuspended at 2 x 105 cells/ml. A constant number 
(2 x 104 in 0.1 ml) of Slcr -labeled YAC-1 cells (target cells) were 
added to each well of a plastic -well rnicrotiter plate followed by the 
addition of aliquots of the incubated splenic cells (effector cells) in 
a total volume of 200 .ul. The desired effector-to-target cell ratios 
were 50:1 and 25 :1 which gave optimal lysis of target cells. Effector 
and target mixtures were spun for 1 min at 1000 g, and then incubated 
for another 4 hr at 37°C. After incubation, cells were pe ll eted by 
centrifugation for 10 min at 1000 g, and the supernatants were decanted 
and counted in a gamma counter (Model 3320, Packard) The labeled target 
cells in the presence of cornpl ete med i urn or 0. 5% steri 1 i zed saponin 
served as the spontaneous Slcr released and total 51 cr released , 
respectively. The triplicate mean was used to calculate the percentage 
of specific lysis of target cells as described earlier (Grabstein, 
1980). 
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Plague Forming Assay 
Numbers of IgM p 1 aque - forming cells ( PFC) were determined by the 
method of Jerne and Nordin (1963) as modified by Cunningham and Szenberg 
(1968) . Each mouse from control and test groups was sensitized by ip 
injection with 0. 25 mL of a 20% sheep red b 1 ood cell SRBC suspension 4 
days before the end of the benzene exposure. Splenic cell suspensions 
were prepared (1 x 107 cells/mL) as described above. A mixture 
containing 45% splenic cells suspension, 45% of a 10% SRBC suspension, 
and 10% guinea pig complement (Cappel Laboratories, Cochranville , PA) 
was delivered to counting chambers, three replicates per animal. 
Cultures were incubated at 37°C for 1 hr and PFC were calculated and 
expressed as plaques/ 106 splenic cells or plaques/ total splenic cells . 
Enzyme - Linked Immunosorbent Assay .li..U.SAl 
Double sandwich enzyme-1 inked immunosorbent assay (ELISA) was used 
to analyze anti -SRBC (0\-SRBC) antibod ies (Voller et al ., 1979) . Serum 
samp 1 es were collected from mice uti 1 i zed in the p 1 aque -formi ng ass ay . 
Plates (Gilford polystyrene EIA cuvettes Medical Instrument s 
Laboratories, Inc ., Oberlin, OH) were coated with 200 JJL sheep red 
blood cell ghosts (prepared as descri bed by Hanahan and Ekholm, 1974) 
containing 3.6 )Jg/mL protein solubilized in 0.1% sodium dodecyl 
sulfate, and kept at 4°C for 24 hr . After several rinses, 200 JJL 
aliquots of sera (dilution 1:150) were added to the plate wells and 
incubated for 2 hr at 37°C, and rinsed. Subsequently, 250 ..uL 
peroxidase -conjugated goat anti -mouse immunoglobulins (Hyclone Sterile 
Systems, Inc., Logan, UT) diluted 1:2000 were pipeted to each well to 
determine ~-SRBC antibody levels, and incubated another 3 hr at 37°C. 
The enzyme reaction was performed by adding the phosphate-citrate 
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solution containing 0.4 mg/mL o-phenylenediamine buffered substrate 
(Sigma) and 0.4 JJL/mL H2o2, prepared immediately before use . The 
results were expressed as change in absorbance (AOO) 15 min after the 
addition of substrate solution . Non - sensitized mice pooled sera were 
used as a negative control . The optical density was determined by using 
an automated spectrophotometer (Gilford, Model EIA 50, Oberlin, OH) ; 
readings were made at 490 nm. 
Statistical Analysis 
The results are expressed as the means ± their standard errors. 
Statistical significances for differences between benzene -exposed and 
corresponding normal water control data were determined by a one -way 
analysis of variance (ANOVA) design followed by multiple comparison 
procedures of Fisher's least significant differences (LSD) test (Dowdy 
and Wearden, 1983), when F ratios indicated significant difference . A 
level of p<O.OS was considered statistically significant . 
RESULTS 
The average concentration of benzene in drinking water as 
determined by gas chromatographic analysis on several days is indicated 
in Table III-I. There was a 10% loss of benzene on the first day , an 
additional 10% loss per day followed on the second and third day, when 
the water was changed. Based on observed average intake of benzene-
treated water, the daily dose of benzene in each animal was estimated to 
be 0, 8, 40, and 180 mg/kg, respectively. 
Body and Organ Weights 
Continuous exposure of adult, CD-1 male mice to various levels of 
TABLE III-I 
ORGAN AND BODY WEIGHTS OF MICE FOLLOWING 4 WEEKS OF BENZENE EXPOSUREa 
Co ncentrat ion 
in 1~a t e r, mg/L Doses 
mg/kg/day 
Body Weight (g)b Organ weight(g/ 100 body weight)b 
Nom i na 1 Observedc Day 0 Day 28 
0 0 Control 23 . 20 ± 0.37 31.22 ± 0.62 
40 31 8 22.68 ± 0. 33 29.94 ± 0.98 
200 166 40 23.74 ± 0.22 32 .98 ± 0.65 
1000 790 180 23.14 ± 0. 29 32.26 ± 0.86 
a Benzene was administered continuously via dr inki ng water 
b Values are given as mean ± SE (n=5) 
Spleen Liver Kidney Thymus 
0. 33 ± 0. 02 5.57 ± 0. 13 1. 55 ± 0.06 0.16 ± 0.02 
0.30 ± 0.01 5.46 ± 0.29 1.58 ± 0.08 0.12 ± 0.01 
0.28 ± 0.01 5.86 ± 0.07 1.65 ±0.1 0 0. 12 ± 0.01 
0.26 ± 0. 01* 5. 98 ± 0.20 1.87 ± o.o5* 0.11 ± 0.01 
c The observed overall ranges of benzene concentration were 28 to 36, 147 to 178 , and 734 to 855 mg/ L, in the 
three treatment groups, respectively 
Significan tly (p<0.05) different from control values 
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benzene via drinking water over a 4-week period did not produce overt 
clinical symptoms of toxicity . Overall , there was no change in food and 
water consumption. No gross lesions were observed on any of the organs 
of mice in all treatment groups. There was no apparent alteration i n 
body weight gain at termination of the study . Although the two groups 
receiving higher doses (40 and 180 mg/kg/day) had a slight increase in 
growth rate, growth was not significantly different than the control s 
(Table II1-l) . The weights of selected organs are also presented in 
Table 111-1. Weights of spleen, a secondary lymphatic tis sue , decreased 
significantly in animals treated with benzene at the 180 mg/kg/ day do se. 
Kidney weights correspondingly increased. Thymu s weight was reduced in 
all treated groups but not significantly. 
Hematological Parameters 
The effects of benzene exposure on erythrocyte counts, hematocrit s, 
mean corpu sc ular volume s (MCV) , leukocyte counts, and leukocyt e 
differential counts are pre sented in Table 111-2 . Numbers of 
erythrocytes decreased sign i fi cantl y as dose increased. Hematocri ts 
were depressed significantly at the 40 and 180 mg/ kg/ day of benzene . 
However, all of the MCV values of treated animals, when calculated from 
the hematocrits and erythrocyte counts, exhibited a significant 
increase. There was a significant dose-related reduction in number of 
total circulating white cells after oral ingestion of benzene. 
Lymphocyte population decreased significantly when leukocyte 
differentials were expressed on an absolute basis . The number of 
neutrophils and other differential white blood cells (monocytes, 
eosinophils and basophils) were not altered greatly by the benzene 
exposure. 
TABLE III-2 
EFFECTS OF BENZENE EXPOSURE ON SELECTED BLOOD PARAMETERS 
Mcvb 
(fL) 
Leukocyte absolute differential s 
Do sea Erytgroc~tes 
mg/ kg/ day (10 /mm ) 
Control 7.01 ± 0.65d 
8 4. 57 ± 0.28t 
40 3. 68 ± 0.65 * 
* 180 3. 43 ± 0.39 
Hematocrit 
(%) 
50.30 ± 0.58 
48.80 ± 0. 46 
46.20 ± 0.46* 
45 .00 ± 1.22 * 
74.01 ± 6.03 5.96 ± 0.60 4.38 ± 0. 52 
108 .30 ± 6. 49* 4.23 ± 0.07* 2.99 ± 0.07* 
125.18 ± 15 .68* 4. 22 ± 0. 57 * 2.35 ± 0.30 * 
136 . 76 ± 12 . 57 * 2.87 ± 0.16 * 1.61 ± o. 1o* 
a Benze ne wa s administered continuously to CD-1 mice via drinking water for 4 weeks 
b Mean corpuscular volume 
c In cluding monocytes, eosinophils and basoph i l s 
d Value s are given as mean± SE (n• 5) 
* Signifi cantly (p<0 .05) different from control values 
1.01 ± 0. 13 0. 45 ± 0.08 
0.85 ± 0. 10 0.38 ± 0.05 
1.46 ± 0.24 0. 40 ± 0. 09 
1.02 ± 0. 07 0.25 ± 0. 09 
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Mitogen-Induced Lymphocytic Proliferations 
Following 4 weeks of benzene treatment, the proliferative res ponse 
of either mitogen stimulated or nonstimulated splenic lymphocytes were 
elevated in low dose group and depressed in higher dose groups (Table 
III -3). At the optimal concentration of LPS (20 ug/ ml) , 3H-TdR uptake 
increased significantly in the group receiving 8 mg/kgjday of benzene. 
In contrast, the benzene- treated groups receiving 40 and 180 mg/kg/ day 
manifested a significant suppression of 3H-TdR incorporation of 
splenocytes upon LPS stimulation. Simil arly, there were significant 
biphasic alterations of lymphoproliferation in T cell mitogen - treated 
ce lls; both the Con A and PHA - induced responses were enhanced in the 
lowest treatment group and inhibited at the two highest levels. The PWM 
or nonmitogen -stimulated responses increased significantly in the 
animals treated with the lowest dose of benzene but were insignificantly 
depressed in groups receiving higher amounts . Total spleen cellularity 
decreased significantly at the highest dose of benzene treatment . 
MLC and CMC Responses 
The results of MLC presented in Figure III-I demonstrated a dose-
related biphasic response, i.e ., 3H-TdR uptake was inhibited at the 
higher benzene doses but increased in lowest dose group. The effect of 
benzene exposure on CMC activity is shown in Table 111 -4. Cytotoxicity 
data was calculated as the % of total releasable counts, corrected for 
spontaneous release of radiolabel. Total release ± SE of the 2 x 104 
Slcr -1 abe 1 ed target ce 11 s was 3253 ± 324 cpm. Spontaneous re 1 ease was 
less than 7% of total releasable counts for all assays . The results of 
Slcr-release assay revealed that benzene significantly impaired the 
capacity of cytotoxic lymphocyte to lyse the alloantigenic cells (target 
TABLE 111-3 
EFFECTS OF BENZENE EXPOSURE ON SPLENIC LYMPHOCYTE PROLIFERATIVE RESPONSE TO MITOGENS 
Spleen Mitogenic responsesc 
Dose a cellular}tyb 
mg/kg/d ay (x1o- ) 
None LPS PWH Con A 
Control 7.51 ± o.4od 1.6B ± 0.31 102.04 ± 23.66 7.45 ± 1.90 154 .69 ± 49 . 33 
3.55 ± O.B9* * 12.92 ± 2. 19* IOB .61* 8 7.91 ± 0.62 261.23 ± 25.62 384 .90 ± 
40 7. 50 ± 0.41 1.13±0. 13 22.43 ± 3.48 * 3.25 ± 0.71 29.30 ± 
180 5.17 ± 0.64 * 0.91 ± 0.19 25 . 44 ± s.2o* 3.65 ± 0. 72 14 .61 ± 
a Benzene was administered continuously to CD-1 mice via drinking water for 4 weeks 
h Reco ve red number of splenocytes per spleen x1o- 7 
c dpm/10- 3;106 splenic cells: response evaluated by incorporation of 
splenocyte cultures for 6 hours pulsing 
d Values are given as mean± SE (nz5). 
Significantly (p<0 .05) different from control values 
7.69 * 
2.66* 
PHA 
6B . 02 ± 1B.57 
285 .81 ± 88.01* 
16 . 43 ± 3. 94* 
8.87 ± 1.83* 
51 
75 
* 
50 
" 
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0. 
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RESPONDERS(R)-TO-STIMULATORS(S) RATIO 
Fig. I II - I. Effect of benzene exposure on mixed 1 ymphocyte culture 
(MLC) response . Benzene was administered continuously to CD- I mice via 
drinking water for 4 weeks . The bar (left to right), 0 , 'Zl, 88l , 
and • , indicate benzene doses at 0 (control) , 8 , 40 , and 180 
mg/kg/ day , r espectively. Stars (*) denote significan t ly (p<O . OS) 
different from control values . Responder cells were the syngeneic 
splenic cells of CD-I mice and stimulator cells were the allogeneic YAC -
1 cells . Several stimulator responder ratios were used, but data are 
presented only from a ratio of 1:2 stimulators to responders which gave 
maximal stimulation. The stimulator cells were treated with mitomycin -C 
before addition to the culture. MLC evaluated by incorporation of 
[methyl -3H] - thymid i ne into day 3 MLC cultures for 6 hours pul si ng . 
Dose a 
mg/kg/day 
Contro 1 
8 
40 
180 
TABLE I II -4 
EFFECTS OF BENZENE EXPOSURE ON CYTOTOXIC 
LYMPHOCYTE FUNCTIONS 
50: I b 
15 . 72 ± 1.16c 
17.94 ± 1.61 
8. 77 ± 1.87* 
5.82 ± 0.94* 
% Cytotoxicity 
25:1 
15.98 ± 2.98 
23.32 ± 2.o5* 
11.09 ± 1.71 
9.1 7 ± I. 53* 
52 
a Benzene was administered continuously to CD-I mice via drinking 
water for 4 weeks 
b Effector (day 5 MLC lymphocytes ) -to -target (Sicr labelled YAC -1 
cells) cell ratio 
c Values are given as mean ± SE (n=S) 
* Significantly (p<0.05) different from control values 
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cells) at 25:1 and 50 : 1 effector (E) - to - target (T) cell ratios after 4 
weeks of oral i ngestion . The lowes t dose (8 mg/ kg/day) of benzene al so 
obviously enhanced the CTL responsiveness in 25 : 1 E:T ratio. 
Antibody Production 
The primary antibody response to SRBC was assessed four days later 
after sensitization with SRBC; the SRBC-specific plaque-forming cells 
( PFC) were counted, and the 0( -SRBC anti body titer was determined. As 
shown in Table III-5, ability of treated animals to produce SRBC -
specific antibody changed . The number of PFC in the animals receiving 
40 and 180 mg benzene/ kg/day was significantly reduced, when expressed 
as either specific activity ( PFC/106 sp 1 een ce 11 s) or who 1 e sp 1 een 
basis. However, there were more PFC per 106 sp 1 eni c cells in anima 1 s 
exposed to the lowest level of benzene. The total number of recovered 
splenocytes was significantly reduced in a dose-related manner . The 
titer of o<. -SRBC antibodies corresponded to the numbers of PFC, but 
si gnificant depression was only found at the highest concentration of 
benzene (Table III-5). 
DISCUSSION 
The results demonstrate that oral administration of various dosages 
of benzene via drinking water ad libitum to CD-1 mice markedly altered 
the immune function. The alteration of immunocompetence was gross 1 y 
evidenced by a decrease of thymic and splenic weights, which are useful 
indicators of immune dysfunction , and a loss of lymphocytes from 
peripheral blood and spleen. Benzene appeared to specifically affect 
lymphocytes since numbers of neutrophils and other leukocytes did not 
decrease significantly (Table III-2) . Various studies have revealed 
TABLE 111-5 
EFFECTS OF 4 WEEKS OF BENZENE EXPOSURE ON THE ANTIBODY RESPONSES 
TO THYMIC-DEPENDENT ANTIGEN SHEEP ERYTHROCYTE (SRBC)a 
Spleen 
PFC/106 
PFC/total 
Dose cellula7ity sp 1 een le 11 s ol-SRBC 
mg/kg/day (x1o- ) Splenic cells (x1o- ) titer 
Control 22 . 59 ± 3.02c 1,254 ± 171 295 . 72 ± 74.51 0. 44 ± 0.06 
B 16.80 ± 1.59* 1, 576 ± 65* 268 .80 ± 36.10 0.57 ± 0. 11 
40 15 .36 ± 0.65* 643 ± 49* 99 . 76 ± 10 . 32 * 0.31 ± 0.05 
180 12 . 70 ± 1.51* 229 ± 40* 31.41 ± 9.52 * 0. 21 ± 0.01. 
a Mice were sensitized with SRBC 4 days before the end of the benzene exposure . 
Splenic lymphocytes were analyzed for anti body forming ce 11 s (p 1 aque -forming 
cell, PFC) and sera were detected for antibody titer (o<.-SRBC) 
b Benzene was administered cont inuously via dr i nking water 
c Values are given as mean ± SE (n-5) 
Significantly (p<0.05) di ffe ren t from control values 
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that lymphocytes are particularly sensitive to benzene toxicity via 
i nha 1 at ion (Rozen and Snyder, 1985; Dempster et a 1., 1984; Snyder et 
al., 1982; Green et al., 1981a) . Benzene increases the permeability of 
1 ymphocyte 1 ysosoma 1 membranes and re 1 eases lysosoma 1 enzyme into the 
cytoplasm, resulting in a decrease in the number of lymphocytes 
(Moszczynsky and Lisiewicz, 1984). Mice exposed to 300 ppm benzene via 
inhalation showed significant depressions in the numbers of a-
lymphocytes (s - IgM+ cells) in bone marrow and spleen and in the numbers 
of T-lymphocytes (Thy 1,2+ cells) in thymus and spleen (Rozen and 
Snyder, 1985). Similar effects on these two lymphocyte populations in 
blood and spleen were also reported in mice after 7 or 14-day inhalation 
exposure to 50 or 200 ppm benzene (Aoyama, 1986). Occupational exposure 
to benzene showed significant 1 y decreased T -1 ymphocyte counts 
(Moszczynsky and Lisiewicz, 1984) . 
In our studies, mice exposed to benzene had significant fewer 
peri phera 1 erythrocyte numbers and hematocrits. The increase in mean 
corpuscular volume (MCV) indicates that benzene ingestion induced a 
macrocytic anemia. In human beings chronic benzene poisoning is most 
easily detected by RBC reduction and increased MCV, but an accurate 
diagnostic also requires other hematologic parameters (Haley, 1977). 
Baarson et al. (1984) reported that repeated exposure to low levels of 
benzene (10 ppm) via inhalation in mice depressed the in vitro colony-
fermi ng abi 1 i ty of one of the erythroid progenitor ce 11 s, the co 1 any-
forming unit-erythroid (CFU-E), the numbers of splenic nucleated red 
cells and the numbers of circulating erythrocytes and lymphocytes . 
Generally, the size of lymphatic organs associated with immunologic 
function decreased. The effect of benzene on immune parameters in the 
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present study was often a biphasic response, enhanced at lowest dose (8 
mg/ kg/ day) and suppressed at the higher doses (40 and 180 mg/kg/ day) . 
Several workers have reported the in vivo immunosuppressive E'ffect of 
benzene (Aoyama, 1986; Rozen and Snyder, 1985; Pandya et a l . , 1986). 
However, differences in animal models, doses and duration of exposure, 
and routes of admi ni strat ion make comparisons difficult (Longacre et 
al., 1981). Inhalation of benzene depressed host resistance to the 
infectious agents, Listeria monocytogenes and K7ebsie71a pneumoniae 
(Rosenthal and Snyder , 1985; Aranyi et a l., 1986). Mitogen-induced 
lymphoproliferation was suppressed in mice treated ip with benzene 
metabolites, i.e., hydroquinone and catechol (Wierda and Irons, 1982) . 
The cell renewal rate as well as the rate of DNA, RNA, and protein 
synthesis in cultured leukocytes and lymphoma ce 11 lines exposed to 
benzene or its metabolites were inhibited (U .S. Environmental Protection 
Agency, 1980a; Pellack-Walker et al., 1985; Post et al ., 1985; Schwartz 
et al., 1985). Hemopoiesis in vitro in stromal cells pretreated with 
low doses of oxidative metabolites of benzene, such as hydroquinone, was 
enhanced (Gaido and Wierda, 1984). Garnett et al. (1983) also obtained 
biphasic responses in vitro with CFUs (colony forming units-spleen) from 
mice that inhaled benzene . These results support the hypothesis that 
benzene or its metabolites may promote as well as suppress the 
hemopoietic system (Harigaya et al., 1981). 
Recently, Post et al. (1985) indicated that exposure of T-
lymphocytes to p-benzoquinone, one of the metabolites of benzene, 
inhibited the formation of lymphokine interleukin-2 (IL-2). IL-2, 
produced by T lymphocytes, is an important regulatory cytokine in 
lymphocyte proliferation since it is a growth factor for helper, and 
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cytotoxic T lymphocytes (Dinarello and Mier, 1986). 
The data from this study show that ingestion of benzene via 
drinking water in CD-I mice noticeably affected all aspects of the 
immune system, including cellular and humoral parameters. Of particular 
importance was the fact that the effects were evident at the lowest dose 
of treatment and a no-effect level could not be established . Further 
studies involving lower levels of exposure are necessary to fully 
ascertain the safety of this chemical in groundwater. 
CHAPTER IV 
ALTERATION OF REGIONAL BRAIN MONOAMINE 
NEUROTRANSMITTERS BY BENZENE IN CO-l MICE 
INTRODUCTION 
58 
Benzene, the simplest aromatic hydrocarbon, is a ubiquitous 
chemical. It occurs naturally in petroleum, trees, fruit, seeds, dairy 
products, eggs and meat (U .S. Environmental Protection Agency, 1980a). 
This chemical is also among the most widely distributed of the 
environmental pollutants. It is produced by the petrochemical industry, 
and is a basic starting material in the manufacture of many beneficial 
products (Fishbein, 1984) . Due to its lipophilic nature and to the 
production of biologically reactive intermediates through metabolic 
biotransformation (Irons, 1985; Bolcsak, and Nerland, !983; Greenlee et 
al ., 1981a), benzene is considered to pose a significant health hazard. 
The major toxicity of benzene reported in humans and laboratory animals 
has mainly focused on the dysfunction of the hematopoietic system 
(Sawahata et al., 1985; Bolcsak and Nerland, 1983). 
Organic solvents have been associated with neurophysiological and 
psyc hological disorders (Grasso et al ., 1984; Savolainen, 1977) . 
However, few studies have concerned the effects of benzene on the 
nervous system, particularly with neurotransmitters. Acute effects 
associated with inhalation of extremely high concentrations of benzene 
(about 25,000 ppm), namely, depression of the central nervous system 
(CNS) and narcosis, most likely are caused by benzene rather than its 
metabol ite(s) (Dempster et al ., 1984; Brief et al., 1980; Haley, 1977). 
Exposure of human beings to lower concentrations of benzene (250-500 
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ppm) has reportedly caused vertigo, drowsiness, giddiness, euphoria, 
headache , and nausea (Brief et al ., 19BO; Haley, 1977) . Chronic 
indu strial exposure to benzene also causes neurological abnormalities 
(Bas 1 o and Aksoy, 19B2). The behavi ora 1 endpoints inc 1 udi ng 1 ocomotor 
activity, appetitive indices, and hind-limb grip strength were 
demonstrated to be altered by benzene in animals (Dempster et al., 
1984) . Recently, Paradowski et al. (1985) showed that subcutaneous 
administration of benzene to rats for 4 weeks increased the 
concentrations of norepinephrine (NE) and dopamine (DA) in brain or 
other internal organs. Under the same conditions, the concentrations of 
the indoleamine serotonin (5 -HT) and its metabolite, 5-hydroxyindole 
acetic acid (5 -HIAA), also increased in brain tissues (Paradowski et 
al., 1984). Intraperitoneal administration of benzene to mice has been 
shown to increase brain levels of 5- HT and 5-HIAA and produce an 
induction of aromatic-L-amina acid decarboxylase, a major enzyme in the 
synthesis of biogenic amines (Juorio and Yu, 1985a). 
Since relatively little information is available concerning the 
effects of benzene on the neurochemi ca 1 transmitters in anima 1 brain, 
current studies were undertaken to evaluate the neurotoxicity of benzene 
in mice. The primary objective was to determine if subchronic 
administration of benzene to CD-1 mice via drinking water altered the 
concentrations of specific brain catecholamines, indoleamine, and their 
metabolites in discrete brain regions. These selected neurotransmitters 
are known to play an important role in physiology and behavior (Rogawski 
and Baker, 1985; Poirier and Bedard, 1984; Willis and Smith, 1985). The 
results of this investigation would help to understand the potential 
neurotoxic actions of this ubi qui to us en vi ronmenta 1 contaminant, which 
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is also a major groundwater pollutant . 
MATERIALS AND METHODS 
An i mals 
Male, adult CO-l mice (Charles River Breeding Laboratory Inc . , 
Wilmington, MA) were quarantined and allowed to acclimatize to the 
animal care facility for one week prior to experiment (approximately 
21 -24 g initial body weight). Room conditions were kept at ambient 
temperature ( 21 ± 1 °C) with re 1 at i ve humidity ranging between 40 and 
60%, and the 1 i ght/ dark eye 1 e was rna i nta i ned at 12 -hour i nterva 1 s. 
Commercial rodent chow (Wayne Products , Chicago . Ill) and tap water were 
given ad libitum . After acclimatization, the apparently healthy animals 
were randomly assigned to control and treatment groups and hou sed (five 
per cage) in plastic cages containing hardwood-chip bedding. 
Exposure 
Analyt i cal reagent grade benzene (99.9% purity , JT Baker Chemi cal 
Co. , Phillipsburg, NJ) was dissolved in normal tap water to provide the 
i ntended concentrations of 40, 200, and 1000 mg/ L. Benzene has a 
solubility of 1,7BO mg/L in water at 25°C (U.S . Environmental Protection 
Agency, 1980a) . Treatments were achieved by supplying the indicated 
concentrations of benzene in the drinking water to mice for 28 days; 
controls received tap water with no benzene. Treated water solutions 
were changed every three days to ensure freshness . Feed and water 
consumptions were measured continuously, and animals were weighed 
weekly. Drinking water samples were collected daily for chemical 
analysis after making the fresh benzene-water solution . Final benzene 
concentration in water was confirmed with a gas chromatographic method 
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described earlier (U.S. Environmental Protection Agency, 1986b). 
Processing of Brain Tissues 
Following four weeks of continuous exposure, the animals were 
killed by decapitation, and their brains were rapidly removed, placed 
on an ice-cooled glass plate and microdissected into the following 
discrete regions according to the methods described by Glowinski and 
Iversen (1966): hypothalamus, medulla oblongata, cerebellum, corpus 
striatum, cerebral cortex and midbrain. The midbrain included the 
hippocampus, thalamus and subthalamus (Coulombe and Sharma, 1986). Each 
brain section was weighed to the nearest milligram and immediately 
placed in tared vials containing various volumes (in relation to tissue 
weight) of ice -cold 0.05 M perchloric acid (containing 0.1% cysteine to 
prevent oxidation of monoamine neurotransmitters). To overcome possible 
diurnal alterations in regional brain neurochemicals, all animals were 
sampled between 10:00 and 12:00 AM on the same day. Brain tissues were 
homogenized individually, and the mixtures were centrifuged at 10,000 g 
(30 min at 4°C) . The clear supernatant fractions were passed through 
0.2 ..um pore cellulose filter membrane by centrifugal filtration (MF-1 
filters, Bioanalytical Systems Inc., W Lafayette, IN) at I ,000 g for 3 
min at 4°C, then transferred to a 1.5 ml conical microcentrifuge tube. 
These filtrates were frozen at -80°C until analyzed within a few weeks. 
Assay of Monoamines and Their Metabolites 
The concentrations of the major brain catecholamines norepinephrine 
(NE), dopamine (DA), and their principal metabolites 3-methoxy-4-
hydroxymandelic acid (vanillymandelic acid, VMA), 3,4 -
dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA); the 
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indoleamine serotonin (5-hydroxytryptamine, 5-HT) and its metabolite , 5-
hydroxyindoleacetic acid (5 - HIAA) in perchloric acid extracts of 
indi vidual brain sections were determined by high performance 1 iquid 
chromatography (HPLC) with a multiple -electrode electrochemical detector 
(Mayer and Shoup 1983). The HPLC system (Bioanalytic Systems Inc., W 
Lafayette, IN) included a Model LC 150 electrochemical analyzer, Model 
LC 3A amphoteric detector, Model LC 22A temperature controller, and a 
Biophase ODS reverse phase column. The mobile phase was prepared 
according to methods described by Mayer and Shoup (1983) and was allowed 
to equil i brate overnight at a flow rate of 1.4 mL/ min before sample 
ana 1 ys is. The co 1 umn temperature was maintained at 30°C . Leve 1 s of 
brain monoamines or their metabolites were computed (using a 3390A 
reporting intergrator, Hewlett -Packard, Avondale, PA) from chromatograms 
derived from the responses of analytical amine standards (Sigma Chemical 
Co. , St . Louis , MO) prepared by diluting amine in 0.05 M perchloric acid 
conta ining 0. 1% cysteine to produce concentrations of 10, 25 , 50, 100 , 
200, 500 ng/ mL. Detector response provided a linear correlation 
coefficient for all standards(r2 > 0.98) . The retention time (min) of 
VMA, NE, DOPAC , DA, 5-HIAA, HVA, and 5-HT is 2.84, 3.66, 5.85 , 6.72, 
9.67, 11 .41, and 16.68, respectively. 
Statistical Analyses 
The levels of monoamines determined from brain regions were 
expressed as .ug/ g wet tissue weight . The effects on each regional 
neurochemi cal were analyzed by one -way analysis of variance (ANOVA), 
followed Fisher ' s least s ignificant difference (LSD) test (Dowdy and 
Wearden, 1983). Statistically significant differences were considered at 
p<0.05 . 
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RESULTS 
Benzene concentration of drinking water mixtures was determined by 
gas chromatography on different days during the test period. Although 
the concentrations of benzene in the drinking water decreased 
approximately 27-30% over a 3-day period, the average concentration was 
31 mg/ l for the 40 mg/l nominal concentration (79% of the intended 
concentration), 166 mg/ l (B3% of the intended concentration) for the 200 
mg/l group, and 790 mg/l ( 79% of the intended concentration) for the 
1000 mg/l group . Based on the observed water consumption during the 
period of exposure, the daily estimated benzene doses corresponded to 0, 
8, 40, 180 mg/ kg, respectively. 
Benzene levels used in this study did not significantly alter body 
weights, compared to the controls. Also, there were no apparent 
treatment-related behavioral alterations in test animals . Food and 
water consumptions were not s i gni fi cant ly affected by benzene addition 
to water in any of the groups. 
Administration of benzene via drinking water induced significant 
increases in monoamine neurotransmitters in several of the brain regions 
studied. In most cases, the changes were dose-related; in several 
instances maximum effects occurred at the benzene dose of 40 mg/kg/day, 
and did not increase in the highest dose group (180 mg/kg/day). An 
elevation in concentrations of NE and its acid metabolite VMA was 
observed in various brain regions after four weeks of benzene treatment 
(Figure IV - I and IV-2, Table IV-I) . Of particular interest, was a 
significant increase in the concentration of NE in the hypothalamus, the 
region containing the highest level of this monoamine, in the two 
higher dosed groups. The NE concentrations in this region increased by 
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Fig. IV-!. Concentrations of the various monoamines and their 
metabolites in the hypothalamus of mice exposed to benzene in drinking 
water for 4 weeks . Stars (*) denote significantly different from 
untreated control (p<0 .05) . Values are given as mean ± SE of five 
animals per group . NE , norepinephrine; 5-HT , serotonin; DA, dopamine; 
VMA, vanillymandelic acid ; 5-H IAA , 5-hydroxyindoleacetic acid; DOPAC , 
3,4-dihydroxyphenylacetic acid; and HVA, homovanillic acid . 
1.2 
CORTI! X IIIDBRAIIII CORPUS STRIATUII 
IIIIDULLA 
OBLONOATA 
CJ Control 
IZ2I 6 mg/kg/day 
~ 40 mg/kg/day 
• 160 mg/kg/day 
CBRZBBLLUK 
Fig. JV - 2. Concentrations of norepinephrine in the various brain regions 
of mice exposed to benzene in drinking water for 4 weeks . Stars(*) 
denote significantly different from untreated control (p<0.05). Values 
are given as mean± SE of five animals per gouup . 
TABLE IV-1 
EFFECTS OF BENZENE EXPOSURE ON REGIONAL CONCENTRATIONS OF BRAIN VANILLYMANDELIC ACID (VMA) 
Dosesb 
(mg/kg/ day) 
Concentrations ( pg/g wet tissue)a 
Control 
8 
40 
180 
a Values 
Medulla 
oblongata 
0 . 189 ± 0. 034 
0. 238 ± 0.009 
0.240 ± 0.005 
0.242 ± 0.008 
Cerebellum 
0.194 ± 0.010 
0.241 ± 0.016* 
0.234 ± 0.006* 
0.281 ± 0.014* 
are given as mean ± SE (n=5) 
Midbrain 
0. 231 ± 0.031 
0.285 ± 0.017 
0.248 ± 0.015 
0.266 ± 0.012 
Corpus 
striatum 
0.204 ± 0.028 
0.282 ± 0.029* 
0.291 ± o.ol3* 
0.295 ± 0.019* 
b Benzene was administered continuously via drinking water for 4 weeks 
* Significantly (p < 0.05) different from control values 
Cortex 
0.170 ± 0.017 
0.287 ± 0.030 * 
0.350 ± 0.040* 
0.293 ± 0.006* 
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40, 58 and 61 % in groups receiving 8, 40 and 180 mg/kg/day, 
respectively. Similar effects on NE were produced by benzene in medulla 
oblongata and cerebellum at various dose levels. As indicated in Table 
IV -1, VMA was induced concomitantly with increases of its parent 
chemical, NE . Significant elevation of VMA was observed in the corpus 
striatum, cerebellum and cerebral cortex in all treatment groups. 
Increases in concentrations of DA and its major metabolites , DOPAC 
and HVA, in the various brain regions were also observed. Concentrations 
of DA increased significantly in the hypothalamus of all benzene-treated 
groups (Figure IV-1) . In the corpus striatum, the region richest in DA , 
the concentrations of this neurochemical increased significantly in 
animals receiving 8 and 40 mg/ kg/ day of benzene. Concomitantly, both DA 
metabolites, DOPAC and HVA, also increased significantly in thi s brain 
region (Figure IV-3). In other brain regions , the concentrations of 
DOPAC , the first acid product of the DA oxidative pathway , were 
si gnificantly elevated only in midbrain (8 and 40 mg/kg/ day) (Table IV-
2). Amounts of DA, DOPAC and HVA in cerebellum, a region containing 
relatively low levels of these chemicals, were not determined . 
Significant benzene-induced increases of 5-HT levels were seen in 
hypothalamus, midbrain, cerebral cortex, corpus striatum and medulla 
oblongata (Figure IV-1 and JV-4) . No effect on 5-HT levels could be 
detected in the cere be 11 urn, where the concentrations of this biogenic 
amine are relatively low. Accompanying increases of 5-HT, there were 
significant increases of its main metabolite 5-HIAA in the midbrain 
corpus striatum and cortex (Table IV-3). The hypothalamic 5-HIAA levels 
generally accumulated to coordinate its precursor chemical, 5-HT 
(Figure JV -1). 
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15 CJ Control 
fZl 8 mg/kg/day 
~ 40 mg/kg/day 
• 180 mg/kg/day 
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DA DO PAC HVA 
Fig . IV-3 . Concentrations of dopamine and its major metabolites in the 
corpus stria tum of mice exposed to benzene in drinking water for 4 
weeks. Stars(*) denote significantly different from untreated control 
(p<0.05) . Values are given as mean± SE of five animals per gouup . DA, 
dopamine; DO PAC, 3, 4-di hydroxyphenyl acetic acid; and HVA, homovani ll i c 
acid. 
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TABLE IV -2 
EFFECTS OF BENZENE EXPOSURE ON REGIONAL CONCENTRATIONS OF BRAIN 
DOPAMINE (DA), 3,4-DIHYDROXYPHENYLACETIC ACID (DOPAC) , 
AND HOMOVANILLIC ACID (HVA) 
Chemicals Dosesb 
Concentrations ( ~9/9 wet tissue)a 
DA 
DO PAC 
HVA 
a Values 
(mg/kg/day) 
Control 
8 
40 
180 
Control 
8 
40 
180 
Contra l 
8 
40 
180 
Medulla 
oblongata 
0.037 ± 0.005 
0. 047 ± 0.006 
0.046 ± 0.003 
0.043 ± 0.006 
0.042 ± 0.006 
0. 058 ± 0.008 
0.054 ± 0.006 
0. 043 ± 0.006 
0.042 ± 0.003 
0. 047 ± 0.006 
0.065 ± 0. 004 
0.056 ± 0.007 
are given as mean ± SE (n=5) 
Midbrain Cortex 
0.265 ± 0.068 0.958 ± 0. 142 
0.494 ± 0.113 I. 349 ± 0. 178 
0.496 ± 0. 129 1.367 ± 0.086 
0. 330 ± 0.058 1.148 ± 0.105 
0.118 ± 0.020 0.209 ± 0.018 
0. 217 ± 0.025* 0.249 ± 0.018 
0. 215 ± 0.038* 0. 270 ± 0.033 
0. 120 ± 0.012 0.195 ± 0.021 
0. 138 ± 0.017 0.187 ± 0. 023 
0. 179 ± 0.021 0. 226 ± 0.008 
0. 218 ± 0.026 0. 246 ± 0.019 
0. 156 ± 0.019 0. 212 ± 0.008 
b Benzene was administered continously via drinking water for 4 weeks 
* Significantly (p < 0.05) different from control values 
1.5 
0.5 
CORTBX 
* 
MIDBRAIN 
* 
CORPUS 
STRIATUM 
* 
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CJ Control 
!Zl 6 mg/ kg/day 
IK8l 40 mg/ kg/ day 
• 160 mg/ kg/day 
NBDOLLA 
OBLONGATA CBRBBBLLOM 
Fig. IV-4. Concentrations of serotonin in the various brain regions of 
mice exposed to benzene in drinking water for 4 weeks . Stars(*) denote 
s ignificantly different from untreated contro l (p<O.OS} . Values are 
given as mean ± SE of five animals per gouup . 
TABLE IV-3 
EFFECTS OF BENZENE ON REGIONAL CONCENTRATIONS OF BRAIN 5-HYDROXYINDOLEACETIC ACID (5 -HIAA) 
Dosesb 
(mg/kgfday) 
Control 
8 
40 
180 
Medulla 
oblongata 
0.400 ± 0.017 
0.438 ± 0.035 
0. 494 ± 0.019 
0. 452 ± 0.031 
Concentrations ( pg/g wet tissue)a 
Cerebellum Midbrain 
0.172 ± 0.010 0. 552 ± 0.029 
0. 192 ± 0.020 0.636 ± 0.013 
0.173 ± 0.007 0.741 ± 0.057* 
0.151 ± 0.007 0.638 ± 0.038 
Corpus 
striatum 
0.451 ± 0.057 
0.598 ± 0.009 
0. 683 ± 0.033 
0.548 ± 0.024 
a Value s are given as mean ± SE (n=5) 
b Benzene was administered continuously via drinking water for 4 weeks 
* Significantly (p< 0.05) different from control values 
Cortex 
0.225 ± 0.014 
* 0.317 ± 0.016* 
* 0.311 ± 0.028* 
0.285 ± 0.010* 
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DISCUSSION 
This study monitored changes in selected regional brain monoamines 
that occurred after four weeks of benzene exposure in mice via drinking 
water. Since the concentration of any neurotransmitter does not by 
itself provide an appropriate indication of the turnover of that 
neurotransmitter to reflect monoaminergic neurophysiological activity 
(Commissiong, 1985), its metabolite(s) were also assayed. Assays in 
various regions of the brain is essential to detect potential 
perturbations of brain neurotransmitters because significant changes of 
certain neurochemicals may be concealed in certain minute brain regions 
and, therefore, remain undetected (Coulombe and Sharma, 1986). Due to 
the rapid changes in brain monoamine concentrations caused by the 
enzymes for both synthesis and catabolism (Faiman et al., 1973), the 
methods used to prepare brain tissues described earlier minimized the 
risk of postmorten alterations . 
The region a 1 concentrations of brain monoamine neurotransmitters 
and their metabolites obtained for the untreated control mice in this 
study were similar to those reported earlier for CD-I mice (Sharma et 
al., 1986) . Ingestion of benzene at the doses studied enhanced 
potentia 1 neurotoxic effects. Although se 1 ected neurotransmitters in 
the various discrete brain regions were significantly altered, no 
toxicological signs were observed during the period of treatment; the 
growth rate, and consumptions of food and water were not influenced by 
the benzene treatment. Similar treatment, however, caused macrocytic 
anemia at all dose levels of benzene (Chapter Ill). 
Benzene had the greatest effect on NE in the hypotha 1 amus and 
medulla oblongata; and on 5-HT in the hypothalamus, medulla oblongata 
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and midbrain. These increases were frequently associated with 
corresponding increases in VMA and 5-HIAA, respectively, suggesting an 
increased turnover of biogenic amines. Dopamine concentrations 
elevated significantly only in the corpus striatum, a brain region 
especially rich in this neurotransmitter, and in the hypothalamus . 
Elevated DOPAC and HVA levels were also observed in these brain regions. 
These findings are compatible with results reported by others 
(Paradowski et al. , 1984; 1985; Juorio and Yu, 1985a,b). However, since 
their studies were performed on whole-brain homogenates or only in one 
or two selected brain regions; our studies provide confirmation of their 
observations . In rats, subcutaneous admi ni strat ions of benzene in doses 
of 67.5 -540 mg/ kg/day for 4 weeks induced increases of brain NE and DA 
concentrations (Paradowski et al ., 1985}, and also produced 
accumulations of both 5-HT and 5-HIAA in the hypothalamus and striatum 
(Paradowski et al ., 1984). The regional concentrations of the various 
monoamines increased enough to suggest that benzene-induced 
perturbations in CNS monoaminergic biosynthetic pathways, as i s 
confirmed by the accompany ing increases in the met abo 1 i tes of these 
monoamines . Both synthesis and catabolism of these neurotransmitters 
increased following benzene intake. Synthesis of NE, DA and 5-HT more 
then compensated for their release and breakdown during the increased 
neuronal activity. In other words, their syntheses could cope with 
increased noradrenergic, dopaminergic and serotoninergic activities . 
Despite rather nonspecific correlations, behavioral changes may 
also indicate the involvement of monoamines. Benzene-induced milk-
licking, tremors, and hind-limb weakness indicated that this chemical 
possesses properties of neurobehavioral alterations in mice (Dempster et 
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al ., 1984), which are often attr i buted to an imbalance in the 
concentrations of catecholamines and indoleamine (Leibowitz 1986; Willis 
and Smith, 1985) . Furthermore, the subjective clinical indices of 
neurobehavior in humans exposed to benzene (250-500 ppm), e.g., vertigo, 
drowsiness, euphoria, giddiness, headache, and nervous irritability 
(Brief et al., 1980) may be mediated by alterations in regional brain 
monoamine levels. 
The mechanism for the benzene - induced changes in levels of 
monoamines and their metabolites is not yet known . The effects of 
benzene on the major enzyme systems in the monoaminergic biosynthetic 
pathway have never been clearly shown. Benzene produced an induction of 
aromatic -L-amino acid decarboxylase (AADC) but no effect on monoamine 
oxidase (MAO) (Juorio and Yu, !985a) . However, due to its high 
enzymatic activity, the induction of AAOC may not result in significant 
changes of endogenous monoamine levels (Cooper et al . , 1986) . Further 
investigations are needed to determine whether benzene alters the 
kinetics of the rate-limiting enzymes, tyrosine hydroxylase and 
tryptophan hydroxylase, in the catecholamines and indoleamine synthetic 
pathways, respectively. Benzene may interact with more than a single 
biological site, so data from nervous system molecular events, 
pharmacokinetics, as well as in vivo neurobehavioral changes are 
essential in the evaluation of the potential neurotoxic risk caused by 
ora 1 ingestion of benzene. 
Similar levels of benzene in drinking water caused alteration of 
various immune responses in CD-I mice as described earlier (Chapter 
I I I) . Although benzene is a hemopoi etoxi c chemica 1 and can directly 
suppress immune functions, the increases in brain catecho 1 ami nes will 
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have an additive adverse effect on the immune system via hypothalamus -
pituitary-adrenal (HPA) axis. Increased levels of catecholamines can 
result in increased adrenal corticosteroid levels (Makara et al ., 1980) 
which in turn are immunosuppressive (Claman, 1972). The pituitary-
adrenal status after benzene treatment is current ly being investigated 
in our laboratory. 
In summary, administratering benzene to CD-I mice for four weeks 
via drinking water significant elevated levels of NE, DA, and 5-HT, and 
their metabolites (VMA, DOPAC , HVA and 5-HIAA) in several brain regions 
studied . More detailed study of these phenomena will identify the 
mechanisms (membrane-mediated, metabolic , or both) that perturb the 
monoaminergic biosynthetic pathways. It is not known whether the 
neurotoxic effects of benzene are produced directly or indirectly (due 
to some metabolite(s) of this chemical) . The data do not predict a no -
effect level of benzene in drinking water. 
CHAPTER V 
EVALUATION OF TOLUENE EXPOSURE ON LEVELS OF 
REGIONAL BRAIN BIOGENIC MONOAMINES AND 
THEIR METABOLITES IN CD-1 MICE 
INTRODUCTION 
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Chemical contamination of groundwater, which is a primary source 
of drinking water for approximately half the population of the United 
States, has become a great matter of public concern (U.S. Office of 
Technology Assessment , 1984). Of major concern is the probable 
subclinical, deleterious effects resulting from continuous long-term 
exposure to low levels of chemicals. Toluene, a major aromatic chemical, 
is produced in enormous quantities , and is extensively employed as a 
starting material for other chemicals, an important component in 
gasoline, and a "safe" replacement for benzene in solvent applications 
(Fishbein, 1985). It has been detected in concentrations up to 6. 4 
mg/L in finished water (Tardiff and Youngren, 1986). The neurotoxic 
properties of this chemica 1 represent an important health hazard 
(Fishbein, 1985; Benignus, 198la). 
Toluene appears to have a pronounced effect on behavior; 
schedule-controlled behaviors have been reported to produce inverted U-
shaped concentration-effect curves on response rates in experimenta 1 
animals (Benignus, 1981b) . Abnormal electroencephalographic (EEG) 
activity following toluene inhalation was found in humans (Grasso et 
al., 1984), as well as in animals (Naalsund, 1986; Dyer et al., 1984). 
Rigorous neurochemi ca 1 studies are needed to better exp 1 a in to 1 uene' s 
neurobehavioral effects. Several studies have indicated that 
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concentrations of various brain biogeni c monoamines are affected by 
acute or subchronic administrat i on of toluene via inhalation or 
intraperitoneal injection to r2ts . Most reports showed that brain 
norepinephrine (NE) increased while dopamine (DA) increased or remained 
unaltered after toluene treatment (Rea et al., 1984; Andersson et al., 
1980; 1983; Arito et al., 1984; 1985) . Significant alterations in brain 
concentrations of serotonin (5 -HT) were also reported (Rea et al., 1984; 
Arito et al., 1984; 1985) . None of those studies involved evaluation of 
regional neurotransmitters after prolonged oral exposure to toluene . 
In this experiment we studied alterations in concentrations of 
region a 1 brain biogenic ami nes (i.e ., catecho 1 ami nes , indo 1 eami ne) and 
their major metabolites in CD-I mice continuously exposed to toluene via 
drinking water for 4 weeks. The neurochemicals selected for analys is are 
known to play an important role in physiology and behavior (Rogawski and 
Baker , 1985 ; Poirier and Bedard , 1984) . The concentrations of 
metabolites were studied since steady-s tate transmitter concentration s 
a 1 one are of 1 i mited va 1 ue about how a to xi cant perturbs the centra 1 
nervous system. Changes in metabolite concentrations indicate the 
metabolic activity of neuronal pathways related to specific 
neurotransmitters (Commissiong, 1985). Discrete brain areas were chosen 
because examination of discrete brain regions demonstrate preferential 
effects on specific pathways. Recently, several studies in our 
laboratory have indicated that chemical-induced neurotox icity might be 
re 1 a ted to the alterations of certain neurochemi ca 1 s in certain minute 
brain regions (Coulombe and Sharma, 1985; 1986; Sharma et al., 1986) . 
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MATERIALS AND METHODS 
Animals 
Adult male CD-1 mice (Charles River Breeding Laboratory Inc . , 
Wilmington, MA) were used in all studies. Mice were kept in an AAALAC-
accredited animal care facility with ambient temperature of 22 - 24°C, 40 -
60% relative humidity, and a 12 h light dark cycle and acclimated one 
week prior to the beginning of the study . Commercial rodent chow (Wayne 
Products, Chicago, IL) and tap water were available ad libitum. 
Chemical Treatment 
To 1 uene (chromatography grade, 99 . 7% purity, Burdick and Jackson 
Labs. Inc ., Muskegon, MI) was dissolved in drinking water to provide 
nominal concentrations of 20 , 100, and 500 mg/L. Toluene has a 
solubility of 535 mg/L in fresh water at 25°C (U.S. Environmental 
Protection Agency, 1980b). Exposures were conducted by continuous 1 y 
supplying the indicated concentrations of toluene in the drinking water 
for 28 days . Control animals received tap water without toluene. The 
treated water solutions were changed every three days to ensure 
freshness, and the volume of water ingested was recorded to estimate the 
dose of toluene intake . Food consumption was also monitored 
continuously, and animals were weighed weekly. Actual toluene 
concentrations in drinking water were determined by a gas 
chromatographic method (U . S. Environmental Protection Agency, 198Gb) . 
Processing of Brain Tissues 
Following 4 weeks of continuous exposure, mice were decapitated and 
their brains removed and immediately placed in an ice-cold glass petri 
dish. The brain was microdissected into six discrete regions: 
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hypothalamus, medulla oblongata, cerebellum, corpus striatum, cerebral 
cortex and midbrain according to the procedures of Glowinski and Iversen 
(1966). The midbrain includes the hippocampus, thal~mus and subthalamus 
(Coulombe and Sharma, 1986). Each dissected brain region was promptly 
weighed in tared vials containing several volumes (in relation to tissue 
weight) of ice-cold 0.05 M perchloric acid with 0.1% cysteine then 
frozen on dry ice. To overcome possible diurnal alterations in regional 
brain neurochemicals, all animals were sampled between 10:00 and 12:00 
AM on the same day. Tissue samples for chromatographic analysis were 
prepared as described in the methods section of Chapter IV. 
Assay of Neurotransmitters 
and Their Metabolites 
The concentrations of biogenic amines and their metabolites in 
various brain regions were assayed by high performance liquid 
chromatography (HPLC) with a multiple -electrode electrochemical detector 
(Mayer and Shoup, 1983) . The HPLC system consisted of a Model LC -150 
electrochemical analyzer, Model LC -3A amphoteric detector, Model LC -22A 
temperature controller, and a Biophase ODS -reversed phase column (Bio -
Analytic System Inc.). The mobile phase, containing sodium octyl sulfate 
as ion -pair reagent, was prepared according to our modifications of the 
methods described previously (Mayer and Shoup, 1983). A constant flow 
rate of 1.4 ml/min was delivered, while the column temperature was 
maintained at 30°C. The neurochemicals were oxidized by setting the 
potential at +0.7 V and the controller at 10 nA full scale. Data were 
recorded with a Hewlett- Packard (Avonda 1 e , PA) 3390A integrator from 
chromatograms derived from the responses of analytical standards (Sigma 
Chemical Co., St. Louis, MO). Standards were prepared by diluting 
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chemicals in 0. 05 M perchloric acid containing 0.1% cysteine to produce 
concentrations of 10, 25 , 100, 200, 500 ng/ml. The detector responses 
provided a linear correlation coefficient of > 0.98. Compounds assayed 
incl uded the major catecholamines norepinephrine (NE), dopamine (DA), 
and their principal metabolites, 3-methoxy-4-hydroxymandel i c acid 
(vanillymandelic acid, VMA) , 3-4-dihydroxyphenylacetic acid (OOPAC) , and 
homovanillic acid (HVA); indoleamine serotonin (5-hydroxytryptamine, 5-
HT) and its metabolite , 5-hydroxyindoleacetic acid (5-HIAA). 
Statistical Analysis 
The concentrations of monoamines and their metabolites determined 
fr om bra in regions were expres sed as ~g/g wet tissue. One-way analysis 
of var i ance (ANOVA) and follow-up Fisher's least significant differences 
(LSD) test were used to analyze the data for differences between 
toluene -exposure and corresponding normal water contra l . A l evel of 
p<0.05 was considered statistically significa nt . 
RESULTS 
Gas chromatographic analyses revealed that concentrations of 
toluene in drinking water mixtures decreased approximately 25-35% over a 
3-day period. The observed concentrations (overall average of the daily 
analysis) for the nominal concentrations of 0, 20, 100 , and 500 mg/ L 
were 0, 17 (±16%) , 80 (±12%), and 405 (±14%) mg/L, respectively. Based 
on water consumption during the duration of exposure, the estimated 
toluene intake doses corresponded to 0, 5, 22 , and 105 mg toluene/kg 
body weight/ day. 
At the doses used in this study, toluene did not adversely affect 
growth, mortality, body weights, nor did it produce any other overt 
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clinical symptoms of toxicity in mice. Food and water consumption 
throughout the study did not suggest any significant differences between 
treatment and control group . 
The regional concentrations of brain biogenic amines (NE, DA, 5-HT) 
and their major metabolites (VMA, DOPAC, HVA, 5-HIAA) in CD-1 mice are 
shown in Figs. V-1 through V-3 and Tables V-1 through V-3. Toluene 
ingestion induced significant increases in concentration of these 
neurochemicals in several of the brain regions studied. In most cases 
where statistical differences are noticed, the increases exhibited a 
biphasic response which began at a dose of 5 mg/kg/day, peaked at 22 
mg/kg/day, then decreased at 105 mg/kg/day. In several instances, the 
effects were dose-related. Figure V-1 indicates the effects of toluene 
on se 1 ected neurochemi ca 1 s in the hypotha 1 amus. The concentrations of 
NE increased significantly by 51, 63, and 34% in groups dosed with 5, 
22, and 105 mg/kg/day, respectively , in this compartment. The 
accumulations of its metabolite, VMA, were not statistically 
significant. Significant increases of DA and DOPAC levels were detected 
in animals receiving toluene doses of 5 and 22 mg/kg/day, but their 
metabolite, HVA, was not influenced. Toluene (22 mg/kg/day) also 
significantly increased concentrations of both hypothalamic 5-HT and its 
metabolite 5-HIAA. 
Figure V-2 illustrates the concentrations of the major amines and 
their metabolites in the corpus striatum following toluene treatment . 
Increases of DA concentrations in the corpus striatum, a brain region 
especially rich in this neurotransmitter, were dosed-related and 
ex hi bi ted significant differences i n the two higher dosed anima 1 groups 
as compared to those in the untreated animals. Toluene increased 
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Fig. V-1. Concentrations of various biogenic monoamines and their 
metabolites in the hypothalamus of mice exposed to toluene in drinking 
water for 4 weeks . Stars (*) denote significant differences from control 
values at p<0.05. Values are given as mean ± SE of five animals per 
group. NE, norepinephrine; 5-HT, serotonin; VMA, vanillymandel ic acid; 
5- HIAA, 5-hydroxyindoleacetic acid; DA, dopamine; DOPAC, 3,4-
dihydroxyphenylacetic acid; and HVA, homovanillic acid. 
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Fig . V-2. Effects of toluene treatment on concentrations of var ious 
biogenic monoamines and their metabol i tes in the corpus striat um . Stars (*) denote significant differences from control values at p<0.05 . Values 
are given as mean± SE of five animal s per group . NE , norepinephr i ne; 5-
HT, serotonin ; VMA, vanillymandelic acid ; 5-HIAA, 5-hydroxyindol eacet ic 
acid; DA, dopamine; DOPAC, 3,4-dihydroxyphenylacetic acid ; and HVA , 
homovanillic acid . 
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striatal HVA at the highest dose level only . No effects on NE were 
observed i n this brain region, but VMA concentrations were signif icantly 
induced in animals dosed with 22 and 105 mg/kg/ day. The two higher do se 
levels of toluene significantly elevated the hypothalamic 5- HT 
concentrations, while concentrations of 5-HIAA in this region were 
significantly higher only in the 105 mg/kg/day dosed animals. 
Concentrations of biogenic amines and their major metabolite in the 
brain regions of cerebellum, midbrain and cerebral cortex are given in 
Table V- 1 through V-3. The results shown in Table V-1 indicate that 
s i gni fi cant increases of NE were found in the midbrain in all to 1 uene 
treatment groups . The concentrations of VMA were correspondingly 
increased in this brain region and showed statistical difference from 
untreated control values in the two higher dosed groups . Toluene also 
caused a significant increase of VMA in cerebral cortex at the highest 
dose . The amounts of DA and its metabolites DOPAC and HVA , were not 
obviously affected in these three brain areas (Table V- 2) . Although HVA 
increased occasionally in the cerebellum, the concentrations of this 
chemical are relatively low in this region . There were significant 
increases of 5-HT in midbrain in all three toluene dosed groups and in 
cerebral cortex in the 22 mg/kg/day dosed mice (Table V-3). 
The effects of toluene ingestion on neurotransmitters and their 
metabolites in the medulla oblongata are presented in Figure V-3. 
Significant toluene-induced increases of NE and VMA were found at the 22 
mg/kg/day dose only . Relatively high concentrations of 5-HT and 5-HIAA 
were noticed in this brain area. There were significant increases of 5-
HT in the two higher toluene dosed animals and 5-HIAA in the 22 
mg/kg/day dosed group. Dopamine and HVA in this brain region were not 
TABLE V-1 
EFFECTS OF TOLUENE EXPOSURE ON NE AND VHA CONCENTRATIONS 
IN CEREBELLUM , MIDBRAIN , AND CEREBRAL CORTEX 
Concentrationb 
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Chemicals Dosea 
(mg/kg/day) 
Cerebellum Midbrain Cerebral Cortex 
Control 0.330 ± 0.041 0.575 ± O.Oll 0.359 ± 0.020 
NE 5 0.335 ± 0.015 0.660 ± 0.031 * 0.409 ± 0.029 
22 0.416 ± 0.023 0.671 ± 0.026 * 0.460 ± 0.026 
105 0.377 ± 0. 018 0. 691 ± 0.019* 0.429 ± 0.021 
Control 0.253 ± 0.015 0.305 ± 0.024 0. 253 ± 0.017 
VMA 5 0. 286 ± 0.009 0.320 ± 0.007 0.265 ± 0.006 
22 0.272 ± 0.020 0.356 ± 0.015 * 0.250 ± 0.013 
105 0.244 ± 0.008 0. 377 ± O.Oll * 0. 347 ± 0. 006 * ' 
a Toluene was administered continuously vi a drinking water for 4 weeks 
b ~g neurochemical/g wet tissue, Mean ± SE (n=5) 
* Signi ficantly different from untreated control at p<0.05 
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TABLE V-2 
EFFECTS OF TOLUENE EXPOSURE ON DA, DOPAC, AND HVA CONCENTRATIONS 
IN CEREBELLUM, MIDBRAIN, AND CEREBRAL CORTEX 
Chemicals Dosea 
Concentrationb 
(mg/kg/day) 
Cerebellum Midbrain Cerebral Cortex 
Control 0.040 ± 0. 004 0.270 ± 0.026 1.197 ± 0.093 
DA 5 0. 044 ± 0. 006 0. 488 ± 0.093 1.121 ± 0.130 
22 0.041 ± 0.007 0.310 ± 0.040 1.243 ± 0. 159 
105 0.046 ± 0. 005 0. 393 ± 0.061 1.134±0.084 
Control 0.027 ± 0.003 0.141 ± 0. 010 0 . 185 ± 0. 008 
DO PAC 5 0.022 ± 0.002 0.192 ± 0.049 0.1 55 ± 0.017 
22 0. 030 ± 0.005 0.1 26 ± 0.016 0.189 ± 0. 013 
105 0.029 ± 0. 003 0. 124 ± 0.011 0.179 ± 0.013 
Control 0. 008 ± 0.008 0.126 ± 0. 021 0.180 ± 0.019 
HVA 5 0.009 ± 0.009 0. 161 ± 0.030 0. 142 ± 0.012 
22 o.043 ± o.oo5* 0. 119 ± 0. 009 0.180 ± 0.023 
105 0.020 ± 0.009 0.132 ± 0.008 0.170 ± 0.017 
a Toluene was administered continuously via drinking water for 4 weeks 
b ~9 neurochemical/g wet tissue , Mean ± SE (n=5) 
* Significantly different from untreated control at p<0 .05 
TABLE V-3 
EFFECTS OF TOLUENE EXPOSURE ON 5-HT AND 5-HIAA CONCENTRATIONS 
IN CEREBELLUM, MIDBRAIN , AND CEREBRAL CORTEX 
Concentrationb 
Chemicals Dose a 
(mg/kg/day) 
Cerebellum Midbrain Cerebral cortex 
Control 0. 222 ± 0.054 0.763 ± 0.017 0.527 ± 0.013 
5-HT 5 0.191 ± 0.028 1.020 ± 0.046* 0.655 ± 0.007 
22 0.274 ± 0.027 1.102 ± 0.072* 0. 788 ± 0.049* 
105 0.194 ± 0. 027 0.982 ± 0.018* 0.654 ± 0.006 
Control 0.091 ± 0.022 0.370 ± 0. 005 0.170 ± 0.007 
5-HIAA 5 0. 084 ± 0.012 0.417 ± 0.023 0. 194 ± 0.013 
22 0.105 ± 0.016 0. 417 ± 0. 063 0. 232 ± 0.026 
105 0.060 ± 0. 005 0.322 ± 0.009 0. 179 ± 0.007 
a Toluene was administered continuously via drink i ng water for 4 weeks 
b ~g neurochemical/g wet tissue, Mean ± SE (n=5) 
* Significantly different from untreated control at p<0 . 05 
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Fig. V-3. Effects of toluene treatment on concentrat i ons of various 
biogenic monoamines and thei r metabolites in the medulla oblongat a . 
Stars (*) denote significant differences from control values at p<0.05. 
Values are given as mean ± SE of five animals per group . NE , 
norepinephrine; 5-HT, serotonin ; VMA , vanillymandelic acid ; 5-HIAA , 5-
hydroxyindoleacetic acid; OA, dopami ne ; DOPAC , 3,4-dihydroxyphenylacet i c 
acid ; and HVA, homovanillic acid . 
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affected by toluene treatment . A significant increase in DOPAC 
concentration was observed in the 22 mg/kgjday dosed group. 
DISCUSSION 
This study eva 1 uated the potentia 1 of to 1 uene to induce monoamine 
transmitter-related neurotoxicity in mice after 4 weeks of exposure via 
drinking water. The highest dose was lower than the solubility of 
toluene in fresh water at 25°C, which is 535 mg/L (U.S. Environmental 
Protection Agency, 1980b). The lowest dose was slightly higher than the 
EPA maximum permissible concentration of 14 .3 mg/L for ambient water 
(U.S. Environmental Protection Agency, 1986a), which was mainly based on 
a general toxicity evaluation of an oral dosing study in rats (Wolf et 
a l . , 1956). 
The concentrations of neurochemicals gained in the control group in 
this study we re similar to those reported earlier for CD-1 mice (Sharma 
et al . , 1986). In addition, since diurnal variations and postmortem 
changes in neurochemical concentrations were avoided, values generally 
varied little within groups. 
The findings indicate that ingestion of ambient water containing 
toluene at the EPA permissible concentration may have neurotoxic 
effects. Significant increases in regional concentrations of various 
neurochemi ca 1 s in several brain regi ens caused by toluene ingestion 
waul d be sufficient to suggest toluene-induced perturbat i ens in 
monoaminergic biosynthetic pathways. The corresponding increases in 
their metabolites support the validity of these findings. Noradrenergic 
neurons and serotonergi c neurons appeared to be high 1 y vul nerab 1 e to 
toluene while dopaminergic neurons were rather resistant. Toluene 
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dramatically affected NE concentrations in the hypothalamus, medulla 
oblongata, midbrain and corpus striatum, and 5-HT concentrations in the 
hypothalamus, medulla oblongata, midbrain, cerebral cortex and corpus 
striatum. Increased concentrations of NE and 5-HT along with their 
respective metabolites (VMA and 5-HIAA) in these regions suggest that 
syntheses of NE and 5-HT more than compensate for their releases and 
breakdown during increased neuronal activities. The significant 
increase in concentrations of DA and its metabolites in the hypothalamus 
may be a secondary effect si nee they are not major neurochemi ca 1 s in 
this brain compartment. Although toluene treatment significantly 
increased DA concentrations in the corpus striatum, only slight 
increases of its metabolites DOPAC and HVA were observed. In addition 
to these two brain areas, no apparent effects on DA or its metabolites 
were found in any of the other brain regions. 
Increases in steady-state levels of NE, DA and 5-HT have been 
reported in whole-brain homogenates or discrete brain areas of rats who 
continuously inhaled 100, 300, or 1000 ppm toluene for 8 hr (Rea et al . , 
1984). Subchronic repeated exposure of rats to toluene vapor also 
increased concentrations of catecholamines and their turnover rates in 
hypothalamus or median eminence (Andersson et al., 1980; 1983). After a 
single ip administration of 200 mg toluene/kg body weight to rats, Arito 
et al. (1984) reported a significant increase in the regional 
concentrations of NE, 5-HT and their respective metabolites, 3-methoxy-
4-hydroxyphenylethyleneglycol (MHPG) and 5-HIAA, however, alterations in 
DA and its metabolites DOPAC and HVA were not detected. In their follow-
up study, however, 14 consecutive days of ip injection of toluene in 
rats significantly increased NE and MHPG only (Arito et al., 1985). 
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Pronounced increases in the concentrations of serum corticosterone , 
growth hormone (GH), follicle -stimulating hormone (FSH) and prolactin 
(PRL) were found in rats under the influence of toluene exposure via 
inhalation (Andersson et al., 1980; 1983) . Hypothalamic monoaminergic 
mechanisms are known to have an important role in the secretion of these 
types of adenohypophyseal hormones. 
Results in the present study also support the possible involvement 
of monoamine metabolism in the available behavioral and 
neurophysiological reports of toluene - induced bell-shaped concentration -
effect curves , i.e . , initially increasing rates and at higher level s 
decreasing rates of response (Dyer et al., 1984; Benignus, 1981b). 
Alterations in the brain concentrations of neurotransmitters and their 
metabolites have been correlated with abnormal behavioral and 
physiological functions (Rogawski and Baker, 1985; Will is and Smith, 
1985; Poirier and Bedard, !984) . 
The mechanisms of these changes in concentrations of biogenic 
amines and their metabolites are not yet known . Changes in the amount s 
of neurotransmitters in neurons may result from the destruction of 
cellular elements in which transmitters reside, or from perturbations 
that profoundly alter neuronal activity or metabolism . Uptake of 
toluene in the central nervous system is highest in the cerebrum, and is 
rapidly eliminated from brain tissue in rats (Savolainen, 1978). 
Subacute treatment of rats with toluene via inhalation was reported to 
reduce affinities in striatal DA receptors (02 type) and cortical 5-HT 
receptors at a high concentration (3 , 000 ppm) (Celani et al., 1983), and 
the number of 5-HT binding sites in hippocampus and pons plus medulla 
oblongata at a concentration of 7,000 ppm toluene (Yamawaki et al. 
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1982) . A down regulation activity at the DA and 5-HT synapses , resulting 
in a ma j or metabolic effort of the presynaptic monoamine nerve cell to 
maintain normal monoamine rgic transmission , was suggested by the se 
workers . In contrast, one st udy demonstrated that no neurostructural 
changes in the rat brain were found following subchronic inhalation of 
less than 1,500 ppm toluene (Lewis and Holdsworth, 1982). The absence of 
neurostructural changes together with the reported increases in response 
rates of neurobehavioural and electrophysiological effects following 
exposure to low toluene concentrations mentioned above suggest that 
toluene -i nduced neurotoxicity may result from elevated concentrations of 
significant neurotransmitters. 
The toluene-induced increase in brain biogenic monoamine metabolism 
may have an additive adverse effect via the hypothalamo-pituitary -
adrenal (HPA) axis. The role of HPA status after toluene treatment is 
currently being investigated . It is important to note that significant 
changes in concentrations of neurochemical s in several specific brain 
regions occurred at the dose near the current U.S . Environmental 
Protection Agency criterion level (i.e ., 14 .3 mg/L) for toluene in 
water . Further investigations to re -evaluate the safety limits of low -
level toluene exposure via drinking water seem warranted. 
CHAPTER VI 
IMMUNOTOXICOLOGICAL EVALUATION OF SUBCHRONIC 
TOLUENE EXPOSURE IN CD-1 MICE 
INTRODUCTION 
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The initial studies of this series of subclinical effects of 
groundwater contaminants focused on benzene (Chapter Ill, VI) . Toluene , 
another major aromatic hydrocarbon of environmental significance, is 
produced in enormous quantities and is widely used in a broad spectrum 
of applications as a solvent, an important component in gasol i ne , and an 
intermediate in the synthesis of a multitude of organic chemicals 
(Fishbein, 1985). It has been detected in finished water supplies in 
concentrations up to 6.4 mg/L (Tardiff and Youngren, 1986) . Potential 
for exposure to to 1 uene exists for both industria 1 workers and the 
general public. 
Toluene exposure is reported to produce a variety of pathologic 
states in humans beings or experimental animals, including cardiac 
se nsitization, kidney and liver damage, and various neurological 
disorders (Benignus, 1981a,b; Hayden et al ., 1977). We demonstrated that 
toluene ingestion causes perturbation of regional brain monoamine 
met abo 1 isms in the centra 1 nervous system of mice (Chapter V) . In 
addition, toluene was found to be embryotoxic in rats, mice, and rabbits 
(Courtney et al., 1986; Ungvary and Tatrai, 1985; Nawrot and Staples, 
1979). Alterations in lymphocyte fu nctions, protei n kinase C activity 
and cl astogen i c effects a 1 so have been noted (Mohtashami pur et a l., 
1987; Roghani et al., 1g87; Suleiman, 1987; Dean, 1985; Fishbein, 1985; 
Schmid et al . , 1985). Both in vivo and in vitro studies have indicated 
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that toluene, via oxidation of the aromatic ring, is activated to give 
reactive intermediates that bind covalently to biomolecules (Pathiratne 
et al., 1986b). 
Despite the many toxicologic studies of toluene in experimental 
animals, only few published studies have examined its immunotoxic 
potential (Fishbein, 1985; U.S. Environmental Protection Agency, 1980b). 
Recently, Aranyi et al. (1985) reported a significant suppression in 
host defense mechanisms against microorganism infections in mice that 
inhaled toluene at concentrations ranging from 2.5 to 500 ppm. Because 
of its benzene-like structure and lipophilic nature, and its common 
occurrence in groundwater, a primary source of drinking water for 
approximately half the population of the United States, it is important 
to fully understand the immunotoxicity of toluene. Toxicity on the 
immune system may be relevant to determine significance to human health 
following chronic low-level exposure to toluene. 
This study was designed to evaluate the general toxicity, 
hematological response, interleukin-2, and both humoral and cell-
mediated immunity in mice exposed to various concentrations of toluene 
vi a ora 1 ingestion for 28 days. The 1 owest concentration of to 1 uene 
employed approached the EPA maximum permissible level (14.3 mg/L) for 
drinking water (U.S. Environmental Protection Agency, 1986a). 
MATERIALS AND METHODS 
Animals 
Six-week-old male CO-l mice were obtained from Charles River 
Breeding Laboratory Inc. (Wilmington, MA) and quarantined 1 week prior 
to being used. Mice were housed in groups of five per cage in a room 
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maintained at a constant temperature (22 -24°C) and humidity (40 -60%) 
with a 12-h light/dark cycle before and during the experiment . 
Commercial rodent chow (Wayne Products, Chicago, IL) and water were 
available ad libitum. 
Exposure Regimens 
To 1 uene ( chromatoqua 1 i ty grade, 99.7 % purity Burdick and Jackson 
Labs. Inc . , Muskegon, MI) was dissolved in normal tap water in 
concentrations of 20, 100, and 500 mg/L. Toluene has a solubility of 
535 mg/L in fresh water at 25°C (U.S. Environmental Protection Agency, 
1980b) . Exposures were conducted by administering the toluene solutions 
to mice continuously for 28 days via drinking water; control animals 
received tap water without toluene . Drinking water was prepared and 
changed at least every 3 days . Food and water consumption were 
monitored continuously, and animals were weighed once a week. The water 
was sampled daily to confirm toluene concentrations by gas 
chromatography (U . S. Environmental Protection Agency, 1986b). 
Gross Observations and Hematology 
Body, spleen, thymus, liver and kidney weights of animals were 
determined immediately upon sacrifice at the end of 28 days continuous 
exposure . Gross pathological examinations were performed on all mice . 
Total erythrocytes and leukocytes of blood samples were counted with a 
Coulter counter. Differential leukocyte counts were evaluated by 
Wright ' s stained smears. The single splenocyte suspensions were 
prepared aseptically as described by Sharma and Gehring (1979). Unless 
stated otherwise, all splenocyte manipulations were performed in 
complete RPM! tissue culture medium containing RPM! 1640 medium 
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supp 1 emented with 5% heat-inactivated feta 1 ca 1f serum, 100 units/mL 
penicillin and 100 ~g/mL streptomycin. 
Mitogen -Stimulated Lymphocyte Proliferation 
Splenocyte lymphoproliferative responses to mitogens were 
determined with optimal concentrations of the T-cell mitogens 
phytohemagglutinin (PHA , 6.0 ~g/mL; Wellcome Reagents Ltd. , Beckenham, 
England), and concanavalin A (Con A, 2.5 ~g/mL; Sigma Chemical Co ., St. 
Louis, MO), the B-cell mitogen E. coli 1 ipopolysaccharide (LPS, 20 
~g/mL ; Sigma), and the T- and B-cell mitogen pokeweed mitogen (PWM , 30 
~g/mL; Gibco). Cells were plated in 96-well sterile flat-bottom 
microtiter plates. Triplicate cultures containing 5xi05 viable (i.e ., 
trypan blue-excluding) cells per well in 0.1 5 mL of medium with or 
without mitogen were prepared for splenic cells from individual treated 
or control mice . Cultures were incubated at 37°C for 48 hr in a 
humidified atmosphere with 4.0% co2 and harvested after a 6-hr pulse 
with tritiated thymidine (3H -TdR, 0.5 ~Ci/well; New England Nuclear, 
Boston, MA) on glass fiber filters using an automatic cell harvester . 
Cell-incorporated radioactivity (dpm) was quantitated with a liquid 
scintillation counter (Model 2660, Packard Instrument Co., Downers 
Grove, IL), and compared against background incorporation with media 
alone. 
Mixed Lymphocyte Culture iMbhl Responses 
The responses of MLC were assessed by measurement of the 
lymphoproliferation of splenocytes (responders) from toluene-treated or 
control CD-1 mice after co-culture with mitomycin C-treated YAC-1 mouse 
lymphoma cells (stimulators), a mouse lymphoma cell line (H -2a) of A/Sn 
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origin, at responder-stimulator ratios of 1:1, 2:1 , and 4:1. The 
complete RPM! culture medium was su pplemented with 5x1o -5 M 2-
merc aptoethanol (2-ME). After a 72 -hr incubation, cells were pulsed 
with 3H -TdR for 6 hr and harvested and counted for the cell -i ncorporated 
radio 1 abe 1 as described for the mitogenesis assays above. Spontaneous 
3H-TdR incorporation was quantitated in cultures incubated without YAC-1 
ce 11 s. 
Antibody Plague-Forming Cell i£££1 Responses 
In a separate experiment , each mouse from control and exposed 
groups wa s sensitized by ip injection with 0. 25 ml of a 20% wa shed SRBC 
sus pensi on 4 days before the end of to 1 uene exposure. Numbers of lgM 
plaque - forming cells (PFC) were quantitated by the methods of Cunningham 
and Szenberg (1968). Results are expressed as PFC/106 splenocytes and 
as PFC/ tota 1 splenic ce 11 s. The titer of anti- SRBC anti body in t he 
serum collected from mice used in the PFC assay was analyzed by a double 
sandwich enzyme - linked immun osorbent ass ay (ELISA) as previously 
reported (Chapter III). 
Interleukin-2 ~Assays 
Jnterleukin -2 production was assayed by the methods de scr ibed 
elsewhere (Gillis et al., 1978; Exon et al., 1983) with minor 
modifications . Briefly, aliquots of splenic lymphocytes (5 X 105) 
obtained from chemical-treated or control animals were cultured in RPM! 
media with 10% FCS, 5x1o-5 M 2-ME, and antibiotics with or without Con A 
at the concentration of 2.5 ug/ml, to stimulate IL-2 production. At 48 
hr, the culture supernatants were collected by removing the cells with 
centrifugation. Supernatants were assayed for IL-2 content by the 
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ability to enhance proliferation of an IL-2-dependent murine T-helper 
cell line (HT-2) of BALB/c origin, originally established by J . Watson 
(1979) . The growth of HT-2 cells was maintained in the supernatants of 
Con A-stimulated rat splenic lymphocyte cultures. Serial two-fold 
dilution of IL-2-containing supernatant samples (100 ~L) and 4X!03 HT-2 
cells (50 ~L) were placed into triplicate wells of a 96 -well microtiter 
plate. Cultures were incubated at 37°C in a humidified atmosphere with 
4.0% co2 for 24 hr and harvested after a 4-hr pulse with 0.4 ~ci of 3H-
TdR per well. The cells were harvested onto glass fiber filters and the 
amount of 3H-TdR incorporation ( dpm) was determined by sci nt illation 
counting. A supernatant of Con A-stimulated rat splenic lymphocyte 
culture was used as positive control. Non -Con A-stimulated supernatants 
from CO-l mouse splenic lymphocyte cultures were tested as negative 
control to assess background induction of IL-2. 
Statistical Analysis 
All data were expressed as the means and their standard errors . 
Statistical evaluation was carried out by a one-way analysis of variance 
(ANOVA) and Fisher's least mean significant differences (LSD) test. A 
level of p<O.OS was considered statistically significant. 
RESULTS 
Concentrations of toluene in the drinking water mixtures as 
determined by gas chromatography decreased approximately 25-35% over a 
3-day period, when water was changed. The actual concentrations 
(overall mean of the daily analysis) for the nominal concentrations of 
0, 20, 100, and 500 mg/L were 0, 17 (± 16%), 80 (±12%), and 405 (±14%) 
mg/L, respectively. Based on toluene concentration in water during the 
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exposure and the estimated water intake , doses of toluene were 0, 5, 22, 
105 mgj kg/ body weight/day . 
Animals exposed to toluene at the doses used did not produce 
mortal i ty or exhibit overt clinical symptoms of toxicity over a 4-week 
period. Overall, no significant change in food and water con sumption 
between treatment and control groups was observed during the study . No 
gross lesions were found at the time of sacrifice , on any of the organs 
of mice in all treatment groups . 
The selected organ and body we ight data for toluene -dosed mi ce are 
presented in Table VI-I. No differences were observed between group and 
those of the control group . Liver weights were s ignificantly i ncreased , 
wh i 1 e the weight of a thymus was decreased, at the highest dose of 
toluene (i.e . , 105 mg/kg/day) . No changes were found in spleen or 
kidney weights. 
Table VI-2 shows the effects of toluene on spleen cellularity , 
erythrocyte and leukocyte counts and absolute differentials . Total 
splenocytes did not show a significant decrease in any treatment groups . 
No significant differences were observed in any of selected 
hematological parameters, although a nonsignificant decrease in total 
circulating leukocyte counts and lymphocyte and neutrophil populations 
was noted in mice receiving toluene at the 105 mg/kg/day dose. 
The splenocyte lymphoproliferative response data for optimal 
st imul at i ng concentrations of the T- and B-ee ll mitogen PWM, T -cell 
mitogens Con A and PHA, the B-cell mitogen LPS are shown in Fig. VI-I. 
Significant reductions in 3H-TdR uptake were found for spleen cells 
cultured in the absence of mitogen or in the presence of PWM from the 5, 
22 , and 105 mg/kg/day dosage groups . Lymphocyte responsiveness to Con A 
TABLE VI-1 
ORGAN AND BODY WEIGHT OF MICE FOLLOWING 4 WEEKS OF TOLUENE EXPOSURE 
Dose a 
Body weight {g)b Organ weight {g/100 g body weight)b 
(mg/ kg/ day) 
Day 0 Day 28 Spleen Liver Kidney 
0 20.62 ± 0. 13 34 .86 ± 1.18 0. 34 ± 0.03 5.67 ± 0.07 1.62 ± 0.05 
20.56 ± 0.02 34 . 26 ± 0.64 0.31 ± 0.01 6.09 ± 0. 17 1. 72 ± 0.06 
22 20.16 ± 0.31 33 . 18 ± 0. 21 0.33 ± 0.01 6. 32 ± 0. 17 1.68 ± 0.03 
105 20 .00 ± 0.23 35 . 12 ± 0.72 0.28 ± 0.01 6. 73 ± 0.14* 1.68 ± 0.05 
a Toluene was administered continuously via drinki ng water for 4 weeks 
b Value s are given as mean± SE (n=5) 
* Signifi cantly different from control values at p<0.05 
Thymus 
0. 19 ± 0.02 
0.18 ± 0.01 
0.18 ± 0.02 
0.13 ± 0.02* 
0 
0 
TABLE VI-2 
EFFECTS OF FOUR WEEKS OF TOLUENE EXPOSURE ON SPLEEN CELLULARITY AND 
SELECTED BLOOD PARAMETERS 
Total Leukocyte absolute differentialsc 
Dose a splenoc7tec ErythGocy~ec Leuk~cyt~{ (mg/kg/day) (X W ) (10 /mm ) (10 /nm ) 
Lym~hoc~te (10 /mm ) ~utrfphil (10 /mm ) 
0 7.71±0 . 27c 9.30 ± 0.26 5.96 ± 1.02 4.40 ± 0.62 1.13 ± 0.38 
6.18 ± 0.52 9.87 ± 0.49 6.34 ± 0.57 4. 46 ± 0.38 1.46 ± 0. 39 
22 6.57 ± 0.91 8.79 ± 0.85 6.43 ± 0.57 4.50 ± 0. 78 1.42 ± 0. 48 
105 6.58 ± 0.47 9.38 ± 0.38 3.90 ± 0.36 2.81 ± 0.82 0.82 ± 0. 16 
a Toluene was administered continuously via drinking water for four weeks 
b Including monocyte, eosinophil and basophil 
c Values are given as mean ± SE (n=5) 
O~herb 
(10 ;mm3) 
0. 41 ± 0.08 
0.42 ± 0.09 
0.50 ± 0.07 
0. 36 ± 0.05 
C> 
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Fig. VI-1 . Effect of toluene exposure on splenocyte lymphoproliferative 
responses to LPS, PWM , Con A, and PHA mitogens. Toluene was 
administered continuously to mice via drinking water for 4 weeks, 
control mice received tap water without toluene. The bars (left to 
right), 0 , • · IZ!, and !RBI . indicate toluene at 0 (control), 5, 
22, and 105 mg/kg/day concentrations, respectively. ~ta·rs (*) denote 
significantly different from control (p<O . OS) . Values represent mean± 
SE of 5 animals per group. 
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and PHA was suppressed significantly for mice exposed to toluene at the 
two highest doses . Splenocytes from toluene -treated mice also exhibited 
a decreased response to LPS at the 105 mg/kg/day dose. 
Figure VI-2 illustrates the effect of toluene exposure on the mixed 
lymphocyte cultures. The ability of splenic lymphocytes to proliferate 
in response to a 11 a anti gens ( YAC-1 1 ymphocyt i c ce 11 s) was unchanged by 
exposure to toluene at the two low dosages, but a significant difference 
was seen in the highest dosed group . 
The results of primary antibody response (T-cell dependent) to SRBC 
are presented in Table Vl-3. A significant reduction in PFC/106 
splenocytes or PFC/total spleen was seen in animals that received 
toluene at 105 mg/kg/day. However, changes in the total number of 
recovered splenocytes or o( -SRBC antibody as determined by ELISA were 
not significant in any toluene-treated group. 
Splenocytes taken from mice treated with 105 mg/kg/day toluene 
produced significantly less IL-2 after induction by Con A in culture 
(Table Vl -4) . The IL-2 activity was reduced to less than half in the 
highest treatment group, compared with controls . There was no change in 
IL-2 synthesis from spleen cells of mice exposed in the two low dosage 
groups. 
DISCUSSION 
Results of evaluations of the hematotoxic potential of toluene 
ingestion via drinking water for 4 weeks revealed that the chemical was 
nontoxic. There is general agreement that toluene does not have the 
hematotoxi c properties of benzene ( Fishbein, 1985; U.S . En vi ronmenta 1 
Protection Agency, 1980b). Wolf et al. (1956) conducted a long-term 
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Fig . VI-2. Effect of toluene exposure via drinking water on mixed 
lymphocyte culture (~C) responses . See legend of Fig. VI - I for detail s. 
Responders indicate H-thymidine incorporat i on in splenic 3cells alone , whereas responders and stimulates indicate the H- thymid i ne 
incorporation when the splenocytes was cocultured in the presence of 
mitomycin C-treated YAC-1 cells. Several stimulator: re sponder ratio s 
were used , but data are presented only from the 1:2 ratio , whic h ga ve 
optimal stimulat ion. Mean± SE of 5 an imals per qroup, each cultured in 
triplicate . Stars (*) denote significantly different from control 
(p<O.OS). 
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TABLE VI-3 
EFFECTS OF 4 WEEKS OF TOLUENE EXPOSURE ON ANTIBODY PLAQUE 
FORMING CELLS (PFC) AND ANTIBODY TITER (oc-SRBC)a 
Doseb 
(mg/kg/day) 
0 
5 
22 
105 
Total 
splenocy7es (x 10- ) 
20.16 ± 2.75 
16.68 ± 1.19 
21. 7B ± 3.05 
13.66±1.79 
PFC/106 
splenocytes 
1,184 ± 90 
985 ± 105 
973 ± 116 
631 ± 27* 
PFC/spleen 
238,545 ± 37,429 
166,015 ± 30,231 
217,891 ± 47,845 
89,936 ± 13,269* 
o(.-SRBC 
0.44 ± 0.04 
0.55 ± 0.06 
0.43 ± 0.05 
0.32 ± 0. 03 
a Mice were sensitized with thymic-dependent antigen sheep erythrocyte (SRBC) 
four days before the end of toluene exposure. Splenocytes were analyzed for 
antibody plaque forming cell and sera were detected for antibody titer (oc-
SRBC). Values are given as mean± S.D. (n=5) 
b Toluene wa s administered continuously via drinking water for four weeks 
* Significantly different from control values at p<O.OS 
C) 
TABLE VI-4 
EFFECTS OF TOLUENE EXPOSURE ON INTERLEUKIN-2 SYNTHESIS BY 
CON A-STIMULATED MOUSE T-LYMPHOCYTEa 
Dose 3H-Thymidin3 uptake Stimulation indexb 
(mg/kg/day) (DPM X W } 
0 12.95 ± 1.9B 15.70 ± 2.39 
5 11.13 ± 2.57 13.49 ± 3.11 
22 10 0 21 ± 1.38 12 0 38 ± 1.68 
105 50 93 ± I. 26 * 7. 18 ± 1.53* 
Positive controlc 14 . 58 ± 0.23 17.66 ± 0.27 
Negative controld 1.34±0. 76 1.62 ± 0.68 
106 
a Several serial dilutions of IL-2 sources (supernatants of 
3plenocyte culture) which showed a decreasing incorporation of 
H-thymidine to IL-2 dependent murine T-helper cell clone, HT -2 
cell , were used. Only data obtained from a 1:2 diluted ratio 
were presented. Values are given as mean ± SE (n=5) 
b Stimulation index (S . I.} = dpm (culture with dilution of 
supernatant}/dpm (culture with media alone) 
c Rat spleen conditioned medium (supernatant of Con A-stimulated 
rat splenocyte culture) 
d Supernatant of non-Con A-s timulated splenocyte cultures of 
untreated mice 
* Significantly different from the untreated control at p<0. 05 
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toxicity study in which toluene was given orally to rats, and indicated 
no adverse effects on the cell counts of circulating blood and bone 
marrow. In a study of toluene-benzene interaction in mice, Andrews et 
al . (1977) noted that toluene had no effect on incorporation of 59 Fe 
into developing erythrocytes. 
Consistent alterations in the immune parameters examined were 
generally found only in mice receiving the highest dose of toluene (105 
mg/ kg/day) . The observed effects of suppressed humoral and cellular 
immunity, and decreased JL-2 synthesis at this dosage were accompanied 
by a decrease in thymus weight. Thymus involution is consistent with 
the impairment of T-cell function. The suppressed proliferation 
responses of lymphocytes from exposed mice to specific mitogen signa 1 
was found at the lower toluene doses, but proliferation of lymphocytes 
were not suppressed in response to allogeneic stimulation, and in vivo 
T-dependent antibody production response was not suppressed . Other 
studies have demonstrated only marginal correlation between lymphocyte 
response to mitogens and alterations in host resistance or any other 
immunologic function assay (Dean, et al., 1985b) . The ability of 
lymphocytes to recognize and respond to foreign histocompatibility 
antigens (versus mitogens) represents a critical juncture in the 
generation of an appropriate immune response . After exposure to toluene 
vapor at concentrations as low as 2. 5 ppm, mice exhibited increased 
susceptibility to respiratory infection with Streptococcus zooepidemicus 
and decreased pulmonary bactericidal activity to Klebise71a pneumoniae 
(Aranyi et al., 1985). Several reports have appeared in the literature 
which 1 ink exposure of toluene to altered immunocompetence in animals 
and humans (U.S. National Toxicology Program, 1987; U.S . Environmental 
108 
Protection Agency , 1980b) . 
Treatment of mice with toluene at the highest dose level 
s i gnificantly reduced IL - 2 synthesis . Inhibition of this basic 
immunoregulatory lymphokine may be a basic mechanism by which toluene 
mediates immunotoxic effects via oral ingestion. IL-2, produced by 
helper T-cell following stimulation with either T-cell mitogens or 
allogeneic cells, is known to augment numerous immune responses 
including proliferation and generation of cytotoxic T-cells and residual 
helper-T cells , and to enhance the antibody-forming cell responses 
(Farrar et al. , 1982; 1986; Gillis et al., 1978). 
Toluene caused immunotoxicity at the 105 mg/ kg/day dose and may 
al so be linked to the induction of corticosteroid release as a result of 
s timulating effects on the hypothalamic - pituitary-adrenocortical (HPA) 
ax is . This exposure regimen has been demonstrated to activate mouse HPA 
status, resulting in increased concentrations of the hypothalamic 
norepinephrine and its major metabolite, vanillymandelic acid, which in 
turn leads to increased secretions of adrenocorticotropic hormone (ACTH) 
and corticosterone from pituitary gland and adrenal gland, respect i vely 
(Chapter VII). Corticosteroids , the end products of HPA axis, are known 
to impair various aspects of immunocompetence and to inhibit IL - 2 as 
well as IL-l synthesis (Goodwin et al., 1986; Cupps et al., 1985; Snyder 
and Unanue, 1982; Gill is et al., 1979a,b). Increased corticosteroid 
concentrations can control the clonal expansion (driven by IL - 2) of the 
committed cells of the immune system (Besedovsky et al. , 1985) . The 
helper T-cell is believed to be the most susceptible lymphocyte subset 
(Esterl ing and Rabin, 1987; Verbruggen et al., 1987). Consequently, 
decrease of helper T-/suppressor T-cell ratio could result in 
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immunosuppression. 
Benzene-induced toxicity has been attributed to various reactive 
intermediates (Irons, 1985). Similarly, it has been indicated that 
formation of cresol from aromatic oxidation of toluene occurs through an 
arene oxide intermediate which, in turn, is a reactive metabolite and is 
responsible for the binding of toluene to biomacromolecules (Pathiratne 
et al ., 1986a; Bakke and Schel ine, 1970) . Superoxide anions are also 
formed during the formation of secondary metabolites, such as 
semiquinones and quinones, from the oxidation of cresol (Pathiratne et 
al., 1986a), suggesting that covalent binding of toluene to biological 
macromolecules involves more than one reactive metabolite. However, the 
covalent binding effects of toluene to biomacromolecules were 
considerably less than those of benzene, which could account for the 
differences in degree of immunotoxicity of toluene and benzene 
(Chapter I I I). Further studies are needed to determine the precise 
biological site of action of toluene. Toluene treatment was found to 
induce the activities of microsomal monoxygenenase, increasing the 
concentration of cytochrome p-450 in the 1 iver and some non-hepatic 
tissues (Pathiratne et al ., 198Gb; Pyykko, 1980; 1983). Increase of 
1 iver weights in the highest dosed group of our study may support the 
validity of these findings. 
For the protection of human health from the toxic properties of 
toluene ingested through water, the current U.S. Environmental 
Protection Agency ( 1986a) criterion 1 eve 1 for to 1 uene in water is 14.3 
mg/L. This permissible concentration is extrapolated from a general 
toxicity evaluation of an oral dose study in rats (Wolf et al. , 1956), 
which at the time was thought to be well below any toxicity-based 
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criterion . Although at the doses used in this study, toluene did not 
elicit any general toxicity and hematotoxicity , the effects of toluene 
on immune function should be examined in more detail and in different 
animal species to more accurately assess the potential hazard to human 
health of chronic low-level exposure to toluene in drinking water . 
CHAPTER VII 
CHANGES IN HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL AXIS 
ACTIVITY AND IMMUNE FUNCTION DURING CONTINUOUS 
ORAL INGESTION OF BENZENE AND TOLUENE IN MICE 
INTRODUCTION 
Ill 
The hypothalamic-pituitary adrenocortical (HPA) axis is a highly 
sensitive index of enviromental changes and may be augmented by a broad 
range of stimuli such as chemical pollultants, infections, and many 
other various "stressors". It is critically involved in the regulation 
of behavioral and physiological adaptations by releasing biogenic amines 
from the hypothalamus, adrenocorticotropic hormone (ACTH) from anterior 
pituitary, and corticosteroids from adrenal cortex {Axelrod and Reisine, 
1984; Dunn and Kramarcy, 1984). Changes in HPA activity are known to 
result in marked modulation of immune functions (Lumpkin , 1987 ; 
Besedovsky et al . , 1985; Ader , 1981). 
Many organic solvents have been associated with a number of 
neurophysiological and psychological disturbances (Baker et al . , 1985 ; 
Grasso et a l . , 1984; Savo l a i nen, 1977) . Benzene and toluene, universal 
solvents are considered as important health hazards (Fishbein, 1984; 
1985) . Previous studies have indicated that both chemicals have a 
pronounced effect on metabolisms of brain neurotransmitters in rats via 
inhalation exposure or the injection route {Arito et al. , 1985; 
Paradowski et al., 1985; Rea et al., 1984 ; Andersson et al., 1980; 
1983). Recently we found that prolonged oral ingestion of either 
benzene or toluene significantly altered both biosyntheses and 
catabolisms of regional brain biogenic amines in mice (Chapter IV, V) . 
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It was therefore desirable to ascertain whether exposure to these 
chemicals affected the secretion of pituitary-adrenocortical (PA) 
hormones . The specific roles of the brain monoaminergic neural system 
in mediating PA hormone releases have received much attention over the 
years but still remain ill-defined (Axelrod and Reisine, 1984; Dunn and 
Kramarcy, 1984; Ganong, 1980). 
The purpose of this study was to investigate the changes in 
hypothalamic catecholamine metabolisms and correlate them with plasma 
ACTH and serum corticosterone levels in CD-1 mice during continuous oral 
administration of benzene or toluene via drinking water . Since it has 
been recognized, corticosteroids, the end products of HPA ax is, have 
powerful effects on immune function (Besedovsky et al ., 1985; Cupps et 
al ., 1985), we also examined if benzene or toluene altered the synthetic 
abilities of lymphocyte-derived interleukin-2 (IL-2) to evaluate the 
hypothesis that chemicals may have an additional adverse effect on 
immune system via HPA status. IL-2 is a soluble glycoprotein that causes 
lymphocyte proliferation when it binds to cells via a specific membrane 
receptor, various immunoenhancing activities have been ascribed to this 
cytokine (Farrar et al., 1982; 1986). Corticosteroids has been reported 
to inhibit IL-2 production (Goodwin et al ., 1986; Gill is et al., 
1979a,b). 
MATERIALS AND METHODS 
Animals 
Adult male CD-1 mice were obtained from Charles River Breeding 
Laboratory Inc . (Wilmington, MA) and quarantined upon arrival for one 
week prior to use. Animals were housed in groups of 5 per cage in a 
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room at a constant temperature (22-24°C) and with a 12 hour light cycle 
before and during the experiment. Commercial rodent chow (Wayne 
Products, Chicago, IL) and water were available ad libitum . 
Treatments 
Analytical reagent grade benzene (99.9% purity, J.T. Baker Chemical 
Co., Phillipsburg, NJ) and a chromatoquality grade of toluene(99 . 7% 
purity, Burdick and Jackson Labs . Inc . , Muskegon, MI) were dissolved in 
normal tap water to make the desired concentrations of 40, 200 and 1000 
mg/L for benzene and 20, 100 and 500 mg/ L for toluene, respectively . 
The so 1 ubi 1 i ty of benzene in fresh water at 25°C is 1780 mg/ L (U .S. 
Environmental Protection Agency, 1980a), while toluene has a solubility 
535 mg/ L (U.S. Environmental Protection Agency, 1980b) . Exposures were 
conducted by free-choice administration of chemical-treated solutions to 
mice for 28 days via drinking water ; control animals received tap water . 
Food and water consumption was monitored continuously , and an imal s were 
we ighed once each week . Actual benzene and toluene concentrations in 
the drinking water of mice were confirmed by gas chromatography (U .S. 
Environmental Protection Agency, 1986b) . 
Twenty -eight days after exposure to benzene or toluene, mice were 
killed by decapitation. The brains were removed quickly, and the 
hypothalamic regions were dissected out by the procedures of Glowinski 
and Iversen (1966). The brain tissue was promptly weighed in a tared 
vial containing 0.3 ml of ice-cold 0.05 M perchloric acid with 0.1% 
cysteine and frozen at -80°C until analyzed. Trunk blood was collected 
into chilled EDTA tubes, and plasma samples for ACTH assay were 
separated by centrifugation (within one hour) at 1500 x g for 20 min at 
4°C . Serum samples for measuring corticosterone 1 eve 1 s were co 11 ected 
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once before and at 2, 7, 14, and 28 days after exposure via 
venepuncture . Spleens were removed aseptically and the single -
splenocyte suspensions were prepared for interleukin-2 assay (described 
1 ater) . 
Neurochemical Assays 
Concentrations of hypotha 1 ami c NE and its metabo 1 ite, VMA, were 
assayed by high performance liquid chromatography (HPLC) with 
electrochemical detection using the methods described elsewhere (Mayer 
and Shoup, 1983; Sharma et al., 1986). The homogenized brain tissues 
were centrifuged (10,000 x g, 30 min) and the supernatants were filtered 
through regenerated cellulose filter of 0.2~m pore size (Bio -Analytical 
System, Inc., West Lafayette, IN) prior to chromatography. The amounts 
of NE and VMA were determined by measuring the height of the individual 
peaks and comparing them with the peak of various standards (Sigma 
Chemical Co . , St. Louis, MO) . The detector response provided a 1 inear 
correlation coefficient of >0.98 for the standard curve . The HPLC 
system consisted of a model LC -150 electrochemical analyzer, Model LC -3A 
amphoteric detector, Model LC-22A temperature controller, and a Biophase 
ODS -reversed phase column (Bio -Analytic System, Inc.) . A 0.15 M 
monoch 1 oro acetate buffer (pH 3. 0) containing sod i urn octyl sulfate as 
ion-pair reagent served as mobile phase (Mayer and Shoup, 1983) . The 
instrument settings were: flow rate 1.4 mL/min, column temperature 30°C, 
detector potential +0.7V, and controller IOnA full scale. 
Radioimmunoassays 
Materials from commercial radioimmunoassay kits were used for 
determination of p 1 asma ACTH and serum corticosterone concentrations 
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(Radioassay Systems laboratories, Inc . , Carson, CA). The kit offers a 
highly sensitive method of measuring ACTH and corticosterone by 
monitoring the competitive binding of radioisotope-labeled hormones 
( 125 I -ACTH and 3H -cort i costerone) and non -1 abe 1 ed hormones (standards) 
with their corresponding specific antibodies . Separation of antibody -
bound 1 abe 1 ed antigen (hormone) from the unbound 1 abe 1 ed antigen was 
achieved by precipitation. The radioactivities of precipitates were 
than counted and amounts of ACTH (pg/ ml) and corticosterone (ng/ ml) were 
measured from the respective standard curves. 
Interleukin-2 ~ Assays 
Splenic lymphocytes for Il -2 as says were prepared from chemical -
treated or control animals according to the procedures of Sharma and 
Gehring (1979) and suspended in RPMII640 media (Gibco Laboratorie s, 
Grand Island, NY) supplemented with 10% heat-inactivated fetal calf 
serum (Hylone Sterile Systems, Inc, Logan, UT) , 5 X I0 - 5 M 2-
mercaptoeth anol , and 100 units penicillin and 100 .ug streptomycin per 
mL. Interleukin-2 production was assayed by the methods described 
elsewhere (Gi 11 i s et al., 1978; Exon et al. , 1983) with our minor 
modifications as described in the methods section of Chapter VI . 
Statistical Analyses 
A 11 data are expressed as means±SE. Statist i ca 1 determinations of 
the neurochemical , ACTH, and Il -2 data were performed by one -way 
analysis of variance (ANOVA) and follow-up Fisher 's least significant 
differences (LSD) test were used to analyze the data for differences 
bet ween chemical-treated and control animals . A fixed-effect, two way 
ANOVA was used for analyzing corticosterone data to evaluate the effects 
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of benzene or toluene concentrations and exposure time. Differences were 
considered significant at p<O.OS . 
RESULTS 
The average concentrations of benzene or to 1 uene in the drinking 
water mixtures as determined by gas chromatography are indicated in 
Table VII -1. There was an approximate 30% loss of both solvents over a 
3-day period, when water was changed. Based on daily analysis the 
overall means of observed concentrations were 78 (±12)%, 83 (±9)%, and 
79 (±6)% of the 40 , 200, and 1000 mg/L benzene nominal concentrations, 
respectively. Likewise, actua 1 to 1 uene concentrations in the drinking 
water were 83 (±14)%, 80 (±10)%, and 81 (±11)% of the 20, 100, and 500 
mg/L intended 1 eve 1 s. The observed concentration va 1 ues are used to 
designate low, medium and high group dosing. 
General Toxicity Evaluation 
At the doses used both benzene and toluene did not elicit mortality 
or any other overt clinical symptoms of toxicity in mice. Comparison of 
the body weight gains of each treated group with those of the control 
groups did not suggest any consistent differences through the treatment 
period. There were also no significant changes between treatment and 
control groups in food and water consumptions. 
Neurochemical 
The effects of benzene or toluene exposure on the concentrations 
of hypothalamic NE and its major metabolite, VMA, are presented in Table 
Vll-1. Both solvents produced marked increases in hypothalamic NE 
concentrations. There was a dose -related response for increased NE and 
TABLE VII - I 
CONCENTRATIONS OF NOREPINEPHRINE (NE) AND ITS METABOLITE 
VANILLYMANDELIC ACID (VMA) IN THE HYPOTHALAMUS OF MICE 
EXPOSED TO BENZENE OR TOLUENEa 
Concentration in water, mg/L 
Chemical Nominal Observed 
0 0 
Benzene 40 31 
Toluene 
200 
1000 
0 
20 
100 
500 
166 
790 
0 
17 
80 
405 
Neurochemical concentrationb 
NE 
1.632 ± 0.422 
2. 284 ± 0.247 
2. 571 ± 0. 281 
2.637 ± 0.123 
1.307 ± 0.067 
1.981 ± 0. 034 
2. 125 ± 0.1 67 
* 
* 
* 
* 
1.762 ± 0.136* 
VMA 
0. 260 ± 0.016 
0.304 ± 0.037 
0.367 ± 0.054 
0.395 ± 0.033 
0.238 ± 0.018 
0.422 ± 0.015 
0. 393 ± 0. 046 
0.596 ± 0. 210 
a Chemical was administered continuously to mice via drinking 
water for 4 weeks 
b In~g neurochemical/g wet tissue, Mean± SE (n=5) 
* Significantly different from untreated control at p<0 . 05 
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VMA with increasing levels of benzene. Significant benzene - induced 
increases of NE were found in the 166 and 790 mg/L dose groups. The 
mean concentrations of VMA were correspondingly increased by 42 and 52% 
in these two treatment groups, although the findings were not 
statistically significant . Toluene produced significant elevations of 
NE at all dose levels but increases were maximal at the medium dose (80 
mg/L). The three toluene doses also caused apparent accumulations of VMA 
with 66-150% increases . 
Plasma ACTH 
Figure VII-I shows the effects of benzene or toluene exposure on 
plasma concentrations of ACTH. The results suggest that increase in 
ACTH secretion was correlated with activation in hypothalamic NE 
metabolisms. Mice exposed to benzene rose ACTH by I. 6, I. 8, and 2. 5-
fold in the 31, 166, and 790 mg/L dose groups, respectively. Toluene 
also caused dose-related elevation of this hormone by 2.1, 2.6, and 3.8-
fold at the three dose levels. Significant differences from untreated 
control values were found in the high dose groups of both chemical 
treatments. 
Serum Corticosterone 
The corticosterone response to benzene or toluene was assessed once 
before and at 2, 7, 14, and 28 days after exposure. Comparisons of 
solvent-exposure mice with same-time controls revealed the 
corticosterone levels were significantly higher in mice exposed to the 
790 mg/L dose at 7 and 28 days and the 166 mg/L dose at the 7th day 
(Fig. VII-2). The marked increases (1.8 fold) of corticosterone at day 
7 in the 31 mg/L dose exposure were not significant due to the large 
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Fig. Vll-1. Effect of 4-- weeks benzene and toluene exposures via 
drinking water on concentrations of plasma ACTH in mice ( 1ZJ , 
control ; ~ , 31 mg/L for benzene and 17 mg/L for toluene; r®l3!l , 
166 mg/L for benzene and 80 mg/L for toluene; • , 790 mg/L for 
benzene and 405 mg/L for toluene). Stars (*) denote a significant 
effect (p<O.OS) relative to control. Values represent mean± SE (n=S) . 
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Fig . VIJ-2 . Serum corticosterone concentrations in control and benzene-
exposed mice ( 0 , control; e , 31 mg/L ; • , 166 mg/ L; • , 
790 mg/L). Values represent mean ± SE ( n ~ 5) . Stars (*) denote values 
significantly different from same-time control values at p<0.05. 
"' 0 
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variation. Toluene elevated corticosterone levels at 14 and 28 days at 
the highest dose (405 mg/L) only (Fig . V1I-3). Two-way analysis of 
variance showed a significant interactive effect of benzene or toluene 
on plasma corticosterone over the exposure time (Table VII-2). During a 
period of 28-day benzene exposure, corticosterone increased and reached 
maximal response at the 7th day, then declined to or below control l eve l 
at the 14th day. However, re-elevated corticosterone concentrations were 
detected in the 790 mg/L dose group at the termination of exposure. The 
e 1 eva ted corticosterone caused by the 405 mg/L dose toluene did not 
return to normal levels during the 28-day exposure. 
IL -2 Synthesis 
The effects of benzene or toluene ingestion on I L -2 synthesis are 
illustrated in Table VII -3. Splenocytes obtained from mice exposed to 
benzene at various concentrations for four weeks and stimulated with Con 
A in vitro elicited a biphasic dose -related response in IL-2 
productions as determined by the proliferation of HT -2 ce 11 s. Mice 
receiving 166 or 790 mg/L benzene manifested a significant suppression 
of 3H-TdR incorporation into DNA of HT -2 ce 11 s. Splenic ce 11 s taken 
from mice treated with toluene produced a lesser change in IL-2 
synthesis; a significant depression was detected in the highest toluene-
dosed group (405 mg/L) only . 
DISCUSSION 
Oral administration of various dosages of benzene or toluene via 
drinking water to CO-l mice for four weeks markedly stimulated the HPA 
activity . Hypothalamic NE activity was highly elevated by both organic 
solvents, indicated by the increased concentrations of NE, and a 
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Fig . VII -3. Serum c!'rticost erone concentration s in control ar.d to luene-
exposed mice ( 0 , control; e , 17 mg/l; • _ , 80 mg/l; • , 
405 mg/l) . Values represent mean ± SE (n• 5) . Stars (*) denote value s 
significantly different from same time control values at p<0.05 . 
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TABLE VII -2 
RESULTS OF A FIXED -EFFECT, TWO-WAY ANALYSIS OF VARIANCE 
FOR SERUM CORTICOSTERONE DATA 
Chemical Source of DF MS F ratio 
variance 
Main effects 35637.83 7.83* 
dose 3 13957 0 62 3.09 * 
Benzene time 4 51897 . 99 I I. 40 * 
Interaction 12 8643.25 1.90* 
Residual 80 4551.74 
Total 99 7245 . 69 
Main effects 27177.28 3.78 * 
dose 3 43529.58 6. 06 * 
Toluene time 4 14913 . 07 2.08 
Interaction 12 19386.72 2. 70 * 
Residual 80 7179.18 
Total 99 10072.89 
DF : degrees of freedom; MS: mean squares (variability) 
* p<0.05 
TABLE Vll -3 
EFFECTS OF BENZENE AND TOLUENE ON IL -2 PRODUCTION BY CON A-
STIMULATED MOUSE T- LYMPHOCYTEa 
Chemica 1 
Benzene 
Toluene 
Solvent 
Concentration 
(mg/L) 
0 
31 
166 
790 
0 
17 
80 
405 
Positive controlb 
Negative controlc 
3H -Thymidine 3uptake (DPM X 10- ) 
16.63 ± 0.62 
20.78 ± 1.36 
9.40 ± 1.25 * 
4.92 ± 0.79* 
17.07 ± 1.38 
14 . 07 ± 1.73 
13 . 75 ± 0.86 
10 .30 ± 1.32* 
18 . 92 ± 0.59 
1.80 ± 0. 47 
a Several dilutions including 1:1, 1:2, 1:4, and 1:8 of IL -2 
sources (Con A-stimulated supernatants) which showed a 
decreasing incorporation of 3H-thymidine to IL-2 dependent 
murine T-helper cell clone, HT -2 cell, were used. Only data 
obtained from a 1:1 diluted ratio were presented. Values are 
given as mean ± SE (n=S) 
b Rat spleen conditioned medium (Con A-stimulated supernatant) 
c Non -Con A-stimulated CD-I mouse lymphocyte cultural supernatant 
* Significantly different from untreated control at p<O.OS 
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parallel trend in its major metabolite, VMA, in this brain region. At 
the same time these were accompanied by increased ACTH/cort i costerone 
releases into blood. Increases in NE concentration, metabolism or 
turnover have been reported in the hypotha 1 amus of rats exposed to 
toluene (Arito et al., 1985; Andersson et al ., 1980; 1983) or in whole -
brain homogenates of rats exposed to benzene (Paradowski et al., 1985). 
Significant elevations of serum corticosterone were also found in rats 
following toluene exposure via inhalation (Andersson et al., 1980). 
The present study provides evidence that organic so 1 vent-induced 
ACTH/corticosterone releases from PA axis is stimulated by the 
hypothalamic noradrenergic neuronal pathway. The specific role of NE in 
the release of PA hormones has remained controversial, but several 
reports involving direct measurement of NE turnover or metaboli sm 
suggest a stimulatory effect of NE neuronal activity on 
ACTH/corticosterone productions (Smythe et al., 1983; 1987; Johnston et 
al., 1985; Hary et al., 1984; Hedge et al., 1976). These workers also 
reported a highly significant correlation between NE neuronal activity 
and p 1 asma ACTH/cort i costerone 1 eve 1 s after chemica 1 exposures . It was 
assumed, therefore, that AP hormone effects were mediated via 
hypothalamic noradrenergic facilitation of corticotropin releasing 
factor (CRF), which then acts on the pituitary gland to release ACTH 
(Smythe et al ., 1987 ; Vale et al., 1981). Lesions of the hypothalamus 
were shown to block both changes in CRF content in median eminence and 
plasma ACTH after a variety of stimuli (Dallman et al., 1987). 
Corticotrophin releasing factor was thought to be the major but not the 
so 1 e means of re 1 easing ACTH/cort i costerone from PA axis (Axe 1 rod and 
Reisine, 1984). It has been previously shown that AP hormone responses 
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to chemical - induced stress were inhibited significantly by clonidine 
( o<.radrenoreceptor agonist) and increased by yohimbine ( o<r 
adrenoreceptor blocker) (Smythe et al . , 1983; 1987), both chemicals have 
greater presynaptic than postsynaptic activity. The o< 1 and j3 2-
adrenergic agonists have also been reported to stimulate ACTH releases 
in vivo by acting on the hypothalamic-pituita] axis (Axelrod and 
Reisine, 1984). The blockade of postsynaptic adrenergic receptors was 
able to significantly blunt the ACTH release induced by chemical stress 
(Hary et al., 1984). In reviewing the roles of monoamine 
neurotransmitters in pituitary ACTH re 1 ease Ganong (1980) interpreted, 
however, that NE concentrations were inhibitory to ACTH secretion. It is 
noteworthy that his postulation was mainly based on either 
neuropharmacological manipulation of brain NE levels or the uses of NE 
agonist or antagonist drugs . The measurement of steady- state 
transmitter concentrations alone is of 1 imited value regarding the NE 
neuronal activity and the relationship between NE and ACTH secretion 
(Commissiong, 1985; Hedge et al., 1976). 
Corticosterone secreted by adrenal cortex is dependent on 
stimulation of the hypothalamic-pituitary axis. The possibility that 
the increased NE activity is due to a positive feedback of 
corticosterone has been excluded by the demonstrations that I) 
exogenously administered corticosterone to unstressed rats had no effect 
on hypothalamic NE status nor on ACTH release, and 2) corticosterone-
deficient (adrenalectomized) rats exhibited enhanced hypothalamic 
noradrenergic neuronal act ivity and ACTH release (Smythe et al., 1983). 
The 1 atter finding suggests that decreased corticosterone may exert a 
negative feedback on central NE neuronal activity which , in turn, 
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increase ACTH release. The negative feedback system on the HPA status, 
however , can be overridden by a second contro 1 system with a higher 
priority. When the animal or man is subjected to a variety of 
environmental challenges, which are collectively referred to as "stress" 
(e.g. chemical intoxication, infection, psychologic stress, and many 
other environmental stressors), noradrenergic neuronal activity and ACTH 
secretion is vigorously stimulated in spite of the fact that circulating 
corticosterones are much higher than those required to inhibit ACTH 
production in the "unstressed" condition (Ader and Cohen, 1985). 
Treatment of mice with benzene significantly reduced JL-2 
production at the two higher doses, while toluene caused a significant 
inhibition of IL-2 synthesis at the highest dose level . Benzene has been 
associated with hematotoxicity and associated immunotoxic effects 
( Fishbein, 1984; Chapter II I) . Exposure of mouse T -lymphocytes to p-
benzoquinone, one of the major metabolites of benzene, was reported to 
inhibit the formation of IL-2 (Post et al., 1985). Although there is 
general agreement that toluene does not elicit the hematotoxic 
properties of benzene, adverse effects on lymphocyte and macrophage 
functions, and host resistance to infectious microorganisms have been 
noted (Suleiman, 1987; Fishbein, 1985; Aranyi et al., 1985). We 
recently found that a 4-week to 1 uene ingestion resulted in suppression 
of T- lymphocyte-related immune functions at the concentration of 405 
mg/L (Chapter VI) . IL-2 has been shown to augment numerous immune 
responses (Farrar et al. , 1982). Inhibition of this immunoregulatory 
lymphokine synthesis via HPA axis stimulation may be a possible 
mechanism by which toluene mediated its immunotoxic effects via oral 
ingestion. Additional studies need to be performed to determine the 
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precise biological site of action of this chemical . The reactive 
metabolite(s)-mediated covalent binding of toluene to biological 
macromolecules has been reported (Pathiratne et al . , 1986b). 
The time-course of the corticosterone response of mice during 
benzene exposure revealed that serum corticosterone was elevated during 
the initial period of exposure but returned to control, or lower, values 
despite the continued exposure to the solvent. The cycling effect of 
benzene on corticosterone with time may be brought about by a feedback 
inhibition of ACTH release , despite the presence of a stressor . From 
the perspective of the general adaptation syndrome (GAS) response to a 
variety of stressors including many pollutants (Selye, 1950), benzene 
may activate the HPA axis, resulting in the process of adaptations to an 
altered environment following a period of alarm. However, re -elevated 
corticosterone levels detected in the high dose group at 28 day suggest 
that mice were unable to completely maintain adaptation at this dose 
1 eve 1 of benzene. Likewise, mice generally adapted to to 1 uene exposure 
at the low and medium doses . Corticosterone remained elevated throughout 
the duration of the high dose toluene exposure and suggested that 
adaptation did not occur . If adaptation of GAS does not occur , the 
organism may progress into producing deleterious effects including 
immunological dysfunction (Makara et al., 1980). 
It is obvious from this study that organic solvents such as benzene 
and toluene have, at least partially, an additive adverse effect on 
immune function via activated HPA status . Cart icosteroids, the end 
products of HPA axis, are well known to impair various aspects of 
immunocompetence (Besedovsky et al ., 1985; Cupps et al . , 1985) and have 
been shown to inhibit IL-2 as well as IL-l productions (Snyder and 
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Unanue, 1982; Gillis et al., !979a,b). Exogenous IL-2 also reverses the 
inhibition of mitogen-induced T cell proliferation by corticosteroids 
(Gill is et al., !979a,b). Increased corticosteroid concentration can 
control the clonal expansion (deriven by IL-l and IL-2) of committed 
cells of the immune system that have high affinities for antigen 
(Besedovsky et al., 1985). Recently, Goodwin et al. , (1986) found 
leukotriene B4, the 5-lipoxygenase product in arachidonic acid 
metabolism, reversed the corticosteroid-induced suppression of T cell 
proliferation and IL-2 secretion, and concluded that corticosteroids, by 
inhibiting leukotriene B4 production, also inhibited IL-2 synthesis, 
resulting in a decreased T -cell pro lifer at ion. Lymphocyte from ACTH-
treated calves which have increased plasma cortisol concentrations have 
an impaired capacity to produce IL-2 (Blecha and Baker, 1986). 
CHAPTER VIII 
EFFECTS OF REPEATED ORAL EXPOSURE TO COMBINATIONS OF 
BENZENE AND TOLUENE ON IMMUNOLOGIC RESPONSES IN MICE 
INTRODUCTION 
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Toxicity of en vi romenta 1 po 11 utants may not necessari 1 y i nvo 1 ve 
exposure to a single chemical exposure, but may reflect the combined 
effects of sever a 1 chemica 1 s ( Lewtas, 1985). Exposures to mixtures of 
chemically related substances are frequently encountered. In such cases 
the balance between different pathways of metabolism for chemicals could 
be radically changed (Sipes and Gandolfi, 1986) . Alteration in 
metabolism of a second compound may be beneficial or detrimental, 
depending upon the toxicity of the parent compound versus its 
metabolite(s). 
Exposure to benzene has been associ a ted with hematotoxi city and 
immunotoxicity (Brief et al. , 1980; Goldstein, 1983; Chapter III). 
Benzene is a carcinogen and mutagen (Aksoy, 1985; Dean, 1985; Ereson et 
al ., 1985) . It has been associated with an increased incidences of 
leukemia in humans (Rinsky et al., 1987), and several solid tumors 
(Maltoni et al., 1985) and possibly leukemia/lymphoma in rodents (Snyder 
et al., 1980; Cronkite et al., 1984). The embryotoxic/teratogenic 
potential of this chemical in experimental animals has been noted (Green 
et al., 1978; Kuna and Kupp, 1981; Ungvary and Tatrai, 1985). Although 
the mechanism of these toxicities is not well elucidated, studies have 
shown that benzene itself is not the primary toxicant but is converted 
by liver microsomal enzymes or bone marrow peroxidases to a reactively 
oxidative metabolite(s) to exert its toxic effects (Irons, 1985; 
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Sawahata et al . , 1985; Eastmond et al., 1987b) . 
Benzene is frequently employed in industry with toluene . 
Pretreatment of rats with toluene has been reported to increase the in 
vitro liver microsomal metabolism of benzene (Pathiratne et al., 1986b). 
However, in vivo coadministration of benzene with toluene, which 
competitively inhibited benzene metabolism (Ikeda et al ., 1972; Andrews 
et al ., 1977; Sato and Nakajima, 1979), prevented benzene toxicity such 
as myelotoxic {Andrews et al., 1977; Tunek et al., 1981; 1982) and 
genotoxic {Tice et al., 1982; Tunek et al., 1982; Gad-El-Karim et al., 
1984; 1985a; 1986) effects. 
We have recently reported that oral ingestion of benzene or toluene 
possesses immunotoxic potentials in mice (Chapter III and VI), and that 
alteration of immune function in to 1 uene-exposed anima 1 s was generally 
evident at a relatively high dose. To our knowledge, no studies have 
been published on evaluation of interaction-mediated immunotoxicity 
after exposure to combinations of benzene and toluene. The present study 
was therefore undertaken to assess the effects of repeated exposure to 
various concentrations of benzene and to 1 uene, a 1 one or combined, on 
hematological and immunological responses in CD-I mice. Since both these 
chemicals are known groundwater contaminants (U.S. Office of Technology 
Assessment, 1984; U.S. Environmental Protection Agency, 1986a), oral 
administration via drinking water was employed. 
MATERIALS AND METHODS 
Animals 
Male CD-1 mice were obtained from Charles River Breeding 
Laboratories (Wilmington, MA). Animals were acclimated in an AAALAC-
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accredited animal care facility with an ambient temperature of 22-24°C, 
40-60% relative humidity, and a 12 -hr 1 ight/ dark cycle for one week 
prior to treatment . Commercial rodent chow (Wayne Product s, Chicago, IL) 
and tap water were available ad libitum. Animals were randomly 
distributed into control and treatment groups of 5 mice each. 
Chemical Treatments 
Analytica l reagent grade benzene (99.9% purity, J. T. Baker 
Chemical Co ., Phillipsburg, NJ) and a chromatoquality grade of toluene 
(99.7% purity, Burdick and Jackson Labs . Inc., Muskegon , MI) were 
dissolved in normal tap water to make the desirable concentrations. Two 
experiments were conducted . In the first experiment, the nomina 1 
concentrations employed were 200 mg/ L benzene, 400 mg/L toluene, and 200 
mg benzene + 400 mg to 1 uene/L for the mixture. The concentration of 
toluene was reduced to 100 mg/ L in the second experiment. The solubility 
of benzene in fresh water at 25°C is 1,780 mg/L (U.S. Environmental 
Protection Agency, 1980a), while to 1 uene has a so 1 ubi 1 ity of 535 mg/L 
(U.S. Environmental Protection Agency, 1980b) . Treatments were achieved 
by continuously administering the test material (s) in drinking water 
to mice at the intended concentrations for 28 days. Control animals 
received normal tap water without test materials. The water was provided 
in glass water bottles with stainless-steel sipper tubes equipped with 
ball bearings. The treated solutions were changed every three days to 
ensure freshness, and bottles were shaken frequently during the 
experiment. Fluid and food intake was monitored continuously, and 
anima 1 s were weighed weekly. Actua 1 benzene or to 1 uene concentrations 
were determined daily by gas chromatography (U .S. Environmental 
Protection Agency. 1986b). 
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Gross Observations and Hematology 
At the end of 28 days of continuous chemical exposures, mice were 
killed by decapitat i on , and gross pathological examinations were 
performed . Selected organs, i.e., liver, spleen, thymus, and kidney were 
removed, trimmed and weighed immediately. Total blood erythrocyte and 
leukocyte counts were determined on a Coulter Model ZB- I blood cell 
counter (Coulter, Electronics, Inc . , Hialeah, IL). Differential counts 
were determined manually by Wright ' s stained blood smears . Single 
splenocyte suspensions (> 95% viability by trypan blue exclusion) were 
prepared asept i call y as described by Sharma and Gehring ( 1979). Cell 
concentration was measured for assay of total spleen cellularity. The 
splenocyte number was adjusted to the desired concentration for each 
immune function assay. Unless otherwise indicated, all splenocyte 
manipulations were performed in RPM! 1640 tissue culture medium that 
contained 5% heat-inactivated fetal calf serum (FCS), 100 units/ml 
penicillin and 100 ~g/ml streptomycin (referred to 
medium) . 
Mitogen-Stimulated Lymphoproliferation 
as a complete 
The proliferative responses of splenocytes to mitogens were 
determined by using a microculture assay. Splenocytes from individual 
animals were added in 0.1 ml (5x105 cell) to triplicate wells of a 96-
well flat-bottomed microtiter plate. The cells were incubated for 48 hr 
at 37°C in a humidified 4. 0% co2 and air mixture with or without 
optimal concentrations of the purified T-cell mitogens 
phytohemagglutinin (PHA, 12.5 ~g/ml; Wellcome Reagents LTD., 
Beckenham, England) or concanavalin A (Con A, 2.5 ~g/ml; Sigma Chemical 
Co., St. Louis, MO), 8-cell mitogen E. coli lipopolysaccharide (LPS, 20 
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JJg/mL; Sigma), and the T- and B-cell mitogen pokeweed mitogen (PWM , 30 
JJg/ mL) and were harvested after a 6-hr pulse with tritiated t hym idine 
(3H-TdR, 0.5 .JJCi / well, New England Nuclear, Boston, MA) onto fiber glass 
strips with a multiple sample harvester (Model M12, Biomedical Research 
and Development Laboratory, Rockville, MD). Amounts of 3H-TdR 
incorporation into DNA of d i vi ding 1 ymphocytes was quantitated with a 
liquid scintillation counter (Model 2660, Packard Instrument Co . , 
Downers Grove , IL). 
Mixed Lymphocyte Culture iMbhl Reaction 
MLC responses were performed under s imi 1 ar conditions as mitogen 
as says by using ratios of 2: 1 and 4: 1 responders ( sp 1 enocytes) to 
stimulators (mitomycin C-blocked YAC -1 lymphoma cells of A/ Sn origin, H-
2a). The complete RPM! culture medium was supplemented with 5x1o- 5 M 2-
mercaptoethanol (2-ME). After 72 hr in 37°C/ 4% co2 humidified 
incubation, the cells were pulsed wi th 3H-TdR for 6 hr and harve sted for 
counting the cell-incorporated radioactivity as described above. 
Spontaneous 3H -TdR incorporation was determined in cultures i ncubated 
without YAC-1 cells. 
Cell -Mediated Cytolysis~ Response 
Cell -mediated cytotoxicity of splenic cytotoxic T-lymphocytes (CTL) 
was generated in vitro against YAC-1 tumor cells as de scribed by 
Grabstein (1980) with minor modifications (Chapter III) . The splenocytes 
(responders) were co-cultured with mitomycin C-blocked YAC -1 cells 
(stimulators) in RPM! complete medium supplemented with 5x1o-5 M 2-ME 
for 5 days . These cultured splenic cells (effectors) were washed, 
counted, and incubated with YAC-1 cells (targets) previously 
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radiolabeled with 51 cr-sodium chromate (New England Nuclear) at 
effector: target (E:T) ratios of 100:1, 50:1; 25:1, 12:1, and 6:1. A 
constant number of 51cr-l abe led target cells (2 x 104) were added to 
each well of a plastic 96-well microtiter plate followed by the addition 
of effector cells. After 4 hr incubation at 37°C, cells were pe ll eted 
by centrifugation, and radioactivity in the supernatant of cultures was 
measured with a gamma counter (Model 3320, Packard). The 51 cr labeled 
target cells in the presence of culture medium or 0.5% sterilized 
saponin a 1 one served as the spontaneous re 1 ease and tot a 1 re 1 ease of 
radioactivity, respectively. Percentage of specific cytotoxicity was 
calculated as described earlier (Grabstein, 1980). 
Jnterleukin-2 ~ Assay 
Supernatants containing IL-2 were prepared by incubating 
splenocytes (5x105) obtained from chemical-treated or control mice with 
or without Con A at the concentration of 2.5 ~g/ml in RPM! 1640 medium 
supplemented with 10% FCS, 5x1o-5 M 2-ME, and antibiotics for 48 hr at 
37°C/4% C02. After incubation, the cell -free supernatant aliquots (100 
~L) were collected by removing the cells with centrifugation at 400 x g 
for 10 minutes and stored at -70°C until analysis for JL-2 activity. 
A single-blind microassay, using JL-2-dependent murine T-helper 
cell line (HT-2) of BALB/C origin (Watson, 1979), was used to quantitate 
IL -2 as described (Gillis et al., 1978; Exon et al., 1983) with minor 
modifications as described in the methods section of Chapter VI. 
Antibody Production Response 
In a separate experiment, each animal from exposed and control 
groups were immunized ip with 0.25 ml of a 20% suspension of saline-
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washed sheep red blood cells (SRBC) 4 days before the end of chemical 
treatments. Numbers of antibody plaque - forming cells (PFC) were 
quantitated by the methods of Cunningham and Szenberg ( 1968) . Results 
were expressed as antibody PFC/106 splenocytes and as antibody PFC per 
spleen. 
The 1 eve 1 of anti- SRBC anti body ( o<. -SRBC) in the serum co 11 ected 
from mice utilized in PFC assay was analyzed by a double sandwich 
enzyme-linked immunosorbent assay (ELISA) as previously reported 
(Chapter III). 
Statistical Analysis 
All data were expressed as the means and their standard errors. A 
one way analysis of variance and Fisher's least significant difference 
(LSD) test were used to determine the statistical significance (p<0.05) 
of experimental data. 
RESULTS 
Based on gas chromatographic analyses, the overall average of daily 
observed concentrations of test materials in the drinking water of mice 
was 166 (± 9. 5%) mg/L for the 200 mg/L nominal concentration of benzene, 
80 (± 12%) mg/L for the toluene 100 mg/L group, and 325 (± 13.5%) mg/L 
for the toluene 400 mg/L group. The benzene or toluene concentrations in 
the drinking water of the mixture groups were the same as in the groups 
of chemical alone. 
Gross Observations 
Animals exposed to various concentrations of treated water over a 
4-week period did not exhibit overt clinical symptoms of toxicity. Food 
137 
and water consumption were not affected by the test chemical(s) . There 
were no apparent differences in body, spleen, kidney and liver weights 
between control and treatment groups (Table VIII-I). No gross lesions 
were detected at autospy in any organ from mice treated with test 
chemical (s). The animals treated with benzene (166 mg/L), showed 
significant reduction in thymus mass. Toluene (325 mg/L) reduced the 
effect of benzene on the thymus weight . Both toluene concentrations (325 
mg/L and 80 mg/L)) had no significant adverse effect on weight of 
thymus. 
Hematology 
Table VIII -2 shows the effects of benzene and toluene, alone or 
combined, on selected blood parameters . Total blood erythrocyte, 
1 eukocyte, and 1 ymphocyte counts were depressed in mice treated with 
benzene alone . Concurrent exposure of either dose of toluene (80 and 325 
mg/L) with benzene (166 mg/ L) resulted in increases of erythrocyte 
counts when compared to the benzene treatment alone . Toluene at 80 mg/L 
did not a 11 evi ate benzene - induced 1 eukocytopen i a and 1 ymphocytopen i a. 
There were significant differences in leukocyte and lymphocyte counts 
between toluene (80 mg/L) and benzene plus toluene (166 plus 80 mg/L) 
treatments. No changes in hemato 1 og i ca 1 responses were observed in 
groups treated with toluene alone when compared to the control values. 
Mitogen-Stimulated Lymphoproliferation 
The lymphoproliferative response data for optimal concentrations of 
the B-ee 11 mitogen LPS, T -ce 11 mitogens Con A and PHA, and the B- and T-
cell mitogen PWM are summarized in Table VIII-3 . A significant decrease 
in 3H-TdR uptake was observed for splenocytes from the 166 mg/L benzene 
TABLE VIII-I 
ORGAN AND BODY WEIGHTS OF MICE FOLLOWING 4-WEEKS OF EXPOSURE TO 
BENZENE AND TOLUENE, ALONE OR COMBINEDa 
Body weight (g) Organ weight (g/100 g body weight) 
Concentration 
in water,mg/L 
Experiment I 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
+Toluene,325 
Experiment II 
Contro 1 
Benzene, 166 
Toluene, 80 
Benzene, 166 
+Toluene, 80 
Day 0 Day 28 
27.02 ± 0.73 34.36 ± 0.78 
27.02 + 0.56 35.70 + 1.01 
27.46 ±: 0.48 37.32 ±: 1.34 
2~.78 ± 0.37 34.22 ± 0.39 
23.38 ± 0.79 31.12 ± 1.02 
22.50 ± 0.72 30.44 ± 0.75 
25.38 ± 0.75 34.72 ± 1.20 
25.42 ± 0.75 34 . 14 ± 1.25 
a Values are given as mean ± SE (n-5) 
b Significantly different from untreated controls 
Spleen 
0.31 ± 0.01 
0. 28 ± 0.02 
0.29 ± 0.02 
0.28 ± 0.01 
0.29 ± 0.01 
0.24 ± 0.92 
0.29 ± 0.03 
0.26 ± 0.01 
(p<0.05) 
Kidney Liver Thymus 
1.46 0.05 5.77 0. 16 0.14 0.01b 
1.59 0.08 6.28 0.17 0.09 0.02 
1.54 0.04 5.92 0.17 0. 11 0. 01 
1.56 0.05 5.77 0.16 0. 11 0.01 
1. 7g 0.10 6.19 0.13 0.17 0.01b 1.73 0.11 6.29 0.17 0.14 0.01 
1. 74 0.05 6.02 0. 17 0.15 0.01b 
1. 73 0.08 6.38 0.23 0.14 0.01 
;::; 
(X) 
TABLE Vlll-2 
EFFECTS OF EXPOSURE TO BENZENE ANO TOLUENE, ALONE OR COMBINED , ON 
SELECTED BLOOD PARAMETERS 
Leukocyte absolute differentials (103/mm3)a 
Concentration 
(mg/L) 
Experiment I 
Centro l 
Benzene, 166 
Toluene, 325 
Benzene, 166 
+Toluene,325 
Experiment II 
Control 
Benzene, 166 
Toluene, 80 
Benzene, 166 
+Toluene, 80 
9.73 + 0. 18 6.90 ± 1.08c 
- c 7.09 + 0.25 4.44 ± 0.16 
9.78 ± 0. 23d 6.46 ± 0.61 
9.45 ± 0.38 5.62 ± 0.35 
9.36+0 . 18 7.54 ± 0.62c 
- c 6. 77 ± 0.35 4.80 ± 0.59 
10.42 ± 0.34d 7. 55 + 0.81 
9.28 ± 0. 25 5.06 ± 0.60c,e 
a Values are given as mean ± SE (n=S) 
Lymphocyte 
5.19 ± I . 03 c 
2.43 ± 0. 16 
4.67 ± 0. 54 
3.60 ± 0.31 
5.66 ± o. s8c 
2.78 ± 0. 52 
5.52 + 0. 76 
2.93 ± 0. 54c,e 
b Including monocytes, eosinophils and basophils 
c Significantly different from untreated controls (p<O.OS) 
d Significantly different from benzene treatment alone (p<O.OS) 
e Significantly different from toluene treatment alone (p<O.OS) 
Neutrophil 
1.17 0. 11 0. 54 0.09 
I. 61 0. 11 0.31 0.04 
1.24 0.05 0. 55 0.08 
I. 57 0.16 0.44 0.07 
1.36 0. 22 0. 53 0.08 
I. 34 0.26 0.57 0.19 
!.58 0.17 0.54 0.07 
I. 72 0. Jl 0.40 0.14 
w 
"' 
Concentration 
(mg/L) 
Experiment I 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
+Toluene,325 
Experiment II 
Control 
Benzene, 166 
Toluene, 80 
Benzene, 166 
+Toluene, 80 
TABLE VIII-3 
EFFECTS OF EXPOSURE TO BENZENE AND TOLUENE, ALONE OR COMBINED, ON SPLENIC 
LYMPHOCYTE PROLIFERATIVE RESPONSE TO HITOGENS 
Splenocytea 
Mitogenic responsesa,b 
(x1o- 7) 
None LPS PWH ·con A 
8. 94 ± 1.90 2.02 ± 0. 48 79 .36 ± 20.14 8.99 ± 0. 43c 85.45 + 39.75 
7.90 + 1.67 1.07 ± 0.29 15 . 01 ± 3. 22 2.53 ± 0.83 13.79 + 3. 48c 
8.61 ± 1.16 1.59 ± 0.52d 32 . 14 + 5. 24 7.72 ± 2.lld 34.87 + 7. 37 
9.26 ± 0.75 3. 17 ± 0. 59 • e 125.41 ± 23 .93d,e 10 . 66 ± 1.31 174.51 ± 83.59d 
10.80 + 1.14 2.10 ± 0.71 55.52 + 10 . 24 6. 72 ± 1.83 72 .03 + 13 .33 
7.80 ± 0.05 0.52 + 0.23 4.07 + 1.10c 3.31 ± 1.32 10 . 55 + 2.82c 
11.38 + 1.87 1. 49 + 0. 28 27 . 43 + 9. 92 4.49 + 0.53 35 . 72 ± 8. 77 
10.74 ± 0.70 2.05 ± 0.72 6. 02 ± 1.68c 3. 79 ± 1.06 23.55 ± 2.82c 
PHA 
103.40 + 34 . 64 
14 . 18 + 2. 15c 
43 .53 ± 13.55d 
119 .57 ± 2.50 
NDf 
ND 
ND 
ND 
a Values are giv%n as mean± SE (n=5) 
b dpm x 10-3;10 splenic cells: response evaluated by incorporation of [methyl-3H]-thymidine into day 2 
splenocyte cultures for 6 hours pulsing 
c Significantly different from untreated controls (p<0.05) 
d Significantly different from benzene treatment alone (p<O .OS) 
~Significantly different from toluene treatment alone (p<0 .05) 
ND, not determined 
... 
0 
141 
dosage group in the presence of all mitogens tested. Toluene (80 or 325 
mg/L) did not significantly suppress the proliferation of splenocytes 
stimulated with mitogen , although apparent reductions (50-60%) were 
observed for the mitogenesis by LPS , Con A, and PHA . Toluene at a 
concentration of 325 mg/L not on 1 y camp 1 ete ly prevented the benzene-
produced depression in mitogenesis but enhanced the 3H-TdR uptake when 
compared to the contra 1 va 1 ues . No antagonistic effects on mitogen -
stimulated lymphoproliferation were found when benzene-exposed mice were 
s imultaneously treated with toluene at the 80 mg / L dose . The 
proliferation of spleen cells cultured in the absence of mitogen 
exhibited a similar mitogen -s timulated response as described above . 
Mixed Lymphocyte Culture iM11l Response 
The results of MLC are presented in Fig. VIII-I. They showed that 
splenocytes from control and chemical(s) -treated mice exhibit different 
abilities to recognize histocompatible murine YAC-1 lymphoma cell s (H -
2a), and to proliferate after recognition. A si gnificant decrease in 3H-
TdR incorporation into the DNA of dividing splenic lymphocytes wa s 
observed for mice exposed to benzene (166 mg/L), toluene (325 mg/ L) , and 
benzene (166 mg/ L) + toluene (80 mg/ L). A high toluene concentration 
(325 mg/L) protected against benzene - induced suppression of MLC 
responses. 
Cell-Mediated Cytolysis~ Response 
Figure VIII-2 illustrates the effects of chemical exposures on CTL 
generation to YAC-1 lymphoma cells. The results of 51 cr-release assay 
revealed that benzene (166 mg/L) significantly impaired the capacity of 
spleen cell populations to lyse tumor cells (target cells) after four 
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R:S=2:1 R:S=4:1 R ALONE 
RESPONDERS(R)-TO-STIMULATORS{S) RATIO 
Fig. VIII-I. Effects of benzene and toluene, alone or combined, exposure 
on mixed lymphocyte culture (MLC) responses. Chemical (s) were 
administered continuously to mice via drinking water for 4 weeks, while 
control mice received tap water . A: the bars (left to right). D, 
ezl, IR8l, and •, indicate control, benzene (166 mg/L) alone, 
toluene (325 mg/L) alone, and benzene (166 mg/L) + toluene (325 mg/L), 
respectively. B: the bars (left to right), CJ, EZ!, l88l, and 
•, indicate control, benzene {166 mg/L) alone, toluene (80 mg/L), 
and benzene (166 mg/L) +toluene (80 mg/L), respectively. (a) Denotes 
significantly different from control (p<O.OS); (b) denotes significantly 
different from benzene treatment alone (p<O.OS); (c) denotes 
significantly different from toluene treatment alone (p<O.OS) . Responder 
cells were the sp l enocytes of CO-l mice and stimulator cells were the 
allogenic YAC-1 lymphoma cells (H-2a) of A/Sn origin. The stimulator 
cells were treated with mytomycin-C before a~dition to the 3ulture. MLR 
was evaluated by incorporation (dpm x 10- ) of [methyl- H)-thymidine 
into day 3 MLR cultures for 6 hours pulsing. Values are given as mean ± 
SE (n•S) . 
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CJ CONTROL 
IZ2 TOLUENE 325 mg/l 
IBlll BENZENE 166 mg/l 
- BENZENE +TOLUENE 
E:T-=50:1 E:T-=25:1 E:T-=12.5:1 E:T-=6.25:1 
EFFECTORS(E)-TO-TARGETS(T) RATIO 
Fig . VIII - 2 . Effects of benzene and toluene alone or combined, exposure 
on cytotoxic 1 ymphocyte functions. See 1 egend of Fig. VI I 1-1 for 
detail. Splenocyte population (e~lector cells) was generated from mixed 
lymphocyte culture (day 5) and Cr-labeled YAC-1 lymphoma cells were 
used as target cells. All determinations were done in triplicate for 
each E:T rat i o. Percent specific cytotoxicity was calculated as percent 
of total releasable counts , corrected for spontaneous relea s e of 
radiolabel. Spontaneous release was less than 8% of total releasable 
counts for all assays. 
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weeks of oral ingestion. Toluene (325 mg/L} itself had no noticeable 
effect on the CMC response . Concomitant administration of benzene and 
toluene resulted in a significant elevation of CMC activity when 
compared to the control, benzene, or toluene treatment alone. 
Antibody Production 
The effects of chemical treatments on the capacity of T-cells, B-
cells and macrophages to cooperate in the production of antibody to a T-
cell-dependent antigen, SRBC, are presented in Table VIII -4. Mice 
exposed to benzene (166 mg/L} had significantly reduced numbers of lgM 
antibody PFC per 106 splenocytes and per spleen, and reduced levels of 
a(. -SRBC serum antibodies. Toluene (325 mg/L} itself had no effect on 
ot -SRBC anti body 1 eve 1 and PFC/sp 1 een, although a reduction of PFC as 
expressed on specific activity (PFC/106 spleen cells} was noted. Toluene 
alleviated the adverse effects of benzene on both PFC numbers and -SRBC 
antibody levels. No significance was detected in the total of recovered 
splenocyte among any of the chemical treatment groups (Table VIII-4} . 
IL-2 Synthesis 
Ability of the supernatants from Con A-stimulated splenocyte 
cultures to promote the growth of an IL-2-dependent T-cell line, HT-2, 
are presented in Table VIII-5. The results clearly indicate that benzene 
( 166 mg/L} exposure suppressed I L -2 secretions. Sp 1 enocytes taken from 
mice treated with 325 mg/L toluene produced less but statistically 
equivalent IL-2. Spleen cells obtained from animals exposed to a mixture 
of benzene (166 mg/L} and toluene (325 mg/L} and stimulated with Con A 
in culture produced significantly higher levels of IL-2 than benzene or 
toluene treatment alone. 
TABLE VIII-4 
EFFECTS OF EXPOSURE TO BENZENE AND TOLUENE, ALONE OR COMBINED, ON THE ANTIBODY 
RESPONSES TO T-DEPENDENT ANTIGEN SHEEP ERYTHROCYTE (SRBC)a 
Total 
PFC/106 Concentration splenoc~te s PFC/spljen o<. -SRBC 
(mg/L) (x W) splenocytes (x 10 - ) antibody titer 
Control, 0 22 .01 ± 2. 29b 1485 ± 66 337 .36 ± 44 .82 0. 78 ± 0.07 
Benzene, 166 17.81 ± 1.18 833 ± 89b 151.41 ± 21.53b o.47 ± o. o5b 
Toluene, 325 19 .02 ± 1.03 1190 ± 109b 229.51 ± 32.30 0.67 ± 0.03 
Benzene, 166 22 .96 ± 1.61 1972 ± 159b,c,d 454 . 90 ± 42 . 48c,d 1. 24 ± 0. 1ob,c,d 
+Toluene,325 
a Mice were sensitized with SRBC 4 days before the end of exposure . Splenic cells were 
analyzed for antibody forming cells (plaque-forming cell, PFC) and sera were 
detected for antibody titer (~- SRBC) . Values are given as mean± SE (n=S) 
b Significantly different from untreated controls (p<0. 05) 
c Significantly different from benzene treatment alone (p<0.05) 
d Significantly different from toluene treatment alone (p<0.05) 
TABLE VIII-5 
EFFECTS OF SIMULTANEOUS EXPOSURE TO BENZENE AND TOLUENE ON 
INTERLEUKIN-2 SYNTHESIS BY CON A-STIMULATED MOUSE T -L YMPHOCYTEa 
Concentration 
in Water, mg/L 
Experiment 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
tToluene,325 
Experiment II 
Control 
Benzene, 166 
Toluene, 80 
Benzene, 166 
+Toluene, 80 
3H-Thymidine ~ptake 
(DPMx10- ) 
11.07 ± 1.09 
6.31 ± 0.36c 
8.09 ± 1.26 
12 .65 ± 1. 40d' e 
12.20 ± 2.41 
4.22 ± 0.59c 
10.07 ± 0.63 
6. 19 ± o. soc,e 
Stimulationb 
index 
13.42 ± 1.32 
7.65 ± 0.43c 
9.81 ± 1. 53 
15 . 21 ± 1. 77d,e 
14 . 79 ± 2.93 
5. 13 ± 0.7oc 
11.71 ± 0.77 
7.51 ± 0.6lc ,e 
a Several doubling dilutions of IL-2 sources (Con A-stimula~ed 
supernatants) which showed a decreasing incorporation of H-
thymidine to IL-2 dependent murine T-helper cell clone, HT -2 
cell, were used. Only data <P,tained from 1:1 diluted ratio 
are presented. Uptakes of H-thymidine by HT-2 cells in 
presence of positive control IL-2 source (supernatants of Con 
A-stimulated rat splenocyte cultures) and negative control IL-2 
source (supernatants of non-Con A-stim ulated splenocyte 
cultures of untreated CO-l mice) were 18.92 ± 0.59 and 1.62 ± 
0.60, respectively. Values are given as mean ± SE (n=S) 
b Stimulation index (S.l . ) = dpm (culture with dilution of 
supernatant/dpm (culture with media alone) 
c Significantly different from the untreated control at p<O.OS 
d Significantly different from the benzene treatment alone at 
p<O.OS 
e Significantly different from the toluene treatment alone at 
p<O.OS 
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DISCUSSION 
The present study reports on the development of an animal model for 
simultaneous subchronic exposure of benzene and toluene via oral 
ingestion in which the immunotoxic interactions between the agents were 
evaluated. The results demonstrate that the combination of ingested 
benzene and sufficient amounts of toluene is less hematotoxic and 
immunotoxic than ingested benzene alone. Compared to treatment with 
benzene alone, the combined exposure (166 mg benzene + 325 mg toluene/L) 
produced a markedly protective effect on benzene-induced depressions of 
tot a 1 blood erythrocyte, 1 eukocyte, and 1 ymphocyte counts, and 
abnormalities of immune-associated parameters, including humoral and 
cellular immunity. 
Alterations in immunocompetence following a four-week oral 
ingestion of benzene alone was evidenced by a significant involution of 
thymus and a loss of circulating lymphocytes, both as useful indicators 
of immune function. The sensitivity of lymphocytes to benzene revea 1 ed 
the immunotoxic potential of this agent. Evidence from several recent 
studies implicated the immune system as a target organ for benzene . 
Administration of benzene by inhalation or injection to experimental 
animals has been shown to suppress the mitogenic response of B- and T-
lymphocyte proliferations (Rozen and Snyder, 1985; Rozen et al., 1984; 
Wierda et al ., 1981), humoral antibody response as measured by plaque-
forming cells to sheep erythrocytes (Aoyama, 1986; Wierda et al ., 1981), 
and host resistance to the pathogenic microorganisms, such as Listeria 
monocytogenes (Rosenthal and Snyder, 1985) and Klebsiella pneumonfae 
(Aranyi et al., 1986). Recently, it has also been reported that 
exposure to 100 ppm benzene (5 days/week x 4 weeks) via inhalation in 
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mice depressed the mixed lymphocyte culture (MLC) response and tumor 
lytic ability of cytotoxic T lymphocytes, and ruled out the 
possibilities that dep ressions in immune function are due to an 
induction of suppressor cell activity (Rosenthal and Snyder, 1987). As 
MLC responsiveness is generally thought to represent the initial phases 
in the induction of cytotoxic T cells ( CTL), the benzene-induced 1 oss 
of CTL lytic ability to tumor cells might be explained by an impaired 
ability of T cells to recognize foreign tissue or tumor-associated 
anti gens during T-he 1 per-ce ll-medi a ted induction of CTL cells. 1 n the 
present study benzene ingestion significantly reduced the production of 
IL -2, a known important immunoregulatory lymphokine and a necessary 
component in MLC response and CTL generation (Farrar et al., 1982). 
Toluene, a widely used organic solvent, is an agent of 
environmental and occupational significance (U.S. National Academy of 
Sciences, 1982). This agent is known to possess the potential to 
significantly alter the metabolism and resulting bioactivity of certain 
other chemicals, thereby influencing their toxicities (Hayden et al., 
1977; Fishbein, 1985). In animal models toluene exposure is associated 
with the induction of microsomal cytochrome P-450 dependent enzymes and 
conjugation enzymes (Pyykko, 1980; Toftgard et al., 1982; Pathiratne et 
al., 1986a), and depletion of liver glutathione (van Doorn et al., 
1980) . Time-course of effects of toluene on several micro so mal 
monoxygenases in 1 iver or some non-hepatic tissues of r ats exposed to 
toluene has been reported (Pyykko, 1983). 
The reasonab 1 e exp 1 an at ion for reduced benzene immunotoxi city is 
that toluene decreases the levels of toxic benzene metabolites. 
Metabolism of benzene is required for its toxicity (Irons, 1985; Snyder 
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et al . , 1983) . Benzene metabolites have been shown to produce a variety 
of alterations in immune function . The ab i lity of phenol , hydroqu i none , 
and catechol to suppress lymphocyte growth and function in vitro 
correlates with their capacity to undergo oxidation and with their 
concentration in the bone marrow or lymphoid organs (Irons et a l., 1981; 
Pfeifer and Irons, 1981; 1982; 1983) . Hydroquinone and its oxidation 
product, p-benzoquinone, inhibit proliferation and differentiation in 
lectin -stimulated lymphocytes in culture at concentrations that are not 
cytotoxic, while phenol or catechol suppress lymphocyte growth or 
function and only at concentrat i ons that result in cell death . 
Suppression of lymphocyte blastogenesis by hydroquinone is probably 
mediated by the interaction of p-benzoquinone with sulfhydryl (SH) 
groups on tubulin (Irons et al., 1981; 1984; Pfeifer and Irons , 1983). 
Post et al. (1985) demonstrated that exposure to p-benzoquinone in mice 
completely inhibits the proliferation and production of the T-cell 
lymphokine, interleukin-2 , by concanavalin A (Con A) -stimulated T-
lymphocytes. Hydroqu i none and catecho 1 have been shown to reduce the 
frequency of spleen and bone marrow progenitor B-lymphocytes and to 
inhibit polyclonal plaque-forming cells (Wierda and Irons, 1982) . 
Toluene is a substrate for cytochrome P-450 and has been shown to 
competitively inhibit benzene biotransformation in vitro or in vivo . The 
conversion of benzene to pheno 1 s in rats , mice or in vitro has been 
reported to be suppressed when benzene was given in combination with 
toluene (Ikeda et al., 1972; Andrews et al . , 1977; Sato and Nakajima, 
1979; Gilmour et al., 1986) . Andrews et al. (1977) coadministered 
benzene and toluene to mice or rabbits and observed a marked reduction 
in levels of benzene metabolites in bone marrow, coupled with a 
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compensatory increase in pulmonary excretion of unmetabol ized benzene. 
It was also demonstrated using liver microsomes in vitro that toluene is 
a competitive inhibitor of benzene metabolism. When benzene and toluene 
were administered in combination to rats i ntraperitoneally , their 
disappearance rates from b 1 ood and the rates of uri nary excretion of 
their metabolites were delayed compared with those observed when they 
were given separately. Their metabolic interaction was found to be 
dose-dependent (Sato and Nakajima, 1979) . Several studies have 
indicated that to 1 uene can significantly influence the myelotoxic and 
genotoxic effects of benzene . It was demonstrated that toluene protects 
against benzene-induced depression of red cell 59Fe uptake in bone 
marrow of mice (Andrews et al., 1977). Toluene not only alleviates the 
benzene-induced leukopenia but the benzene-induced increase in leukocyte 
alkaline phosphatase activity (Li et al., 1986). Toluene significantly 
decreased the adverse effects of benzene on granulopoietic stem cells 
(CFU per tibia) and on tibial bone marrow cellularity in mice (Tunek et 
al., 1981 ; 1982). When benzene-exposed mice were simultaneously given 
an ip injection of toluene, the sister chromatid exchange (SCE) 
incidence was reduced by up to 90% compared with ani rna 1 s exposed to 
benzene alone (Tice et al., 1982). Gad-El-Karim et al. (1984; 1985a; 
1986) found that toluene antagonized benzene's mye 1 ocl astogeni city and 
metabolism when mixtures of both chemicals were administered orally to 
CD-1 mice. On the other hand, toluene-induced protection against benzene 
toxicities might be related to the enhancement of detoxication 
reactions, i.e., conjugation reactions . Pretreatment of rats with 
toluene has been found to increase the in vitro liver microsomal 
metabolism of benzene (Pathiratne et al., 1986b). 
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Toluene treatment alone (at doses used) did not show the dramatic 
immunosuppresive effects of benzene . A previous study has indicated that 
alteration in immune functions of mice ingesting toluene is generally 
evident at relatively high doses (Chapter VI) . Alterations in host 
resistance to infectious microorganisms, lymphocyte and macrophage 
functions has also been noted (Aranyi et al . , 1985; Fishbein, 1985 ; 
Suleiman, 1987). Similar to the metabolite(s)-mediated mechanism of 
benzene to xi city, it has been reported that formation of cresol from 
aromatic oxidation of toluene occurs through an arene oxide intermediate 
which, in turn, is a reactive metabolite and is responsible for the 
binding of toluene to biomacromolecules (Pathiratne et al., 1986a; Bakke 
and Scheline, 1970). Superoxide anions are also formed during the 
formation of secondary metabolites, such as semiquinones and qui nones, 
from the oxidation of cresol (Pathiratne et al., 1986a). This suggests 
that covalent binding of toluene to biological macromolecules involves 
more than one reactive metabolite. However, the covalent binding effect 
of toluene to biomacromolecules is considerably less than that of 
benzene. This could account for the differences in the degree of 
immunotoxicity of toluene and benzene in this study. 
Enhancements of immune responses in the combined exposure (166 mg 
benzene + 325 mg toluene/L) group, when compared to the untreated 
control, might involve the fact that concurrent administration of 
toluene decreases benzene metabolism and results in low amounts of 
reactive oxidative metabolites of benzene. Several studies have 
indicated that low concentrations of benzene or its metabolite(s) 
possess promotive effects on the immune and hemopoietic systems (Chapter 
III; Gaido and Wierda, 1985; Garnett et al., 1983; Harigaya et al ., 
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1981). 
In conclusion, the present study demonstrates that oral ingestion 
of toluene in combination with benzene over a four-week period causes 
antagonistic effects on benzene immunotoxicity, while toluene itself 
shows no strong immunosuppressions . Since time of exposure to toluene 
relative to the time of exposure to a second chemical is quite 
important, further studies involved in the time-course of effects of 
toluene on benzene metabolism or toxicity seem to be warranted in order 
to better assess their interaction mechanisms. 
154 
CHAPTER IX 
EFFECTS OF REPEATED ORAL EXPOSURE TO COMBINATIONS OF 
BENZENE AND TOLUENE ON REGIONAL BRAIN MONOAMINE 
METABOLISM IN MICE 
INTRODUCTION 
Exposure to chemicals in combinations has received much attention . 
The possible modes by which chemicals modify the toxicity of other 
compounds include an interaction at the target site, an interaction with 
drug-metabolizing enzymes, a modification of the absorption site 
changing the body burden, or alterat i on of the chemical or physical 
characteristics of the compounds leading to an alteration in biological 
action (Mitchell, 1976; Sipes and Gandolfi, 1986). Such interactions 
may be very critical in environmental situations and the investigations 
of synergism and antagonism are important area s. 
Benzene and toluene, the major aromatic hydrocarbons, are known to 
produce numerous to xi co 1 ogi ca 1 effects on a variety of organ systems 
(Fishbein, 1984; 1985). Both compounds are extensively coemployed in 
industry, chemistry, and used as important components in gasoline. The 
potential for human exposure to one or both of these agents is great 
(U .S. National Academy of Sciences, 1982). Several in vitro or in vivo 
studies have indicated that toluene is a competitive inhibitor of the 
biotransformations of benzene (Ikeda et al . , 1972 ; Andrews et al ., 1977; 
Sato and Nakajima, 1979; Gilmour et al . , 1986), and can significantly 
alter the hematotoxic and genotoxic effects of benzene (Andrews et al., 
1977; Tunek et al., 1981; 1982; Tice et al., 1982; Gad-El-Karim et al., 
1984; 1985a; 1986). We have recently reported that toluene has an 
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antagonistic effect on benzene immunotoxicity (Chapter VIII). However, 
none of these studies involved evaluation of interaction-induced 
neurotoxicity after simultaneous exposure to the mixtures of these two 
compou nd s. Neuro l ogi cal effects produced by either benzene or toluene 
alone have been characterized (Brief et al., 1980; Evans et al., 1981; 
Benignus, 198Ja,b; Dempster et al ., 1984). Changes in regional brain 
catechol amine and indoleamine metabolisms in mice following benzene or 
toluene ingestion have also been noticed {Chapters IV and V). 
The present study was designed to assess the effects of continuous 
exposure to various levels of benzene and toluene, alone or combined, on 
concentration of regional brain monoamines and their major metabolites 
in CO-l mice. The results of this investigation should help our 
understanding of the possible mechanisms of solvent action on the 
central nervous system. 
MATERIALS AND METHODS 
Animals 
Male CO-l mice obtained from Charles River Lab. Inc. (Wilmington, 
MA) and 6 weeks old on arrival were used. After 1-week acclimatization 
in a AAALAC-accredited animal care facility with an ambient temperature 
of 21 ± J°C, a relative humidity of 50 ± 10%, and a 12 -h light-dark 
cycle (7 a.m. - 7 p.m.), animals were randomized into control and test 
groups of 5 mice each. A standard commercial rodent chow (Wayne 
Products, Chicago, IL) and water were available ad libitum throughout 
the entire experimental period. 
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Chemical Exposures 
Benzene (analytical reagent grade, 99 .9% purity ; J. T. Baker 
Chemical Co ., Philipsburg, NJ) and toluene (chromatoquality grade, 99 .7% 
purity; Burdick and Jackson Labs. Inc., Muskegon, MI) were dissolved in 
normal tap water to make the desirable concentrations. Two experiments 
were conducted . The first experiment was designed primarily to study a 
combination exposure of 200 mg benzene plus 400 mg toluene/ L. The 
results of this experiment were compared to single exposures of benzene 
(200 mg/L) and toluene (400 mg/ L) that were conducted sim~ltaneously . 
The concentration of toluene was reduced to 100 mg/L in the second 
experiment. Benzene and toluene have a solubility of 1,7BO and 535 mg/L, 
respectively, in fresh water at 25°C (U .S. Environmental Protection 
Agency, 19BO a,b) . Exposures were achieved by continuously administering 
chemical (s)-treated solutions to mice for 2B days. Water and food 
consumption was monitored continuously , and animals were weighed weekly. 
Actual concentrations of benzene and toluene were confirmed daily by gas 
chromatography (U.S . Environmental Protection Agency, 19B6b) . 
Process ing of Brain Tissues 
Twenty-eight days after continuous exposure to test material (s) , 
mice were decapitated and brains were microdissected immediately, on an 
ice-cold plate, into six discrete regions: hypothalamus, medulla 
oblongata , cerebellum, corpus stria tum , cerebral cortex and the 
remainder of the brain, midbrain, according to the procedures of 
Glowinski and Iversen (1966). The midbrain includes the hippocampus, 
thalamus and subthalamus (Coulombe and Sharma, 19B6). Each dissected 
brain region was promptly weighed in tared vials containing several 
volumes (in relation to tissue weight) of ice-cold 0. 05 M perchloric 
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aci d with 0. 1% cysteine . To overcome possible diurnal alternations in 
regional brain neurochemicals (Matsumoto et al. , 1981). All an imals of 
eac h experiment were samp 1 ed between 9:30 and 11 :30 a .m. on the same 
day . Ti ss ue samples for chromatographic analysis were prepared as 
described in the methods section of Chapter IV. 
Assay of Neurochemical s 
Brain regional concentrations of the major catecholamines 
norepinephrine (NE), dopamine (DA) , and their principal metabolites, 3-
methoxy - 4- hydroxymandelic acid (vanillymandelic acid, VMA) , 3,4-
dihydroxyphenylacetic acid (DOPAC) , and homovanillic acid (HVA); the 
indo 1 eami ne serotonin ( 5-HT) and its met abo 1 ite 5-hydroxyi ndo 1 eacet i c 
acid (5-HIAA) in perchloric acid extracts were simultaneously determ i ned 
by high performance 1 iquid chromatography with eletrochemical detection 
( HPLC - ECD) using the method s described e 1 sewhere (Mayer and So up , 
1983). The HPLC system consisted of a Model LC-150 electrochemical 
analyzer, Model LC-3A amphoter ic detector, Model LC-22A temperature 
controller, and a 250 x 4.6 nvn ODS -- 5 )Jm-- reversed phase column (Bio-
Analytic Systems Inc . ). A 0. 15 M monochloroacetate buffer (PH 3.0) 
containing sodium octyl sulfate as ion-pair reagent served as mobile 
phase . The instrument settings were : flow rate 1. 4 ml/ min, column 
temperature 30°C, detector potentia 1 +0. 7 V, contro 11 er 10 nA full 
scale, and sample volume 20 JJL . The amounts of neurochemicals were 
determined by measuring the height of the individual peaks and comparing 
them with the peak of various reference compounds (Sigma Chemical Co. , 
St. Louis , MO). The detector response provided a 1 inear correlation 
coefficient of >0.98 for the standard curves. Data were collected with a 
Hewlett - Parkard (Avondale, PA) 3390A integrator. 
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Statistical Analysis 
The concentrations of monoami nes and their met abo 1 i tes obtai ned 
from brain regions were expressed as JJg/g wet tissue. All data were 
given as mean ± SE. Analysis of variance (ANOVA) and followed-up 
Fisher's least significant differences (LSD) test were used to determine 
the statistical differences (p<0.05) of experimental data . 
RESULTS 
Concentrations of test material(s) in the drinking water mixtures 
of mice as determined by gas chromatography decreased approximately 30% 
over a three-day period, when the water was changed. Overall means of 
the daily analyses for the nominal concentrations of 200 mg/L benzene, 
100 mg/L toluene, and 400 mg/L toluene were 166 (± 9.5%), 80 (± 12%), 
and 325 (± 13.5%) mg/L, respectively. The benzene or toluene 
concentrations in the drinking water of the mixture groups were the same 
as the group treated with benzene or toluene alone. 
Repeated exposure to benzene and toluene, alone or combined, over a 
four -week period did not adversely affect growth, body weights, water 
and food consumption, nor did it elicit mortality and any other overt 
clinical symptoms of toxicity and gross treatment-related behavioral 
alterations in test animals . 
At the doses used, both benzene and toluene treatments (alone or 
combined) induced significant increases in concentrations of biogenic 
monoamines (NE, DA, 5-HT) and their major metabolites (VMA, DOPAC, HVA, 
5-HIAA) in several of the brain regions studied . Furthermore, in several 
instances, the increased metabolite concentrati ons were greater in the 
combined treatment than when either chemical was used alone . Fig. IX-1 
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and Table IX-I show the effects of chemical(s) exposures on 
concentrations of selected neurotransmitters and their metabolites in 
the hypotha 1 amus. When compared to the untreated contro 1, s igni fi cant 
increases of NE in the hypothalamus, the region containing the highest 
1 eve 1 of this amine, were found in the benzene ( 166 mg/L), to 1 uene ( 80 
and 325 mg/L), and benzene plus toluene (166 plus 325 mg/L) mixture 
groups (Fig. IX-lA). Dopamine concentrations increased significantly in 
the hypothalamus of animals treated with 166 mg/L benzene, 80 mg/L 
toluene, or 166 mg benzene + 325 mg toluene/L (Fig. IX-18). Elevated 
levels of 5-HT also appeared in this region of mice exposed to benzene 
(166 mg/L) and toluene (325 mg/L), alone or in combination (Fig. IX-
JC) . Increases of various monoamine metabolites in the hypothalamus were 
noticed and statistical differences were detected in the 166 mg/L 
benzene (HVA, 5-HIAA), 325 mg/L toluene (5-HIAA), and their combination 
groups (VMA, HVA, 5-HIAA) (Table IX - I) . 
Concentrations of monoamines and their major metabolites in the 
corpus striatum are illustrated in Fig. IX-2 and Table IX-2, 
respectively. Benzene (166 mg/L) had no obvious effects on the stri atal 
NE , while toluene increased NE at a concentration of 80 mg/L. 
Coadministration of benzene with toluene (80 mg/L) resulted in an 
increase of this neurochemical when compared to control (Fig. IX-2A). 
Increases of DA in the corpus striatum, a brain area especially rich in 
DA, were seen in animals exposed to benzene alone or its combination 
with either dose of toluene (80 and 325 mg/L) (Fig. IX-28). 
Concentrations of striatal 5-HT in animals receiving benzene and toluene 
(325 mg/L), alone or together, were significantly higher than those in 
the untreated control (Fig. IX-2C). Increases of amine metabolites in 
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Fig . IX - !. Effects of benzene and toluene, alone or combined , exposure 
on monoamine concentrations in the hypothalamus of CD-I mice. A: 
effects of chemical treatments on norepinephrine; B: effects of chemical 
treatments on dopamine; C: effects of chemical treatments on serotonin; 
BTH: exposure to 166 mg/L benzene, 325 mg/L toluene, and combination of 
benzene (166 mg/L) and toluene (325 mg/L); BTL : exposure to 166 mg/L 
benzene, 80 mg/L toluene, and combination of benzene (166 mg/L) and 
toluene (80 mg/L) . The bars (left to right), O , IZI , !ZD, and 
111, indicate treatment groups of control, benzene, toluene, and 
benzene + toluene mixture, respectively . Values are given as mean± SE 
(n•S). Stars (*) denote significant differences from control values at 
p<0 .05 . 
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TABLE IX-1 
CONCENTRATIONS OF MONOAMINE METABOLITES IN HYPOTHALAMUS OF MICE TREATED 
WITH BENZENE AND TOLUENE, ALONE OR COMBINEDa 
Concentration 
in water, mg/l 
Experiment 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
+Toluene,325 
Experiment II 
Control 
Benzene, 166 
Toluene, 80 
Benzene, 166 
+Toluene, 80 
VMA 
0.202 + 0.031 
0.275 :;: 0.054 
0.266:;: 0.037 
0.383 :± 0.045c 
0.219 + 0.042 
0.270 :;: 0.030 
0. 266 :± 0.038 
0.261 ± 0.032 
Neurochemical concentrationb 
DO PAC 
0. 224 + 0.038 
0.368 :;: 0.074 
0.351 :;: 0.054 
0.424 :± 0.048 
0.206 + 0.030 
0.338:;: 0.050 
0. 273 :;: 0.014 
0.263 :± 0.022 
HVA 
0.156 + 0.016 
0.260 :;: 0.026c 
0.243 :;: 0.025 
0.288 :± 0.03lc 
0.156 + 0.020 
0. 435:;: 0.140 
0.259 :;: 0.040 
0.259 :± 0.032 
5-HIAA 
0.316 + 0.066 
0.686 :;: 0.037c 
0.677 :;: 0.046c 
0.756 :± 0.057c 
0.601 + 0.058 
l.l80+0 . J83c 
0.836 :± 0. 175d 
0. 708 ± 0.076 
a Chemical(s) was (were) administered continuously to mice via drinking water for 
b 4 weeks. Abbreviations for various chemicals have been described in text 
In~g neurochemical/g wet brain tissue , mean± SE (n=5) 
c Significantly different from untreated control at p<O .OS 
d Significantly different from benzene treatment alone at p<O.OS 
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Fig . IX -2. Effects of benzene and toluene, alone or combined, exposure 
on monoamine concentrations in the corpus striatum. A: effects of 
chemical treatments on norepinephrine; B: effects of chemical treatments 
on dopamine; C: effects of chemical treatments on serotonin. The bars 
(left to right) indicate treatment groups of control, benzene, toluene, 
and o~nzene + toluene mixture, respectively. Values are given as mean ± 
SE (nKS). Stars (*) denote significant differonces from control value s 
at Q<0 .05. BTH : exposure to 166 mg/L benzene, 325 mg/L toluene, and 
combination of benzene {166 mg/L) and toluene (325 mg/L); BTL :exposure 
to 166 mg/L benzene, 80 mh/1 toluene, and combination of benzene (166 
mg/L) and toluene (80 mg/L). 
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this brain region were detected in the 166 mg/L benzene (VMA, HVA), 80 
mg/L toluene (VMA, HVA), and both combination groups (DOPAC, HVA) . There 
were significantly higher concentrations of striatal DOPAC and HVA in 
the benzene (166 mg/L) plus toluene (325 mg/L) and benzene (166 mg/L) 
plus toluene (80 mg/L) groups, respectively, than in the single chemical 
treatment groups (Table IX-2). 
Figure IX -3 showed the effects of benzene and toluene, alone or 
combined, on major ami nes in the cerebral cortex, midbrain, medulla 
oblongata, and cerebellum. Benzene caused increases of NE in the cortex, 
midbrain, and medulla oblongata. Toluene significantly increased NE in 
the medulla oblongata. Concurrent exposures of toluene (325 mg/L) with 
benzene (166 mg/L) reduced the benzene-induced effects on this 
neurotransmitter in the cortex and midbrain (Fig. IX-3A) . Significant 
higher concentrations of DA were also observed in the cerebral cortex of 
animals receiving both toluene doses, i.e., 80 and 325 mg/L (Fig. IX-
3B). Amounts of DA in the cerebellum, a region containing relatively low 
levels of this catecholamine, were not determined. Benzene (166 mg/L) 
increased 5-HT concentrations in the cortex, midbrain and medulla 
oblongata, while toluene-induced increases of this indo l eami ne were 
detected in the cortex and midbrain of mice treated with 325 mg/L 
toluene (Fig. IX-3C). 
Concentrations of the major metabolites of biogenic amines in the 
brain regions of cortex, midbrain, medulla oblongata, and cerebellum are 
given in Table IX-3 - IX-6. The results shown in Table IX-3 indicate 
that significant increases of the NE metabolite, VMA, were observed in 
the midbrain and medulla oblongata of mice coadministered with benzene 
(166 mg/L) and toluene (325 mg/L) as compared to the untreated control 
TABLE JX-2 
CONCENTRATIONS OF MONOAMINE METABOLITES IN CORPUS STRIATUM OF MICE TREATED 
WITH BENZENE AND TOLUENE, ALONE OR COMBINEDa 
Concentration 
in water, mg/L 
Experiment 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
+Toluene, 325. 
Experiment II 
Control 
Benzene, 166 
Toluene, 80 
Benzene, 166 
+Toluene, 80 
VMA 
0.122 ± 0.017 
0.162 + 0.010 
0.138 ± 0.010 
0.109 ± 0.012 
0.156 + 0.014 
0.249 + 0.022c 
0.199 ± 0.041c 
0.223 ± 0.037 
Neurochemical concentrationb 
DO PAC 
1.206 + 0.038 
1.425 + 0.074 
1.458 + 0.054 
1.920 ± 0.158c,d,e 
0.822 ± 0.076 
1.068 + 0.054 
1.161 + 0.058 
1. 2 4 9 ± o. 098c 
HVA 
0.930 + 0.068 
1.281 ±. 0.088c 
1. 088 + 0. 0 53 
1.272 ± 0.054c 
0.886 + 0.107 
1.209 + 0.045c 
1.280 + 0.044c 
1. 510 ± 0.066c,d,e 
5-HIAA 
0.547 + 0.069 
0.671 + 0.059 
0.582 + 0.047 
0.722 ± 0.036 
0.408 + 0.036 
0.491 + 0.056 
0.537 + 0.053 
0.564 ± 0.078 
a Chemical (s) was (were) administered continuously to mice via drinking water for 4 
weeks 
b In ~g neurochemical/g wet brain tissue, mean ± SE (n=5) 
c Significantly different from untreated control at p<0.05 
d Significantly different from benzene treatment alone at p<0.05 
e Significantly different from toluene treatment alone at p<0.05 
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Fig. IX-3 . Effects of benzene and toluene, alone or combined, exposure 
on monoamine concentrations in cerebral cortex, midbrain, medulla 
oblongata, and cerebellum. A: effects of chemical treatments on 
norepinephrine; B: effects of chemical treatments on dopamine; C: 
effects of chemical treatments on serotonin. Stars (*) and (~) denote 
significant (p<0.05) differences from untreated control and benzene 
treatment alone, respectively . Values are given as mean± SE (n•5) . 
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TABLE IX-3 
CONCENTRATIONS OF VANILLYMANDELIC ACID (VMA) IN CEREBRAL CORTEX, MIDBRAIN, 
MEDULLA OBLONGATA AND CEREBELLUM OF MICE TREATED WITH BENZENE 
Concentration 
in water, mg/L 
Experiment 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
+Toluene,325 
Experiment II 
Control 
Benzene, 166 
Toluene, BO 
Benzene, 166 
+Toluene, BO 
AND TOLUENE, ALONE OR COMBINEDa 
Cortex 
0.106 + 0.020 
0. 147 + 0.01B 
0. 131 + 0.006 
0. 132 ± 0. 009 
0.220 + 0.033 
0. 251 ± 0.015 
0.21B + 0.029 
0.224 ± 0.030 
Neurochemical concentrationb 
Midbrain 
0.085 + 0.020 
0.078 + 0.004 
0.101 + 0.005 d 
0.133 ± 0.012c, 
0.166 ± 0.033 
0. 198 + 0. 041 
0.164 ± 0. 032 
0. 167 ± 0.025 
Medulla 
oblongata Cerebell urn 
0.107 ± 0.007 0.117 ± 0.015 
0.120 + 0.003 0.099 + 0.017 
- c -0.168 ± 0.025 d 0.143 ± 0.045 
0.208 ± 0.012c, 0.152 ± 0.030 
0.150 ± 0.011 
0.178 + 0.024 
0. 212 ± 0.020 
0.235 ± 0.036 
0.121 ± 0.033 
0.132 + 0. 015 
0.164 ± 0.041 
0.137 ± 0. 018 
a Chemical(s) was (were) administered continuously to mice via drinking water for 
4 weeks 
b In ~9 neurochemical/g wet brain tissue, mean ± SE (n=5) 
c Significantly different from untreated control at p<0.05 
d Significantly different from benzene treatment alone at p<0 . 05 
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or benzene treatment alone . Toluene (325 mg/ L)-treated animals al so 
showed higher concentrations of VMA in the medulla oblongata than 
control group. Occasional increases of DOPAC and HVA , the main acid 
metabolites of DA, were detected in the cortex and medulla oblongata 
(Table IX-4 and IX-5). The effects of solvent exposures, alone or 
combined, on the concentration of the 5-HT metabolite, 5-HIAA , in these 
brain areas are illustrated in Table IX-6 . Benzene (166 mg/L) caused 
elevations of 5-HIAA in midbrain. Mice exposed to toluene (80 mg/ L) had 
higher 5- HIAA concentrations in the cortex, midbrain and medulla 
oblongata than control group . Simultaneous exposure of benzene and 
toluene raised this neurochemical in the midbrain and cortex when 
compared to the untreated control. Concentrations of 5-HIAA in the 
cortex of mice treated with benzene plus toluene (166 plus 80 mg/ L) were 
s ignificantly different from benzene treatment alone . 
DISCUSSION 
Benzene and toluene are known neurotoxicants . Alteration of 
neurotoxicity has been previously shown to occur between different 
neurotoxicants (Savolainen, 1977; Abou -Donia et al., 1985a,b) . This 
study was undertaken to i nvestigate the possible interaction effects 
between benzene and toluene, on the catecholamine and indoleamine 
metabolism. The neurochemicals selected for evaluation are known to play 
an important role in physiology and behavior (Rogawski and Baker, 1985 ; 
Poirier and Bedard, 1984). Changes in concentrations of their 
metabolites provide an appropr iate indication of neural activity 
(Commissiong, 1985). Assays in various brain regions are essential to 
detect potential perturbation s of a specific neurotran smitter(s). 
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TABLE IX-4 
CONCENTRATIONS OF 3,4-DIHYDROXYPHENYLACETIC ACID (DOPAC) IN 
CEREBRAL CORTEX, MIDBRAIN, AND MEDULLA OBLONGATA OF MICE 
TREATED WITH BENZENE AND TOLUENE, ALONE OR COMBINEDa 
Concentration 
in water, mg/L 
Experiment 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
tToluene,325 
Experiment II 
Control 
Benzene, 166 
Toluene, 80 
Benzene, I66 
+Toluene, 80 
Neurochemical concentrationb 
Cortex 
0.205 ± 0. 009 
0.232 + 0. 028 
0.273 + 0.034 
0.283 ± 0. 033 
0.137±0.005 
0. 175 ± 0.008 
0. 200 ± 0.020c 
0.193 ± O.OI9c 
Midbrain 
0.212 ± 0.031 
O.I75 ± 0.006 
0.2 I6 ± 0.040 
0.183 ± 0. 011 
0.127 ± O.OI4 
0.134 ± 0.007 
0. 117 ± 0.016 
0.169 ± 0.031 
Medulla oblongata 
0.062 ± 0.018 
0.066 ± 0.013 
0.040 ± 0.005 
0. 066 ± 0.011 
0.030 ± 0.002 
0.047 ± 0.005 
0.040 ± 0.004 
0.056 ± 0.007c 
a Chemical (s) was (were) administered continuously to mice via 
drinking water for 4 weeks 
b In ~g neurochemical/g wet brain tissue, mean ± SE (n=5) 
c Significantly different from untreated control at p<0 . 05 
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TABLE IX-5 
CONCENTRAT IONS OF HOMOVANILLIC ACID (HVA) IN CEREBRAL CORTEX , 
MIDBRAIN, AND MEDULLA OBLONGATA OF MICE TREATED 
WITH BENZENE AND TOLUENE , ALONE OR COMBINEDa 
Concentration 
in water, mg/L 
Experiment 
Control 
Benzene, 166 
Toluene, 325 
Benzene , 166 
+Toluene,325 
Experiment II 
Control 
Benzene , 166 
Tol uene , 80 
Benzene, 166 
+Toluene, 80 
Neurochemical concentrationb 
Cortex Midbrain Medulla oblongata 
0. 155 ± 0.014 0. 129 ± 0.010 0.050 ± 0.007 
0. 218 ± 0.047 0. 193 ± 0.068c 0.064 ± 0.007 
0.234 ± 0. 044 0. 178 ± 0.024 0. 054 ± 0. 008 
0.211 ± 0.018 0. 157 ± 0. 012 0.057 ± 0.006 
0. 165 ± 0.010 0. 163 ± 0. 019 0.030 ± 0.005 
0.220 ± O.Ollc 0. 194 ± 0.014 0.047 ± 0. 007 c 
0. 260 ± 0.02 1c 0. 154 ± 0. 009 0. 040 ± 0.004c 
0.256 ± 0.019c 0. 220 ± 0.026 0.056 ± 0.004c 
a Chemical (s) was (were) administered continuously to mi ce vi a 
drinking water for 4 weeks 
b In~g neurochemical/g wet brain tissue, mean± SE (n=5) 
c Significantly different from untreated control at p<0.05 
TABLE JX-6 
CONCENTRATIONS OF 5-HYDROXYINDOLEACETIC ACID (5-HIAA) IN CEREBRAL CORTEX, 
MIDBRAIN, MEDULLA OBLONGATA, AND CEREBELLUM OF MICE TREATED 
WITH BENZENE AND TOLUENE , ALONE OR COMBINEDa 
Concentration 
in water, mg/L 
Experiment 
Control 
Benzene, 166 
Toluene, 325 
Benzene, 166 
tToluene,325 
Experiment II 
Control 
Benzene, 166 
Toluene, 80 
Benzene, 166 
+Toluene, 80 
Cortex 
0.283 + 0.023 
0.361 + 0.019 
0.336 + 0.017 
0.344 :± 0.021 
0.245 + 0.010 
0.263 + 0.010 
- c 0.318 + 0.020 d 
0.305 :± o.oo9c, 
Neurochemical concentrationb 
Midbrain 
0. 550 t O.Oll 
0.705 :± 0.036c 
0.628 + 0.030 
0. 708 :± 0.025c 
0.491 + 0.020 
0.657 + 0.044c 
0.670 + 0.075c 
0.669 ± 0.043c 
Medulla 
oblongata 
0.371 + 0. 036 
0.456 :± 0.033 
0. 432 + 0.031 
0.489 :± 0.030 
0.390 + 0. 034 
0. 480 :;: 0.020 
0.513 + 0.035c 
0.449 ± 0.010 
Cere be 11 urn 
0. 167 + 0.009 
0.165 + 0.003 
0.162 + 0.017 
0. 178 :± 0.008 
0.135 ± 0.016 
0.142 + 0.011 
0.163 + 0.010 
0. 151 ± 0.003 
a Chemical(s) was (were) admin istered continuously to mice via drinking water for 
4 weeks 
b In ~g neurochem cal/g wet brain ti ss ue, mean± SE (n=5) 
c Significantly d fferent from unt reated control at p<0.05 
d Significantly d fferent from benzene treatment alone at p<0. 05 
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Recently, several studies have indicated that chemical-induced 
neurotoxicity might be related to the alterations of certain 
neurochemical (s) in certain minute brain region(s) of mice or rats 
(Coulombe and Sharma, 1985; 1986; Sharma et al . , 1986). 
Significant increases in concentrations of various biogenic amines 
and their respective metabolites in several brain regions caused by 
benzene treatment alone would be sufficient to suggest benzene-induced 
alterations in brain monoamine metabolisms. In rats a four-week 
prolonged sc administration of benzene has been shown to increase the 
contents of NE and DA in brain and other internal organs such as spleen, 
liver, and kidney (Paradowski et al., 1985), and also produced 
accumulations of both 5-HT and its metabolite, 5-HIAA, in the 
hypothalamus and corpus striatum (Paradowski et al, 1984). 
Intraperitoneal administration of benzene to mice caused increased 
striatal levels of 5-HT and 5-HIAA (Juorio and Yu, 1985a). The mechanism 
for benzene-induced changes in levels of monoamines and their 
metabolites is not yet known. Benzene produced an induction of aromatic-
L-amino acid decarboxylase (AADC) but showed no effect on monoamine 
oxidase (Juorio and Yu, 1985a) . However, due to its high enzymatic 
activity, the induction of AADC may not result in significant changes of 
endogenous monoamine levels (Cooper et al., 1986). Further 
investigations are needed to determine whether benzene alters the 
kinetics of the rate-limiting enzyme, tyrosine hydroxylase and 
tryptophan hydroxylase, in the catecho 1 amine and indo l eami ne metabolic 
pathways, respectively. 
Toluene ingestion also caused dramatic effects on brain monoamine 
metabolisms. Several studies have indicated that concentrations of 
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various brain biogenic amines are affected by acute or subchronic 
admi nistration of toluene via inhalation or ip injection to rats . Mo st 
reports sho~:ed that brain NE increased wh i 1 e DA increased or remained 
unaltered after toluene treatment (Rea et al., 1984; Andersson et al ., 
1980; 1983; Arito et al., 1984; 1985). Significant alterations in brain 
concentrations of 5-HT were a 1 so reported (Rea et a 1 . , 1984; Arito et 
al., 1984; 1985). We have recently demonstrated that toluene - induced 
increases in CNS neurotransmitter metabolisms exhibited a biphasic dose -
effect in mice (Chapter V), and that toluene, by significantly 
increasing concentrations of hypothalamic NE and a parallel trend in i ts 
major metabolite VMA, markedly stimulated the hypothalamic -pituitary-
adrenocorticol (HPA) axis, resulting in an elevated serum corticosterone 
and a decreased immune function (Chapter VII) . 
Increases in the region a 1 concentrations of brain neurochemi ca 1 s 
produced by the combined exposures , compared to the untreated control, 
indicate the absence of protective effect on monoamine - related 
neurotoxicity between benzene and toluene , at least at the doses 
administered in this study. Toluene has been shown to alleviate benzene-
induced hematotoxicity (Andrews et al ., 1977 ; Tunek et al . , 1981; 1982 ; 
Li et al . , 1986), genotoxicity (Tice et al . , 1982, Gad-El-Karim et al ., 
1984; 1985a; 1986), and immunotoxicity (Chapter VIII). Contrarily, the 
fact that concurrent administration of two compounds raised the 
concentrations of biogenic amine metabolites in few instances when 
compared to either chemica 1 treatment a 1 one suggests that there are 
marginal additive effects of the combined treatment. 
One possible explanation for these phenomena is that toluene 
competitively inhibits the biotransformation of benzene (Ikeda et al., 
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1972; Andrews et al., 1977; Sato and Nakajima, 1979; Gilmour et al. , 
1986). When benzene and toluene were administered in combination to rats 
intraperitoneally, th~ir disappearance rates from blood and the rates of 
urinary excretion of their metabolites were delayed compared with those 
observed when they were given separately (Sato and Nakajima, 1979). The 
prolonged half-life of both benzene and toluene, which have been 
reported to be readily taken up by the CNS and possess high ability to 
modify membrane environments (Baker et al., 1985), may render CNS cell 
more susceptible to the toxic effects of these organic solvents. The 
effects of two or more solvents in combination may be potentiating 
rather than additive (Savolainen, 1977). 
However, the possible role of oxidative metabolism and tissue 
binding in the CNS has been suggested as a factor for benzene and 
toluene in particular (Savolainen, 1977; Baker et al., 1985). The 
decreased concentrations of regional brain monoamines and their 
metabolites produced by phenol, a major metabolite of benzene, following 
a four-week repeated exposure in mice (Hsieh et al., 1988) together with 
the reported delayed excretion of this benzene metabolite caused by a 
sufficient amount of toluene (Sato and Nakajima, 1979) support the 
findings in the present study. Additional research on in vivo 
neurobehavioral assays, pharmacokinetics, and nervous system molecular 
events may provide relevant information to realistically evaluate 
neurotoxic mechanisms of benzene-toluene interaction. 
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SUMMARY AND CONCLUSION 
Benzene and toluene are major aromatic hydrocarbon compounds with 
enviromental and occupational significance. The basic immunotoxic and 
neurotoxic mechanIsms of these chemicals and the! r InteractIons were 
evaluated in this study by utilizing various immunological and neuro -
endocrinobiochemical parameters in CO-l mice continuously exposed to 0, 
31, 166, and 790 mg/L benzene and 0, 17, 80, and 405 mg/L toluene, 
respectively , in drinking water for four weeks . 
Benzene exposure caused a dose-dependent reduct I on In numbers of 
peripheral blood leukocytes, lymphocytes, erythrocytes and resulted in a 
severe macrocytic anemia . Splenic lymphocyte proliferation to both B 
cell and T cell mitogens (lipopolysaccharide, pokeweed mitogen , 
concanavalin A, and phytohemagglutinin) was followed by a dose -related 
biphasic responsiveness, enhanced at the lowest dose (31 mg/L) and 
depressed in the higher dosage groups (166 and 790 mg/ L) . Cell-mediated 
immunity as measured by mixed-lymphocyte culture response to allogeneic 
cells and cytotoxic lymphocyte activity to YAC-1 tumor cells exhibited a 
si milar biphasic phenomenon . Antibody production as assessed by 
enumeration of sheep red blood cell (SRBC)-specific plaque -forming 
cells (PFC) indicated a significant suppression of PFC in animals 
exposed to 166 and 790 mg/L benzene. A decrease In ant I -SRBC ant I body 
titer corresponded to the numbers of PFC. The findings indicate that 
oral ingestion of benzene produced a biologically significant alteration 
in both humoral and cellular immune responses. 
Benzene also Induced both synthesIs and catabolIsm of reg! on a l 
brain monoamine neurotransmitters . In the hypothalamus, the brain region 
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richest in NE, concentrations of NE increased by 40, 58 and 61% when 
mice received doses of 31, 166 and 790 mg/L benzene, respectively . 
Significant increases of NE were also observed in the medulla oblongata 
and cerebellum. Dopamine concentrations increased significantly in the 
hypothalamus and corpus striatum. Increases of catecholamine metabolites 
were seen in a number of brain regions: midbrain (DOPAC), corpus 
striatum (VMA, DOPAC, HVA), cerebral cortex (VMA) and cerebellum (VMA) . 
Benzene treatment significantly increased 5-HT concentr ations in the 
hypothalamus, corpus stria tum, midbrain, cerebral cortex and medulla 
oblongata . Concomitant with increases of 5-HT, 5-HIAA increased in 
hypothalamus , corpus striatum, midbra in, cerebral cortex and medulla 
oblongata . 
Toluene is not as strong an immunotoxicant as its analogue benzene . 
No effects on hemato logical parameters , including erythrocytes, 
leukocytes and their differentials were noticed . Splenocyte 
lymphopro l i ferat ion to all oant igens decreased at the 405 mg/ L toluene 
dose only . Numbers of SRBC -specific PFC decreased in the 405 mg/ L dosed 
animals, however, no significant change was observed in anti -SRBC 
antibody level . Toluene (405 mg/L) also adversely affected IL -2 
synthesis . It appeared that suppresion of immune functions of mice 
ingesting toluene was generally evident at relatively high do ses , 
except for splenic lymphocyte responses to selected mitogens. 
The maximum toluene - induced increases in brain biogenic amines and 
their metabolites occurred at a toluene concentration of BO mg/L . In the 
hypothalamus , the concentrations of NE significantly increased by 51 , 
63, and 34% in groups dosed with 17, 80, and 405 mg/L toluene, 
respectively . Increases of NE were also observed in the medulla 
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oblongata and midbrain. Correspondingly, concentrations of VMA increased 
in various brain regions . Concentrations of DA were higher in the 
corpus striatum and hypothalamus. Alterations in levels of the DA 
metabolites, DOPAC and HVA, were marginal. Toluene increased 5-HT in all 
dissected brain regions except cerebellum, and 5-HIAA levels in the 
hypotha 1 amus, corpus stria tum and cerebra 1 cortex. Noradrenerg i c and 
serotonergic neurons appeared to be highly vulnerable to toluene while 
dopaminergic neurons were rather resistant. 
The concentrarions of hypothalamic NE and VMA, plasma ACTH and 
serum corticosterone were increased following both chemical exposures. 
Comparisons of benzene-treated mice with appropriate - time -controls 
revealed that corticosterone levels were significantly higher in mice 
after 7 days ( 166 and 790 mg/L benzene) and at 28 days ( 790 mg/L of 
benzene). Toluene elevated corticosterone levels at 14 and 28 days at 
the 405 mg/L exposure. IL-2 production was suppressed in the two higher 
benzene- treated groups, while toluene decreased IL-2 synthesis at the 
405 mg/L concentration only. Results indicated that both benzene and 
toluene ingestion stimulated the hypothalamic-pituitary-adrenocortical 
(HPA) axis, resulting in elevation of corticosterone which has been 
reported to inhibit IL-2 production and impair immunocompetence. 
Toxicity of environmental pollutants may be expressed as combined 
effects of the chemicals. Benzene frequently occurs in a cocontaminated 
enviroment with toluene, a competitive inhibitor of the 
biotransformation of benzene. When coadministered with benzene (166 
mg/L), toluene (325 mg/L) completely inhibited benzene-induced 
immunotoxicity, i.e., involution of thymic mass and suppressions of both 
B- and T-cell mitogeneses, mixed lymphocyte culture response to 
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alloantigens, the ability of cytotoxic lymphocytes to lyse tumor cells, 
antibody production response to SRBC, and IL-2 secretion by Con A-
stimulated mouse T-cells. However, the low dose of toluene (80 mg/L) did 
not protect against benzene-induced depressions of immune function. The 
results demonstrate that toluene, in sufficient amounts, has an 
antagonistic effect on benzene immunotoxicity. When compared to the 
untreated controls, mice given the combined treatments of benzene and 
toluene exhibited elevated regional concentrations of brain amines and 
their metabolites in several brain regions. Increased concentrations of 
biogenic amine metabolites in a few brain regions were greater in the 
combined exposures of benzene and toluene than when either chemical was 
used alone; there was a marginal additive effect between these two 
types of neurotoxicants. 
The present study demonstrates that both benzene and toluene 
possess the potential for inducing immunotoxic and neurotoxic effects in 
CO-l mice following four weeks of continuous exposure via drinking 
water. Of particular importance was the fact that the neurotoxic effects 
were evident at the lowest dose of benzene or toluene treatment, and a 
no-effect level could not be established. Further studies involving 
lower levels of exposure are necessary to fully assertain the safety of 
these compounds in drinking water. The results of combination studies 
suggest that benzene i mmunotoxi city is mainly due to action of the 
reactive metabolites, whereas benzene neurotoxicity results from benzene 
itself. In addition, both benzene and toluene have, at least partially, 
an additive negative effect on immune function via the activated HPA 
axis. 
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